The effects of oestradiol-17beta on protein synthesis in the immature rat uterus by Beaumont, Joanne Mary
 
 
 
 
 
 
 
https://theses.gla.ac.uk/ 
 
 
 
 
Theses Digitisation: 
https://www.gla.ac.uk/myglasgow/research/enlighten/theses/digitisation/ 
This is a digitised version of the original print thesis. 
 
 
 
 
 
 
 
 
Copyright and moral rights for this work are retained by the author 
 
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge 
 
This work cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the author 
 
When referring to this work, full bibliographic details including the author, 
title, awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten: Theses 
https://theses.gla.ac.uk/ 
research-enlighten@glasgow.ac.uk 
THE EFFECTS OF OESTRADIOL-17^ 
ON PROTEIN SYNTHESIS IN 
THE IMMATURE RAT UTERUS
Joanne Mary Beaumont B.A.
Thesis submitted for the Degree 
of Doctor of Philosophy
Faculty of Science 
University of Glasgow
Department of Biochemistry, April 1982
ProQuest Number: 10644184
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uesL
ProQuest 10644184
Published by ProQuest LLO (2017). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLO.
ProQuest LLO.
789 East Eisenhower Parkway 
P.Q. Box 1346 
Ann Arbor, Ml 48106- 1346
TABLE OF CONTENTS
Page
Acknowledgements i
Abbreviations ii
Summary iii
h. INTRODUCTION 1
1.1 Steroid hormones 1
1.2 The mechanism of action of steroid hormones 1
1.3.1 The oestrogen receptor 3
1.3.2 Heterogeneity of oestrogen-binding sites 4
1.3.3 Binding of oestrogen to the cytoplasmic receptor 6
1.3.4 Translocation of the steroid receptor complex
to the nucleus 1 1
1.4 Nuclear acceptor sites 14
1.5 Transcriptional effects of oestrogen and other steroids 21
1.5.1 Changes in chromatin structure 21
1.5.2 Oestrogen-induced transcription in chick oviduct 26
1.5.3 The oestrogenic response in immature rat uterus 30
1.6 Differential responses of uterine cell types to oestrogen 40
1.7 The aim of the project 42
^  MATERIALS AND METHODS 43
MATERIALS 43
2.1 Suppliers 43
2.2 Experimental animals 44
2.3 Glassware 44
2.4 Radiochemicals and liquid scintillation counting 45
EXPERIMENTAL METHODS 45
2.5 Preparation of samples 45
2.5.1 The preparation of radioactively labelled
proteins in whole uteri 45
2.5.2 Determination of radioactivity in protein samples 47
Page
2.5.3 Protein assay 47
2.5.4 Fractionation of uterine cell types 48
2.5.5 Microscopic examination of cell samples 51
2.5.6 Labelling of uterine cell-type proteins 51
2.5.7 Isolation of uterine polyribosomes 51
2.5.8 The preparation of polyribosomes from fractionated
uterine cell types 53
2.5.9 Cell-free translation assays 54
2.5.10 Preparation of protein samples for cofractionation
with labelled uterine proteins on two-dimensional gels 55
a Rabbit skeletal muscle actin 55
b Rat leg muscle actin 56
c Induced protein (IP, creatine kinase) 56
d Uterine chromatin proteins 56
e Rat liver hnRNP particle proteins 57
f Ribosomal proteins 58
2.6 Two-dimensional gel electrophoresis of samples 59
2.6.1 The O'Farrell gel system 59
2.6.2 First dimension isoelectric focussing gels 59
2.6.3 First dimension non-equilibrated pH gradient
electrophoresis 61
2.6.4 Second dimension sodium dodecyl sulphate,
polyacrylamide gels 62
2.6.5 Two-dimensional polyacrylamide gel electrophoresis
of ribosomal proteins 64
2.6.6 Fluorography 65
h. RESULTS 66
3.1 The detection of labelled uterine proteins from
immature rats 6 6
3.2 The investigation of proteins synthesised in vitro
in whole uteri 6 6
3.3 The investigation of the protein population
of isolated cell types 71
3.4 The investigation of uterine proteins synthesised
in vitro by cell-free translation systems 78
3.4.1 The choice of translation system 78
Page
3.4.2 Cell-free translation directed by total
uterine polysomes 80
3.4.3 Cell-free translation directed by polysomes isolated
from fractionated cell types 82
3.5 Cofractionation of known proteins with labelled
uterine samples 84
3.5.1 The contribution of the cofractionation technique
to the identification of uterine proteins 84
3.5.2 Cofractionation of uterine protein samples with actin 85
3.5.3 Cofractionation of labelled uterine proteins
with IP (creatine kinase) 8 6
3.5.4 Cofractionation of MDL translation products with
non-histone chromatin proteins 87
3.5.5 Cofractionation of MDL translation products with
hnRNP particle proteins 8 8
3.5.6 Cofractionation of MDL translation products with
ribosomal subunit proteins 89
4. DISCUSSION 91
REFERENCES 110
LIST OF FIGURES
FIGURE
(i) pH gradient of an isoelectric focusing gel
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
Electrophoresis of L-[U-^^C]-labelled uterine 
proteins on two-dimensional polyacrylamide gels
Electrophoresis of L-[U-^^C]-labelled uterine 
cytoplasmic proteins from rats responding to short 
periods of oestrogen stimulation.
Electrophoresis of L-[U-^^C]-labelled uterine 
cytoplasmic proteins from rats responding to 0  & 1 2  
hours of oestrogen stimulation
The effect of oestradiol-17^ on polysome profiles 
of immature rats
Electrophoresis of L-[U-^^C]-labelled uterine 
nuclear proteins from rats in various hormonal 
states
Transmission electron microscopy of fractionated 
cell types
Electrophoresis of proteins from L-[^^S]-labelled 
fractionated cell types
Electrophoresis of L-[^^S]-labelled uterine cell 
type proteins from immature rats responding to 4 
hours of oestrogen treatment
Electrophoresis of L-[^^S]-labelled uterine cell 
type proteins fractionated from pre-labelled uteri
Electrophoresis of L-[U-^'^C]-labelled uterine cell- 
type proteins, fractionated from pre-labelled uteri
Staining patterns of control cell-type proteins
Electrophoresis of MDL translation assays directed 
by total uterine polysomes from rats in various 
hormonal states
Comparison of MDL translation products of polysomes 
from uteri responding to short periods of oestrogen 
treatment with total L-[U- C]-labelled uterine 
protein
Fluorograms of MDL translation products of 
polysomes isolated from fractionated uterine cell 
types
Translation products of epithelial cell-type 
polysomes from uteri responding to 1 2  hours 
oestrogen treatment
Facing
Page
61
Following
Page
66
68
69
69
70
71
72
73
75
77
77
80
81
83
83
Following
Page
16. Cofractionation of rabbit muscle actin with L-[U-
C]-labelled uterine proteins on two-dimensional 
gels 85
17. Cofractionation of rat leg muscle actin with L-[U-
C]-labelled uterine proteins 85
18. Cofractionation of purified rat brain IP with
labelled uterine proteins 8 6
19. Cofractionation of purified rat uterine chromatin
proteins with labelled uterine proteins 87
20. Cofractionation of rat liver hnPNP particles with
MDL translation products using NEpHGE 8 8
21. Cofractionation of small ribosomal subunit proteins
with MDL translation products of uterine polysomes 89
22. Cofractionation of large ribosomal subunit proteins
with MDL translation products of uterine polysones 90
(i)
Acknowledgements
My thanks are due to Professors R.M.S. Smellie and A.R. Williamson 
for making the facilities of the Department of Biochemistry available 
for this work. The people who have helped are innumerable, but I must 
thank the staff of the animal house in particular, for their constant 
supply of rats, often at a moment's notice. I must also mention Mike 
McGarvey who contributed the ribosomal proteins, Ian Kennedy who ran 
the ribosomal gels, and Ian Montgomery who performed the electron 
microscopy. Wolfgang Schuch kindly taught me to prepare and run 
reticulocyte lysate translation assays. I acknowledge the financial 
support of a Research Studentship from the U.K. Medical Research 
Council.
I am indebted to Dr. J.T. Know 1er for accepting me into his lab. and 
for his friendly help and excellent advice throughout the course of 
this project. I would also like to thank all my friends, especially 
Andrew, Mary, Rob, Andy, Wajeeh and Riona for their encouragement and 
for all our discussions, but also for being so considerate in helping 
to control my allergic reaction to rats.
This thesis was completed after taking up a Research Fellowship at the 
Department of Pharmacy, University of Strathclyde, and I should like 
to thank Dr. Carolyn Converse for her sympathetic response to my 
divided attentions.
Finally my deepest gratitude goes to my husband Steve for his 
encouragement, patience, understanding and support throughout all my 
studies. In particular, he has borne most of the work that went into 
producing this thesis, by typing and editing the manuscript and by 
undertaking all the photography. Only he knows how difficult this has 
been.
(ii)
Abbreviations
The abbreviations recommended by the Biochemical Journal in its 
Instructions to Authors, 1981, have been used throughout this thesis 
with the following additions:-
Oestradiol-1^6 1,3,5,(10)-estratriene-3,l^G-diol
IP
hnRNA
hnRNP
MDL
PPO
DMSO
TEMED
lEF
NEpHGE
Induced protein
heterogeneous nuclear ribonucleic acid 
heterogeneous nuclear ribonucleoprotein 
messenger-dependent rabbit reticulocyte lysate 
2 ,5-diphenyloxazole 
d imethyIsulphox ide 
N,N,N' ,N '-tetr ame thy le thy lene d iamine 
isoelectric focussing
non-equilibrated pH gradient electrophoresis
 ^JLJLJ.;
SUMMARY
A number of previous studies have built up a picture of the early 
events in the oestrogenic response of the immature rat uterus. This 
consists of an overall growth and development of the tissue preparing 
it to support a pregnancy. The most important requirement in this 
chain of events is the massive increase in protein synthesis as the 
lining of the uterus differentiates and proliferates. This requires 
the synthesis of large numbers of new ribosomes. The evidence suggests 
that this synthesis is preceded by and is dependent on stimulated 
hnRNA synthesis which is detectable 30 minutes after giving the 
hormone. It is apparently vital that messenger sequences present in 
this hnRNA be translated before the stimulation of ribosomal RNA can 
occur. Hybridisation studies suggest that the proteins eliciting this 
response are encoded by a small number of moderately abundant 
messenger sequences, all of which appear in the polysome population 
between 2 and 4 hours after oestrogen administration.
This project set out to detect and characterise these proteins by 
radio-labelling immature rat uteri in vitro after short periods of 
oestrogen stimulation vivo and analysing the protein species by two 
dimensional gel electrophoresis and fluorography.
The three approaches adopted were the labelling of whole uteri in 
vitro; the labelling of fractionated epithelial, stromal and 
myométrial cells in vitro; and the translation of uterine polysomes in 
cell free systems. These three methods, yielded different information. 
Whole uteri labelled ju vitro showed very little difference between 
the protein populations from control and stimulated animals, although 
analysis of their polysome profiles showed the translational statuses
(iv)
of the two groups of uteri to differ greatly.
The study of fractionated cell type proteins revealed a differential 
response to the hormone. Epithelial cells showed relatively small 
quantitative differences between the control and hormone-treated 
uteri, but at least three new proteins were reproducibly detected as 
radioactive spots. Stromal protein synthesis was strongly stimulated 
after four hours of oestrogen treatment and in addition to the 
quantitative changes, some further qualitative changes were also 
detected. Nine new species were seen in response to oestrogen 
treatment and the labelling of a number of other species was strongly 
enhanced. Little data wer<e collected on the response of the myometrium 
which, showed lower levels of radioactive incorporation, and fewer 
protein species than the other two fractions examined.
Cell-free translation revealed a number of changes in the protein 
population during the first four hours of stimulation. The synthesis 
of at least ten proteins was stimulated 2  hours after oestrogen 
administration although only five of these were totally reproducible. 
Further changes were observed by 4 hours after treatment. 
Unfortunately, none of the new proteins detected by cell-free protein 
synthesis could be identified with oestrogen-induced species in 
intact, isolated cells. However, the possible identity of some of the 
proteins synthesised in increased quantities by polysomes from 
oestrogen-treated rats was investigated. These experiments established 
the presence of actin and IP, an induced protein, in the uterine 
protein population. None of the stimulated uterine protein species 
comigrated with a number of other candidate proteins, including non­
histone chromatin protein and hnRNP particle protein, however, the 
presence of low levels of ribosomal proteins was established. The
(V)
results obtained by each method are assessed, discussed and compared 
with results from other systems. It is thought that the bulk of early 
induced proteins we sought to identify was., present in quantities too 
small to be detected using the methods employed in this study.
INTRODUCTION
1. INTRODUCTION
1.1 Steroid Hormones
The complex processes of growth and differentiation in animals require 
control signals to coordinate these developments. Hormones are the 
chemical messengers which perform this function and in particular, it 
is steroid hormones which bring about long term changes in the 
macromolecular synthesis patterns of their target cells. This has led 
to a great deal of interest in the mechanism of steroid action as a 
handle to further the understanding of the control of gene expression.
Steroid hormones are derived from the 27-carbon compound cholesterol. 
The removal of a Cg side chain results in the C 2 1  compound 
pregnenolone, which is the precursor of progesterone. This in turn can 
be converted into the corticosteroids (glucocorticoids and 
mineralocorticoids) in the adrenal cortex, and the androgens which are 
made in the testis. Androgens are also made in the ovary where they 
are converted into the 18-carbon oestrogens by loss of a carbon atom,
1.2 The mechanism of action of steroid hormones.
Steroids are transported from their site of synthesis bound to plasma 
proteins in the blood. They do not appear to be excluded from any cell 
types in the body and enter the cell, probably by passive diffusion 
across the plasma membrane. They are retained only in the cells of 
their target tissues by binding to specific cytoplasmic receptor 
molecules (Jensen & DeSombre,. 1972; Gorski & Gannon, 1976). In general 
the steroid binding molecules are heat labile and non dialyzable and 
their protein nature has been demonstrated by their sensitivity to 
proteolytic enzymes (Toft & Gorski, 1966). They are characterised by
high affinity for steroids (K^ and are found in both
cytoplasm and nuclei of target cells (Jost, 1978). The hormone 
receptor complex is translocated to the nucleus where it binds to the 
chromatin and induces specific gene transcription. This two step 
mechanism of action was originally observed for oestrogens {Jensen et 
al., 1968; Jensen & DeSombre, 1972), but has been shown to be general 
and can be demonstrated for progesterone {Schwartz et al., 1976; 
Buller et al., 1976a), androgens (Mainwaring & Pfeterken, 1971; Bullock 
& Bardin, 1974) mineralocorticoids {Edelman et al., 1968) and 
glucocorticoids (Baxter et al., 1972; Higgins et al., 1973a; Rousseau 
et al., 1973).
In a number of target tissues, steroids stimulate the synthesis of 
major new secretory proteins. These are .valuable markers for 
monitoring the control and kinetics of the response and have enabled 
specific probes to be made with which to study the genes that specify 
such proteins. The most extensively studied of these systems is the 
chick oviduct. Oestrogen treatment of immature female chicks causes 
development of the tubular gland cells of the oviduct and these 
secrete the major egg-white proteins, ovalbumin, conalbumin, lysosyme 
and ovomucoid (O'Malley et al., 1969). It has been shown that 
oestrogen treatment causes an increase in the level of the messenger 
RNA species coding for these proteins (Means et al., 1972; Palmiter, 
1973; Rhoads et al., 1973; McKnight et al., 1975). Progesterone also 
stimulates the levels of conalbumin and ovalbumin messenger RNA in 
oestrogen-primed birds and induces another egg-white protein, avidin 
(Chan et al., 1973; McKnight et al,, 1975; Palmiter et al., 1976)
Another much-studied system is the induction by oestrogen of the egg- 
yolk protein precursor, vitellogenin, in the H v e r s  of the toad
Xenopus laevis (Clemens, 1974; Tata, 1976) and chicken (Jost et al., 
1978; Ryffel, 1978), Androgens have been shown to stimulate specific 
messenger RNA and protein synthesis in rat ventral prostate 
(Mainwaring et al., 1974; Parker & Scrace, 1978) and to stimulate both 
specific and total protein synthesis in the rat seminal vesicle 
(Higgins et al., 1976; Higgins & Burchell, 1978; Ostrowski et al., 
1979). A number of secreted proteins have been shown to be regulated 
at the transcriptional level, and this occurs as part of a general 
stimulation of the synthesis of all classes of RNA and subsequently 
of general protein synthesis. This is similar to the effect of 
oestrogens on mammalian uteri where RNA and protein synthesis are 
stimulated and the organ hypertrophies. Oestrogens and progesterone 
have been shown to exert some translational control in the chick 
oviduct (Palmiter, 1972; Robins & Schimke, 1978; Pennequin et al.,
1978), but the major effect is at the level of stimulated 
transcription. The following sections will expand on the mechanism of 
action as it is known for oestrogen, comparing this with other 
hormones.
1.3.1 The Oestrogen receptor.
This was first characterised by Toft & Gorski (1966) in uterine 
tissue. Cells of the newborn rat uterus contain receptor at low 
levels, which increase to a maximum at about day 1 0  and remain nearly 
constant until the onset of puberty at 28 days (Clark & Gorski, 1970; 
Barbanel & Assenmacher, 1980). There are about 15-20,000 cytoplasmic 
receptor sites per cell (Clark et al., 1978a), although estimates as 
low as 6 , 0 0 0  and as high as 1 0 0 , 0 0 0  per cell have been reported 
(Jensen & DeSombre, 1972; Leake, 1976). The protein is a single 
polypeptide with a molecular weight of approximately 80,000, having a 
single hormone binding site (Notides & Nielsen, 1974). Toft & Gorski
(1966) isolated the receptor in association with radioactively 
labelled oestradiol-17^ on sucrose gradients of low ionic strength. 
Under these conditions, the sedimentation coefficient can vary from 
7-9S, although 8 S is the usually reported value. Sucrose density 
centrifugation generates a wide variety of sedimentation coefficients 
depending on the salt concentration used during extraction and 
sedimentation (Chamness & McGuire, 1972) but it is generally accepted 
that the cytoplasmic form of the oestrogen receptor exists in 4S form. 
In common with other steroid receptors it has a tendency to aggregate 
and to bind other proteins in tissue homogenates (Stancel et al., 
1973).
1.3.2 Heterogeneity of oestrogen-binding sites •
It has long been known that oestrogen binds to sites in the cell other 
than the classical receptor (Erdos et al., 1969; Best-Bolpomme et al., 
1970; Steggles & King, 1970). Usually these have been discounted as 
serum albumin or cx-fetoprotein (Michel et al., 1974). Further study 
by Clark and his co-workers, however, has characterised these sites in 
both cytoplasm (Eriksson et al., 1978) and nucleus of rat uterus 
(Markaverich & Clark, 1979). Type I sites represent the classical 
oestrogen receptor, having high affinity (Kj^'^lnM) and low capacity 
(Ipmol/uterus) in the cytosol and are translocated to the nucleus 
after an injection of oestradiol. Cytoplasmic Type II sites are 
present in four times the concentration and have an affinity for 
oestradiol about 40 times lower than that of the Type I sites (K^ 
30nM). This means that they are undetected by low concentrations of 
tritiated oestradiol and release labelled hormone during sucrose 
gradient centrifugation. However, they can be detected by post 
labelling gradients and sediment at the 4S position (Clark et al., 
1978b). Type II sites are not found in blood and persist in adult
rats; they are therefore distinct from the serum albumins and o(- 
fetoprotein. Up to 50% of oestrogen bound in the uterus is distributed 
between these secondary sites (Peck et al., 1973). Although their 
function is not known it m a y  be that Type II sites serve to 
concentrate oestrogen in the target cells.
Type II nuclear oestrogen-binding sites do not originate from either 
Type I or Type II cytoplasmic sites. They also have a lower affinity 
for oestradiol (Kg 10-30nM) and exist in higher concentrations than 
the Type I sites. They are stimulated by oestradiol and high levels 
may be maintained for up to 72 hours after a single oestradiol 
injection, whereas Type I sites decline to low levels by 24 hours 
(Markaverich & Clark, 1979). Markaverich & Clark observe that 
oestrogen stimulation of these sites is highly correlated with the 
long term uterine growth responses, but not with early responses. 
Their increase is dependent on long term ( > 6  hours) nuclear occupancy 
by Type I sites and thus weak oestrogens such as oestriol which do not 
elicit the full growth response, also do not stimulate either the long 
term retention of Type I sites or elevated levels of Type II sites. 
The observation that nuclear type II sites are absent from target 
tissues such as pituitary and hypothalamus, which do not grow in 
response to oestrogen, supports the premise that they are involved in 
growth responses (Kelner & Peck 1981).
Smith Sc Taylor (1981) have recently shown that an oestrogen-binding 
site distinct from the classical receptor, but which is translocated 
into the nucleus by oestrogen, mediates the effect of the receptor (X) 
on ovalbumin mPNA induction. This second receptor (Y) is absent from 
unstimulated oviduct and its disappearance from hormone-treated 
oviduct can be achieved by using the drug Danazol. In the presence of
Danazol, X is unaffected and oestrogen stimulates both its 
translocation and RNA polymerase II activity. The absence of Y 
however, is correlated with the decreased transcription of ovalbumin 
mRNA after oestrogen stimulation.
Secondary binding sites for oestrogen have now been described for rat 
and guinea-pig uterus (Capony & Rochefort, 1978; Sumida & Pasqualini, 
1979), mouse and human mammary tissue (Watson & Clark, 1980; Panko et 
al., 1981), chick oviduct (Smith et al., 1979) and rabbit corpus 
luteum (Yuh & Keyes, 1979). Multiple binding sites have also been 
described for glucocorticoids (Barlow et al., 1979; Do et al., 1979), 
for progesterone (Giannopoulos & Munowitz, 1980) in a variety of 
tissues and for aldosterone (Farman et al,, 1978). These findings 
suggest that secondary binding sites for steroids are a general 
phenomenon.
1.3.3 Binding of oestrogen to the cytoplasmic receptor 
The binding of steroid hormones to their receptors results in 
increased affinity for nuclei, chromatin and DNA, which is believed to 
be caused by an allosteric effect (Jensen et al., 1969; Samuels & 
Tomkins, 1970; Yamamoto & Alberts, 1974). In the case of the oestrogen 
receptor only, there is also an increase in the sedimentation 
coefficient, from 4S to 58. These changes are termed 'activation' or 
'transformation' in the literature. To avoid confusion in the case of 
the oestrogen receptor, Gschwendt & Kittstein (1980) have suggested 
that 'activation' be reserved for the increase in affinity for nuclear 
components and that 'transformation' should be used to describe the 
increase in sedimentation coefficient. They have shown that for the 
oestrogen receptor in chick oviduct, activation, measured as increased 
affinity for DNA-cellulose, can be achieved by high salt treatment
with no accompanying increase in receptor size. Work on the rat 
uterine oestrogen receptor confirms that the two processes are 
separable and occur at different rates with different orders of 
reaction , 4S & 5S receptors recovered from gradients show equal 
proportions of activated receptors thus disproving the possibility 
that inactive 4S receptors are transformed to active 5S receptors in a 
single step (Bailly et al., 1980).
Activation is a temperature dependent process for all steroid hormone 
receptors. When the hormones are incubated at low temperatures (0- 
4°C), either with target cells or with cytosols from such cells, they 
form 'non-activated' complexes that do not bind nuclei (King & 
Mainwaring, 1974). As shown originally with oestrogens (Jensen et al., 
1972) and subsequently for glucocorticoids (Munck et al., 1972; Baxter 
et al., 1972), if these cytosols are warmed to 20-37°C in the absence 
of nuclei the complexes become activated and will then bind nuclei 
even at low temperatures. Activation can also be brought about by 
increased ionic strength (Williams, 1974; Baxter et al., 1972; Higgins 
et al., 1973b; Kalimi et al., 1973), gel filtration, dilution (Goidl 
et al., 1977), and in the case of the oestrogen receptor, by dialysis 
(Sato et al., 1979). This last treatment is of interest since it does 
not require the presence of hormone, and suggests the oestrogen 
receptor is bound by a low molecular weight inhibitor of activation. 
Evidence for similar inhibitors of glucocorticoid (Goidl et al., 1977; 
Bailly et al., 1977), progesterone (MacDonald & Leavitt, 1982) and 
androgen (Sato et al., 1980) receptor activation have also been 
reported . This agrees with Notides' (1978) model of oestrogen 
receptor activation in which he predicts such an inhibitory molecule 
from kinetic data. It is not known if activation occurs immediately as 
a result of hormone binding in vivo or if a nonactive complex is
formed first. In the case of the glucocorticoid-receptor complex, 
Munck and Foley (1979) argue that a nonactive complex is an obligatory 
short-lived intermediate. This may indicate a step in which the 
inhibitor is released.
The hormone-binding capacity of receptors decreases after activation 
and it is possible that activation involves a conformational change in 
the receptor causing steric hindrance at the steroid binding site. 
This could slow down the dissociation of hormone from complexes and 
prevent the steroid-binding by free receptors. High salt or elevated 
temperature activation have been shown to inactivate free 
glucocorticoid receptors to a form incapable of binding free steroid 
(McBlain & Shyamala, 1980). The low molecular weight factors have been 
implicated in this process and some authors have suggested that they 
include a shortlived reducing activity (Leach et al., 1979, 1982? 
Nishigori & Toft, 1980; MacDonald & Leavitt, 1982). Reduced sulphydryl 
groups are required for optimal steroid-binding by some receptors and 
this is stabilised by reducing agents such as EDTA and dithiothreitol 
(Rees & Bell, 1975; Sando et al,, 1979; MacDonald & Leavitt, 1982). 
The loss of steroid receptor hormone-binding capacity can be prevented 
by the metal oxyanion molybdate and in some cases by tungstate and 
vanadate (Leach et al., 1979; Nishigori & Toft, 1980; Noma et al., 
1980; Shyamala & Leonard, 1980; Dahmer et al., 1981). In stabilising 
the nonactivated receptors these substances inhibit receptor 
transformation and may interfere with the dissociation of the low 
molecular weight inhibitors. An example is the case of the mouse 
mammary glucocorticoid receptor, where molybdate causes the 
nontransformed receptor to sediment at 7-8S instead of the 45 form 
usually found (McBlain et al., 1981).
since molybdate, tungstate and vanadate are phosphatase inhibitors, it 
has been suggested that a phosphorylation process is involved in 
steroid-binding and the activation of receptors (Shyamala & Leonard, 
1980? Nishigori & Toft, 1980). Recently Auricchio et al. (1981a) have 
demonstrated that the oestrogen-binding capacity of the receptor can 
be activated in vitro by an ATP-dependent enzyme isolated from uterine 
cytosol. A nuclear phosphatase causes the release of oestrogen in 
vitro, from both cytosolic and nuclear steroid-receptor complexes 
(Auricchio et al., 1981b,c). Their observation that the phosphatase is 
ineffective in releasing the antioestrogens nafoxidine and tamoxifen 
has led them to propose that this explains the long-term nuclear 
retention of non-steroidal antioestrogens in intact cells (Auricchio 
et al., 1981c). A dephosphorylating process which releases 
glucocorticoids from cytosolic receptor complexes has also been 
demonstrated (Wheeler et al., 1981). Furthermore, the chick 
progesterone receptor has been shown to be a substrate for 
heterologous phosphorylases, and phosphatase inhibitors prevent the 
loss of the receptor hormone-binding activity vitro (Weigel et al., 
1981). Thus a number of factors and processes may modulate the 
activation of all types of steroid hormone receptor.
The binding of the hormone may elicit a change in conformation that in 
part causes the transformation of the oestrogen receptor from the 4S 
to the 5S form. However much evidence has built up to show that this 
is a second order reaction involving another molecule as well as the 
hormone-receptor complex (Yamamoto & Alberts, 1972? Yamamoto, 1974; 
Thrower et al., 1976; Murayama et al., 1980). The binding of this 
factor increases the molecular weight of the complex by 50,000, from 
80,000 to 130,000. This factor was recently characterised by Thampan & 
Clark (1981) in rat uterine cytosol. They reasoned that the receptor
10
activating factor might be similar to cytoplasmic proteins which 
stimulate eukaryotic RNA polymerases. These are basic proteins which 
are not adsorbed onto DEAE-cellulose and have a sedimentation 
coefficient of about 3S (Seifart et al,, 1973). Indeed, the fraction 
of cytosol which did not bind DEAE-cellulose was found to contain a 
protein with these properties, which was shown to bind to the 4S 
oestrogen-receptor complex although it did not bind oestrogen alone. 
This protein caused activation and transformation to the 5S receptor 
form, which could then bind uterine nuclei, DNA-cellulose and native 
calf thymus DNA, It is possible that the function of the receptor is 
to translocate this factor to the nucleus where it stimulates 
transcriptional events (Thrower et al., 1976; Thampan & Clark, 1981). 
It is interesting that the binding of a similar factor has not been 
demonstrated for other steroid hormones. For example, the progesterone 
receptor isolated from exactly the same protein environment as the 
oestrogen receptor shows no increase in size when activated. This has 
been shown for rabbit and rat uterus, and in chick oviduct 
(Fleischmann & Beato, 1979; Bailly et al., 1980; Gschwendt & 
Kittstein, 1980).
It is not entirely clear whether oestrogen receptor transformation 
occurs in the cytoplasm or in the nucleus. Whilst transformation can 
occur in the absence of nuclei (Jensen et al., 1971) it occurs much 
more rapidly in the presence of DNA (Yamamoto, 1974). In addition, 
pulse chase experiments by Si iter i et al. (1973) have shown a nuclear 
48 form which decreases as the 58 form increases. Kinetic evidence 
which shows the disappearance of cytoplasmic 48 hormone-receptor 
complexes, coincident with the appearance of nuclear 58 complexes, 
indicates that the 48 and 55 forms are related (Shyamala & Gorski, 
1969; Giannopoulos & Gorski, 1971). This is confirmed by sedimentation
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studies which show that the isolated 5S hormone-receptor complex 
sediments at 4S in the presence of urea (Notides & Nielsen, 1974). In 
addition, antisera raised against calf uterine nuclear receptor cross- 
react with both cytoplasmic and nuclear receptors from rat uterus 
(Greene et al., 1977).
1.3.4 Translocation of the steroid-receptor complex to the nucleus 
Nuclear concentration of receptor-bound steroid was one of the 
earliest observations in the study of receptor function (Noteboom & 
Gorski, 1965; King & Gordon, 1966; Maurer & Chalkley, 1967; Stumpf, 
1968a), However the translocation step in steroid action is poorly 
understood. There is an absolute requirement for the specific steroid 
and it is reported not to be energy dependent or protein synthesis 
dependent (Shyamala & Gorski, 1969). However there is some work which 
indicates that ATP is involved in alleviating the effects of a 
macromolecular inhibitor of translocation of glucocorticoid receptors 
(Horiuchi et al., 1981), and the level of nuclear binding of 
corticosteroids is related to the cellular ATP level (Sloman & Bell, 
1976). Nuclear binding of the oestrogen-receptor complex is enhanced 
by incubating with ATP (King et al., 1971), and progesterone receptor 
complexes will bind ATP-sepharose (Miller & Toft, 1978; McBlain et 
al., 1981). Thus although its function seems unclear, ATP may be 
involved in steroid receptor function. There are frequent reports of 
factors (both macromolecular and of low molecular weight) inhibiting 
translocation and nuclear binding. Inhibitors of glucocorticoid and 
oestrogen receptor translocation have been described as both protein 
and RNA (Chamness et al., 1974; Andre & Rochefort, 1975; Milgrom & 
Atger, 1975; Simons et al., 1976; Cake et al., 1978; Isohashi et al., 
1980; Feldman et al., 1981).
12
It has been suggested that steroid receptors are metalloproteins, and 
that activation causes an allosteric change, involving the altered 
availability of the metal ions, which are important in the 
translocation process (Schmidt et al., 1981). This hypothesis is based 
on the finding that 1 ,1 0 -phenanthroline, a metal-ion chelating 
compound, inhibits the binding of glucocorticoid receptors to DNA- 
cellulose. The effect is not due to the chelation of free metal ions, 
or to damage to the DNA, Furthermore, the inhibitor causes activated 
receptor complexes to elute from DEAE-cellulose as if they are 
nonactivated. The results from this study suggest that the metal ions 
are integral parts of the receptor protein, and are directly 
associated with a DNA binding site or regulate it allosterically. 
There is also evidence that the oestrogen receptor is a metalloprotein 
(Shyamala, 1975) and that phenanthroline inhibits the binding of 
progesterone receptors to nuclei (Lohmar & Toft, 1975). It has been 
suggested that molybdate may stabilise steroid-free receptors by 
interaction with a heavy metal (Nishigori & Toft, 1980).
The exact mechanism of translocation is unclear, most authors 
attribute it to the increased affinity of the stero id-r eceptor complex 
for a nuclear component. Gannon et al. (1976) propose an elegant model 
based on the work of Horowitz & Moore (1974) on the intracellular 
movements of solutes. They hypothesised that not all of the water 
present in the cell may be available to solutes due to the existence 
of gels of macromolecular cellular constituents. These would make a 
large proportion of the cytoplasmic water unavailable as a solvent, 
and act as molecular sieves preventing free access. of solutes to all 
areas of the cell. The cytoplasmic exclusion model suggests that the 
receptor is loosely bound to a cytoplasmic molecule preventing its 
movement into the nucleus. Binding of the hormone causes an allosteric
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change releasing the receptors so that they can equilibrate with the 
larger water space available in the nucleus.
The amount of oestrogen-receptor complex in the nucleus declines 
slowly after translocation,- to control levels at about 24 hours after 
hormone treatment. Cytoplasmic receptor levels are elevated above 
control values at this time (Clark et al., 1973) and this indicates 
that oestrogen is inducing the synthesis of its own receptor. Studies 
with actinomycin D, a transcriptional inhibitor, and cycloheximide, an 
inhibitor of protein synthesis, suggest that about 60% of the 
oestrogen receptors reappearing in the cytoplasm after their depletion 
by translocation are newly synthesised, because they are dependent on 
de novo RNA or protein synthesis (Jensen et al., 1969; Sarff & Gorski, 
1971). The remaining 40%, however, are most likely replenished by 
recycling of the nuclear receptors. It seems likely that both de novo 
synthesis and recycling contribute to cytoplasmic receptor 
replenishment and Mester & B a u l i e u ’s findings (1975) that 
replenishment can be divided into an early phase which is not affected 
by inhibitors and a later protein-synthesis dependent phase is 
compatible with existing results. Kassis & Gorski (1981) report that 
after a single injection of the short acting oestrogen 16o( - 
oestradiol, cytoplasmic receptor replenishment is complete within 4 
hours and is not blocked by cycloheximide treatment. The disappearance 
of nuclear receptor corresponds to reappearance of receptor in the 
cytoplasm. Short acting oestrogens such as 16o<-oestradiol and 
oestriol induce early oestrogenic responses such as the imbibition of 
water and stimulated protein synthesis, but fail to induce long term 
responses such as DNA synthesis and uterine growth. The long acting 
oestrogens such as ITp-oestradiol also lead to a decrease in total 
numbers of receptors by a loss of some nuclear molecules. This
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"processing" (Horwitz & McGuire, 1978a) may involve modification or 
degeneration, but it is inhibited by actinomycin D (Horwitz & McGuire, 
1978b). ■ ■
Because it is characteristic of long acting oestrogens, receptor- 
modification may be important in long term responses in the uterus. 
Schoenberg & Clark (1979) have found an endogenous nuclease in 
immature rat nuclei which solubilises nuclear receptors and is also 
susceptible to actinomycin D inhibition. They subsequently found that 
nuclear-bound receptors resistant to exogenous DNAase treatment 
correspond to those sites which are processed (Schoenberg & Clark, 
1981). This suggests that some of the nuclear receptors are involved 
in a function other than binding to chromatin sites and that only this 
subset of receptors is processed . In cultures of human breast cancer 
cells (MCF-7) processing of nuclear receptors after oestradiol 
treatment is associated with the induction of progesterone receptor. 
When anti-oestrogens such as tamoxifen or nafoxidine are added to the 
culture, they translocate the receptors to the nucleus but processing 
is only partial or absent. In this case no progesterone receptor is 
induced (Horwitz & McGuire, 1979c).
1.4 Nuclear acceptor sites.
Because of the steroid induction of specific gene expression, much 
effort has been put into the attempt to identify the particular sites 
at which the receptor complex binds in the nucleus, to elicit this 
response. These sites are known as 'acceptor' sites, and are expected 
to have a limited capacity and high affinity for the steroid-receptor 
complex. They should also be hormone and target tissue specific. The 
demonstration of nuclear acceptor sites has been difficult and 
controversial (Chamness et al., 1974; Buller et al., 1975). Several
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investigators have shown nuclear binding to be a saturable phenomenon, 
thus suggesting that limited numbers of acceptors do exist (Fang & 
Liao, 1971; Mainwaring & Peterken, 1971; King & Gordon, 1972; O'Malley 
et al., 1972; Higgins et al., 1973a), while others claim that limited 
numbers of specific nuclear sites do not exist and that nuclear 
saturation is an artifact (Chamness et al., 1973; Andre & Rochefort, 
1975). The problems associated with the interpretation of in vitro 
binding experiments was highlighted after a study by Higgins et al. 
(1973c) on the nuclear binding of glucocorticoid receptors in hepatoma 
cells and oestrogen receptors in immature rat uterus. It was shown 
that saturation of cells with hormone did not inhibit the subsequently 
isolated chromatin from binding further hormone-receptor complexes. 
This led to the proposal that the available sites vivo are not 
identical to those vitro and that results are dependent on the 
isolation procedure used. Yamamoto and Alberts (1975) have argued, 
however, that a small number of specific acceptor sites would be 
completely masked by large numbers of low affinity sites which may 
facilitate rapid transfer of receptor complex to the high affinity 
acceptors. They may also be necessary for multiple binding of steroid 
receptors which may function cooperatively in activating a 
transcription unit (Yamamoto & Alberts, 1976). This correlates with 
the work of Clark and others who have shown that the usual method of 
potassium chloride extraction of uterine nuclei does not remove all 
nuclear-bound oestrogen. This indicates that some oestrogen-receptor 
complexes are bound more tightly than others (Clark & Peck, 1976; 
Barrack et al, 1977; Traish et al., 1977). Clark's group have shown 
that only a limited number of nuclear binding sites, 1-3000 per cell, 
are involved in the production of maximal uterine growth (Anderson et 
al., 1972, 1973, 1975), These sites are retained for longer than 4 to 
6  hours in the nucleus and equate - in number to the sites resistant to
lb
salt extraction. Clark & Peck propose these as the true acceptor sites 
for oestrogen-receptor complex. Salt-resistant nuclear oestrogen- 
binding sites are also found in the immature mouse uterus where 0.4M 
KCl exposes 3,500 salt resistant sites per cell {Korach, 1979).
The nuclear envelope (Jackson & Chalkley, 1974a,b), histone (King & 
Gordon, 1967; Slyser, 1969), non-histone protein (Spelsberg et al., 
1971; King & Gordon, 1972; Liang & Liao, 1972; Lebeau et al., 1973; 
Puca et al, 1974; Mainwaring et al., 1976), DNA (Clemens & Kleinsmith, 
1972; Musliner & Chader, 1972; Higgins et al., 1973a; Yamamoto & 
Alberts, 1975), ribonucleoproteins (Liao et al., 1973) and the nuclear 
matrix (Barrack et al.,1977) have all at different times been proposed 
as the acceptor sites.
Early DNA digestion experiments suggested that ENA might be involved 
in binding the steroid-receptor complex. Deoxyribonuclease (DNAase) 
destruction of ENA in rat uterine nuclei, prevented the formation of 
nuclear oestradiol-receptor complex upon subsequent incubation with 
cytosol containing activated complexes. The digestion did not release 
any component capable of binding either oestrogen or the receptor 
complex, and thus appears to destroy the acceptor (Musliner & Chader, 
1971). DNAase also releases prebound receptor complexes from the 
nucleus (Harris, 1971). Schoenberg and Clark (1981), examining the rat 
uterus 1 - 1 2  hours after oestrogen stimulation, have shown a 
correlation between the levels of nuclear-bound receptors which can be 
solubilised by exogenous nucleases, and the numbers of salt resistant 
nuclear receptor sites they designate as acceptors. They also describe 
a class of receptor-binding sites resistant to nuclease digestion 
which decline rapidly during stimulation, and suggest that these are 
involved with processing and turnover of the receptor. This is in
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contrast to a report on the glucocorticoid receptor, which appears to 
be successively present in a nuclease sensitive and then a nuclease- 
resistant site in hepatoma tissue culture (HTC) cell nuclei (Defer et 
al., 1981). The 5S receptor has been shown to bind a variety of 
heterologous and homologous DMAs with similar affinity (King & Gordon, 
1972; Yamamoto & Alberts, 1974), including those from rat uterus, calf 
thymus, salmon sperm and Escherichia coli.
Much work has been done on the base sequence specificity of this 
binding for various steroid-receptor complexes. These studies make 
particular use of synthetic deoxyr ibopolymers; and halodeoxyur idine 
substitution of DNA, which in several cell systems has resulted in 
altered gene expression (Rutter et al., 1973). Of interest is the 
specific inhibition, by 5-bromodeoxyuridine, of an oestrogen-induced 
glycoprotein secreted by the human breast cancer cell line MCF-7. 
Inhibition is only effective when the bromodeoxyuridine is 
incorporated into the DNA and the synthesis of other proteins not 
regulated by oestrogens is unaffected. This suggests that the 
inhibition is due to interference with the recognition of chromatin 
acceptor sites by the oestrogen-receptor complex (Garcia et al., 
1981). Although binding preferences have been reported for individual 
steroids, there is no concensus between studies; thus while oestrogen- 
receptor complex binds preferentially to AT-rich DNA and to 
halosubstituted DNA (Kallos & Hollander, 1978; Kallos et al., 1978,
1979), androgen receptor has a greater affinity for poly dGdC than 
poly dAdT and binding is unaffected by bromodeoxyur idine (Lin & Ohno, 
1981). Even a study of the interaction of the chick oviduct 
progesterone receptor with cloned DNA coding for the ovalbumin it 
induces, has shown no sequence specificity for any part of the gene. 
In contrast, the three dimensional structure of the DNA was found to
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be the most important parameter (Hughes et al., 1981). Recent studies 
have shown, however, that the DNA sequence at or close to the 
activated genes is important in hormone recognition. Thus, fluorescent 
derivatives of the insect steroid hormone ecdysone have been shown to 
bind specifically at the puffs on polytene chromosomes which mark the 
site of induced protein synthesis (Gronemeyer & Pongs, 1980). 
Furthermore, when cloned sequences of genes for glucocorticoid-induced 
proteins are introduced into non-target cells, their transcription 
becomes hormone-inducible (Buetti & Diggelman, 1981; Hynes et al., 
1981; Kurtz, 1981).
Although steroid receptors bind DNA they do so with relatively low 
affinity (Buller & O'Malley, 1976). DNAase treatment of chromatin 
prevents receptor-binding and releases previously bound receptor (King 
& Gordon, 1972; Higgins et al., 1973a). However, this only suggests 
that DNA is an essential component of the final three dimensional 
acceptor site and does not indicate that DNA is the exclusive 
acceptor.
The chromosomal proteins also bind the hormone-receptor complex and 
there is evidence that it is the non-histone proteins which confer 
specificity of binding on the chromatin. O'Malley's group has shown 
that chick oviduct chromatin binds 3 to 9 fold more progesterone- 
receptor complex than does chromatin from non-target tissues such as 
spleen, heart or erythrocytes (Steggles et al., 1971a). Spelsberg has 
fractionated the chromosomal proteins from target and non-target 
tissues and carried out binding studies with heterologous 
reconstituted chromatins. This method showed that binding of labelled 
progesterone-receptor complex to DNA-histone was lower than to native 
chromatin, and that the source of histone did not affect the amount of
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binding (Steggles et al., 1971b). A major class of acidic non-histone 
proteins, designated AP 3 , was found to be responsible for the 
increased binding of the progesterone-receptor complex to chromatin 
(Spelsberg et al., 1971, 1972). Target cell chromatin in which the AP 3  
fraction has been replaced with non-histone proteins from another 
tissue loses its ability to bind the complex (Spelsberg et al., 1976). 
Furthermore in a recent study Thrall & Spelsberg (1980) confirm that 
non-histone protein-DNA complexes show the characteristics of native 
acceptor sites and show that much of the reported DNA binding by 
progesterone receptors to pure DNA can be artificially induced by the 
assay conditions. It should be mentioned however, that chromatin 
reconstitution on which many of these studies depend, is a very 
controversial technique which has been shown to give rise to a number 
of artifacts (Biessman et al,, 1976; Zasloff & Felsenfeld, 1977; 
Fulmar & Fasman, 1979; Stein, 1979).
Puca et al. (1974, 1975) have studied the interaction of oestrogen- 
receptor complexes with nuclear components immobilised on an inert 
matrix, agarose. A fraction of basic non-histone chromatin proteins 
was isolated from calf uterus, that showed very high affinity for the 
receptor, even in absence of nucleic acids, Basic non-histone proteins 
were also implicated as the acceptor sites for androgen receptors in 
rat ventral prostate (Mainwaring et al., 1976). Hiremath et al. (1980) 
report two distinct androgen acceptor sites - a soluble, loosely bound 
non-histone protein of molecular weight 14,000 and a second site, 
resistant to 2M salt extraction of the chromatin (Hiremath et al,, 
1981).
There is still much controversy as to the involvement, if any, of 
histone molecules. Whilst they cannot satisfy the specificity
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requirement’for acceptors, Kallos et al. (1981) claim that histones 
are important in stabilising the binding of oestrogen to DNA and may 
account for the salt-resistant binding sites reported by Clark & Peck 
(1976), They may also account for the salt-resistant androgen acceptor 
described by Hiremath et al. (1981). Although some authors advocate 
that the non-histones serve only to mediate the availability of the 
acceptor-DNA (King & Gordon, 1972), the collected evidence suggests 
that DNA and non-histone protein are both involved in defining the 
acceptor site for steroid-receptor complexes.
O'Malley & Schrader's model for the binding of the chick oviduct 
progesterone receptor (O'Malley & Schrader, 1976; Schrader et al., 
1977) is based on their finding that this steroid-hormone receptor 
consists of a dimer of non-identical polypeptides. These each have a 
molecular weight of about 1 0 0 , 0 0 0  and a single progesterone-binding 
site, and can be isolated because they elute from DEAE-cellulose as 
two separate peaks of progesterone-binding activity (Kuhn et al., 
1975). The A subunit binds DNA but will not bind chromatin, and the B 
subunit binds APg non-histone chromatin proteins. The model suggests 
that the receptor binds chromatin through the B subunit after which 
the A subunit dissociates and binds DNA. This changes the chromatin 
structure allowing RNA polymerases to gain access to initiation sites. 
In subsequent work, Hughes et al. (1981) showed a binding preference of 
the A subunit for single-stranded ENA (ssENA) and suggested it might 
be a helix-destabilising protein. These proteins have been associated 
with replication, recombination, repair and transcription - all 
processes involving transient single-stranded nucleic acid 
conformations (Champoux, 1978). Schrader proposes that since receptors 
for androgens, oestrogens and glucocorticoids can be separated into 
two peaks of h o rmone-binding activity upon DEAE-cellulose
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chromatography, the model is applicable to all steroid receptors. 
However, the two forms of glucocorticoid receptor show a precursor- 
product relationship and are the nonactivated and activated complexes 
(Sakaue & Thompson, 1977; Munck & Foley, 1979). Although the 5S 
oestrogen receptor has a subunit structure there is no evidence for 
the pre-existence of a separate DNA-binding subunit. All other steroid 
receptors undergo an activation process from a DNA non-binding to a 
DNA-binding form without an increase in size. The fact that 
progesterone receptors from rabbit uterus undergo activation 
(Fleischmann & Beato, 1979) and that antibodies raised against them do 
not cross-react with chick progesterone receptors (Logeât et al., 
1981), suggests that the avian progesterone receptor is a special case 
and argues against the model being applicable to all receptors 
(Gschwendt, 1980).
1.5 Transcriptional effects of oestrogen and other steroids.
1.5.1 Changes in chromatin structure. '
The idea that the steroid-receptor complex in some way opens up the 
chromatin structure, thus facilitating transcription, is founded on 
studies using nuclease digestion of the DNA. Chromatin to which 
oestrogen-receptor complex has bound shows a highly increased 
sensitivity to DNAase 1 digestion, suggesting that the DNA is exposed 
(Chamness et al., 1974). Examination of endometrial chromatin by 
electron microscopy reveals that oestrogen treatment both vivo and 
in vitro transforms condensed chromatin into dispersed chromatin 
within one hour of administration. Substances which block oestrogenic 
effects such as the transcriptional inhibitor actinomycin D, also 
prevent the ultrastructural change caused by the hormone (Vic et al.,
1980), and this links the decondensation of chromatin to 
transcriptional activity.
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A similar decondensation of chromatin occurs in insects. The salivary 
glands of Diptera such as Chironomus and Drosophila contain giant 
polytene chromosomes which are easily visualised by light microscopy. 
These respond to the ecdysteroid hormones in the insect by puffing up 
at certain sites along their length. These "puffs" are interpreted as 
the uncoiling of chromatin, and are sites of RNA synthesis (Felling, 
1959). The puffs are specific for a particular hormone and appear in a 
particular sequence for specific periods during development, and then 
regress (Clever, 1963; Clever et al., 1973).
Oestrogen can be shown to induce target-tissue-specific changes in the 
conformation of particular genes whose activities it stimulates. The 
presence of structural gene sequences can be monitored after digestion 
of nuclei with DNAase, by hybridisation of the remaining DNA to 
labelled specific gene probes. These are complementary DNAs (cDNAs) 
transcribed jui vitro from the particular messenger RNA using the 
mviral enzyme reverse transcriptase, DNAase treatment reduces 
exposed DNA to non-hybridisable fragments. Thus an increase in the 
DNAase sensitivity of the four Vitellogenin genes can be demonstrated 
in oestrogen-treated Xenopus liver cells, but this change does not 
occur in erythrocytes of the hormone-treated animal (Gerber-Huber et 
al., 1981). Similar results have been obtained in chick oviduct where 
oestrogen induces the egg-white proteins ovalbumin and ovomucoid with 
a concomitant increase in the DNAase sensitivity of their structural 
genes (Garel & Axel, 1976, 1977; Lawson et al,, 1980).This change does 
not occur in non-target tissues such as liver.
The DNAase sensitivity must be mediated by a change in some property 
of the chromosomal proteins. Although the histones are thought to have
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a mainly structural function many workers have investigated the 
possibility of a regulatory role. It was first suggested in 1950 that 
they served as repressors of gene transcription (Stedman & Stedman, 
1950), and it has been shown since, that histones repress ovalbumin 
and globin gene activity (Axel et al., 1973; Tsai et al., 1976). This 
may be due to the inhibition of RNA polymerase (Butler & Chipper field, 
1967), or an interference in RNA chain elongation (Koslov & Georgiev, 
1970), but a change in chromatin structure at active genes would also 
be consistent with a change in the availability of DNA to the RNA 
polymerases (Axel & Felsenfeld, 1973; Gilmour & Paul, 1973; Steggles 
et al., 1974). These changes could be caused by post-translational 
modifications of the histones (Ruiz-Carillo et al., 1975) and might 
include phosphorylation, méthylation and acétylation. Acétylation 
particularly has been shown to be a characteristic of histones present 
in cells undergoing biological changes, and has been found associated 
with hormonal stimulation, embryonic development and cellular 
differentiation (Gottesfeld et al., 1975; Cohen et al., 1975; Riggs et 
al., 1977a,b; Johnson & Allfrey, 1978). Although it is uncertain 
whether histone acétylation is the cause or effect of gene activation 
it is probable that histones on active genes are hyperacetylated 
(Davie & Candido, 1978). ENAase 1 preferentially degrades active genes 
and releases a hyperacetylated fraction of the histone population 
(Vidali et al., 1978). Chromatin which has been acetylated chemically 
becomes very sensitive to DNAase, as does chromatin from butyrate 
treated cells (Bonner et al., 1978). Sodium butyrate is an inhibitor 
of histone deacetylation and interestingly, it has been shown to block 
the induction of egg-white protein genes by steroid hormones (McKnight 
et al., 1980). The authors suggest that oestrogen receptors normally 
bind to highly acetylated regions of chromatin and that butyrate 
blocks protein induction by creating a large number of non-productive
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binding sites for the receptor. However, this presupposes that 
acétylation is a causal agent, rather than an effect of receptor 
binding - a point which at present is unclear. Transient increases in 
histone acétylation have been observed in the uterus and are maximal 5 
to 10 minutes after oestrogen administration. Similar changes are 
noted in response to corticosteroid treatment of kidney and 
lymphocytes. The increased acétylation is unaffected by RNA or protein 
synthesis inhibitors given prior to hormone and the turnover of acetyl 
groups is extremely rapid (Libby, 1972, 1973; Jackson et al., 1975).
The non-histone proteins are more likely candidates as regulators of 
gene transcription because of their diversity and their specific 
composition in different tissues. They are present in elevated levels 
in actively transcribing tissue, whilst amounts of histone remain 
constant (Dingman & Sporn, 1964), and they can be shown to stimulate 
the vitro transcription of chromatin from both homologous and 
heterologous tissues (Kostraba et al., 1975; Wang & Kostraba, 1977). 
They have also been shown to bind specifically to different DNA 
regions (Chytil & Spelsberg, 1971; Teng et al., 1971; Sevall et al., 
1975). Like the histones, post-translational modifications by 
phosphorylation, méthylation and acétylation occur and have been 
observed accompanying changes in gene expression in response to 
steroid hormones (O'Malley & Means, 1974).
The high mobility group (HMG) of non-histone proteins, so called 
because of their migration characteristics on polyacrylamide gels, are 
strongly implicated in defining the structure of actively transcribing 
genes. The HMG proteins were first discovered by Goodwin et al. 
(1973), as loosely bound chromosomal proteins ex tractable in buffers 
of low salt concentration. Although similar, they are distinct from
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the histones by virtue of an unusual amino acid composition. There are 
four major proteins, the high molecular weight HMG 1 & 2, and the low 
molecular weight HMG 14 & 17. These are all released by DNAase 
digestion of chromatin in conditions chosen to selectively digest 
active genes (Vidali et al., 1977; Levy-Wilson et al., 1977; Levy- 
Wilson & Dixon, 1978; Weisbrod & Weintraub, 1979; Georgieva et al,
1981). Significantly, the selective digestion of the chick globin gene 
in erythrocytes can be abolished if HMG proteins are previously 
extracted in 0.35M salt. Reconstitution experiments show that the 
presence of HMG 14 & 17 alone is sufficient to restore DNAase 
sensitivity to the chromatin (Weisbrod & Weintraub, 1979; Gazit et 
al., 1980). These two proteins have also been shown to preferentially 
bind single-stranded DNA (Isackson & Reeck, 1981), and to be 
components of the nucleosomes of active chromatin (Weisbrod et al., 
1980) ,
Some specific modifications of the HMG proteins have been reported. 
HMG 14 & 17 can be phosphorylated (Bhorjee, 1981;'Linnala-Kankkunen & 
Maenpaa, 1981) and glycosylated (Reeves et al., 1981) and HMG 1 & 2 
are acetylated. In the presence of butyrate the deacetylation of these 
proteins, as well as of histones, is inhibited (Sterner et al., 1979). 
HMG 14 & 17 have been found to partially inhibit histone deacetylase 
in active chromatin (Reeves & Candido, 1980).
HMG protein levels are related to the hormonal status of a target 
tissue, for example, prostatic chromatin from androgen-treated rats 
has a higher HMG protein content than the corresponding chromatin from 
castrated animals (Hiremath et al., 1981). In the same system Lesser & 
Elliot (1981) have described a "specific DNA-binding activity" present 
in the non-histone protein fraction which is dependent on the presence
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of androgen. In addition it has recently been reported that levels of 
HMG 1 increase in chick oviduct after oestrogen treatment (Teng & 
Teng, 1981).
These proteins, then, are likely to be involved in the early stages of 
the steroid-induced response by participating in the change of 
chromatin structure necessary to facilitate transcription.
The ENA of active and inactive genes may also-be expected to exhibit 
some differences. Thus, the degree of méthylation of both transcribed 
and flanking sequences of genes, has been implicated in the control of 
transcription (Desrosiers et al., 1979; Marcaud et al., 1981; 
Weintraub et al., 1971). DNAase-sensitive, active gene sequences are 
under-methylated (Naveh-Many & Cedar, 1981), and recently Compere & 
Palmiter (1981) have shown that glucocorticoid induction of 
metallothionein only occurs when the gene for the protein is not 
methylated. It is not known at present, whether steroid hormones exert 
any control over the extent of méthylation of the genes which they 
stimulate.
1.5.2 Oestrogen-induced transcription in chick oviduct.
Before describing in detail the transcriptional responses in immature 
rat uteri, it is useful to describe some of the work on the avian 
oviduct which illustrates the oestrogenic control of specific gene 
activity as previously outlined in Section 1.2.
Administration of oestrogen to immature chicks stimulates the 
synthesis of egg-white proteins in the oviduct. The use of the 
inhibitor rifampicin in jui vitro transcription assays has shown that 
the number of nuclear initiation sites in this tissue rises and falls
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in conjunction with the number of hormone-receptor complexes present 
in the nucleus {S.Y. Tsai et al., 1975; Schwartz et al., 1976; Kalimi 
et al., 1976). The assay is done in such a way that the inhibitor 
limits RNA synthesis to a single round of transcription, and the 
number of RNA molecules transcribed, which should then equal the 
number of initiation sites, is estimated from the radioactive 
incorporation and the average length of an RNA molecule synthesised 
under those conditions of assay (M.-J. Tsai et al., 1975; Schwartz et 
al., 1976). Most of the assays are done using excess, exogenous, 
bacterial RNA polymerase, and there is some doubt as to the fidelity 
and efficiency with which this enzyme recognises eukaryotic initiation 
sites. This means that numerical data obtained with bacterial 
polymerase must be viewed with caution. A recent study showed that 
hormonally induced transcription by this enzyme was attributable to 
contaminating messenger RNAs, however these authors confirmed an 
oestrogen-stimulated increase in activity of endogenous RNA 
polymerases (Palmiter & Lee, 1980). This emphasises the dangers of 
using crude systems which may cause template independent stimulation 
of RNA synthesis as pointed out by O'Malley's group (Buller et al,, 
1976b).
The oestrogen-induced synthesis of the egg-white proteins ovalbumin, 
ovomucoid, conalbumin and lysosyme is preceded by the accumulation of 
their messenger RNAs in the tubular gland cells (Harris et al., 1975, 
1976; Palmiter et al,, 1976; Hynes et al., 1977; McKnight, 1978). The 
fine control exerted on the production of the proteins is indicated by 
the dose responses and the kinetics of induction of ovalbumin and 
conalbumin. Conalbumin mRNA begins to accumulate within 30 minutes of 
oestrogen administration, whereas there is a lag of 3 to 4 hours 
before ovalbumin mRNA begins to accumulate (Palmiter et al., 1976).
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The rate of conalbumin mRSfA synthesis is directly proportional to the 
concentration of nuclear receptors and half maximal induction occurs 
when nuclear receptor levels are 50% of maximum. Half maximal 
induction of ovalbumin mRNA is not reached until nuclear receptor 
levels are 80% of saturated (Mulvihill & Palmiter, 1977). Both Thomas 
& Teller (1981) and Palmiter et al. (1981) have put forward a model to 
explain these results. They suggest that the interaction of hormone- 
receptor complex at a single site on the gene is sufficient to induce 
conalbumin, whereas synthesis of ovalbumin mRNA requires interaction 
of the complexes at multiple sites on the ovalbumin gene. This is 
supported to some extent by the fact that increasing dosage and using 
a direct route of administration of hormone to the lumen of the 
oviduct'can induce maximal ovalbumin mRNA synthesis within 1 hour 
(Swaneck et al., 1979a). Palmiter et al. (1981) have extended their 
model by proposing that different types of steroid receptor interact 
at the same chromatin sites with different affinities. This could 
explain the different synergistic and antagonistic effects of 
oestrogen and progesterone on ovalbumin and conalbumin synthesis. They 
further propose that receptor-binding is coupled to transcriptional 
activation by unstable intermediary proteins. The activity of these 
could be regulated by covalent modifications, such as acétylation, 
which could explain the effect of butyrate on egg-white protein 
induction.
Oestrogen stimulates the number of ovalbumin mRNA molecules per chick 
oviduct cell, during primary stimulation, from near zero to 48,000 per 
cell- If hormone is withdrawn this declines to near zero again over 12 
days (Harris et al., 1975). Monahan et al. (1976) have estimated the 
number of different polyadenylated mRNA sequences per cell as over 
25,000. They stated that after 12 days of hormone withdrawal the
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sequence complexity (the number of different sequences) in chick 
oviduct had fallen by 50% and that the highly abundant sequences 
present in laying hen & stimulated chick oviduct were absent. Mizuno & 
Cox (1979) claim that 95% of the unique DNA sequences transcribed in 
the stimulated oviduct are still represented in the nuclear RNA 
population up to 6  days after withdrawal and suggest that the loss in 
cytoplasmic sequences coded for by unique DNA is due to a hormone- 
dependent change in the processing and export from the nucleus of 
these sequences rather than a cessation of transcription. This seems 
unlikely in view of the short half-lives of the hnRNA molecules, 
although oestrogen does have a stabilising effect on ovalbumin mRNA 
(Palmiter & Carey, 1974), and withdrawal decreases the half-life (Cox, 
1977). A recent study on the ribonucleoprotein particle population of 
chick oviduct nuclei shows that the number of ovalbumin messenger 
sequences in these complexes rises and falls in response to oestrogen 
stimulation and withdrawal (Thomas et al., 1981).
Molecular cloning of the conalbumin, ovalbumin and ovomucoid genes has 
shown that in common with other eukaryotic genes, the coding regions 
of the ENA are interrupted by non-coding regions known as intervening 
sequences, inserts, or introns. In the ovalbumin gene there are seven 
such sequences interrupting eight coding regions (Breathnach et al., 
1977; Doel et al., 1977; Dugaizyck et al,, 1978, 1979). There are at 
least six introns in the ovomucoid gene (Catterall et al., 1979), and 
the conalbumin gene has at least sixteen introns (Cochet et al., 
1979). The function of these regions is unknown but they are 
transcribed in response to oestrogen (Roop et al., 1978; Swaneck et 
al., 1979b; Nordstrom et al., 1979). These sequences are processed out 
of the primary transcript before its export from the nucleus as mature 
messenger RNA,
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Utilisation of the cytoplasmic messenger RNAs is affected by both 
progesterone and oestrogen. Progesterone enhances the initiation of 
translation of ovalbumin messenger RNA, and both hormones stabilise 
the messenger in the cytoplasm. Oestrogen may be involved in the 
translation process itself since translational efficiency cannot be 
maintained if the hormone is withdrawn (Robins & Schimke, 1978).
1.5.3 The oestrogenic response in immature rat uterus.
In the mammalian uterus oestrogen does not stimulate the production of 
major new proteins but initiates a chain of events leading to overall 
growth and development of the tissue. This may involve a multiplicity 
of new minor proteins, preparing the uterus for the implantation of a 
fertilised egg. The majority of the uterine responses are inhibited by 
actinomycin D and therefore appear to arise from an effect of the 
hormone on the transcription of RNA. The synthesis of all classes of 
RNA is stimulated by oestrogen, and this is followed by increased 
protein synthesis, and later in the response by stimulated DNA 
synthesis. In the immature rat uterus this sequence of events is 
characterised by an overall hypertrophy followed by hyperplasia of the 
organ (Billing et al., 1969).
A number of early studies demonstrated oestrogen-induced stimulation 
of the chromatin template activity in immature and ovariectomised rat 
uteri. The increased ability of the chromatin DNA to act as a template 
for bacterial RNA polymerase (Hamilton, 1968) coincides with the early 
increase in endogenous RNA polymerase activities (Teng & Hamilton, 
1968; Church & McCarthy, 1970). These findings correlate with the 
increased number of nuclear initiation sites measured by the 
rifampicin challenge assay (Markaverich et al., 1978).
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Classer et al. (1972) showed that the earliest detectable response to 
oestradiol-17^ administered to ovariectomised rats was an increase in 
RNA polymerase II activity. This polymerase is responsible for 
transcribing the large heterogeneous nuclear RNA species assumed to be 
precursors of messenger RNA. The increase in RNA polymerase II 
activity occurs 15 minutes after oestrogen administration, peaks at 30 
minutes and falls to control levels at 1  to 2 hours after hormone 
stimulation. A second increase occurs over 2 to 12 hours, and this 
declines to control levels by 24 hours (Classer et al., 1972; 
Borthwick & Smellie, 1975; Clark et al., 1978c).
Increased synthesis of ribosomal RNA (rRNA) has been shown by an 
increase in RNA polymerase I activity in the uterus of rat and rabbit. 
Activity increases from 1 to 2 hours after oestrogen administration 
and remains constant from 2 to 12 hours (Widnell & Tata, 1966; 
Hamilton et al., 1968; Borthwick & Smellie, 1975; Hardin et al., 1976; 
Wêil et al., 1977). The activity of polymerase III which transcribes 
small RNAs such as tRNA and 5S ribosomal RNA also increases at about 
the same time as that of polymerase I, to a maximal level between 3 
and 4 hours (Webster & Hamilton, 1976). The stimulation by oestradiol 
of these RNA polymerase activities was shown to be template dependent 
by Borthwick & Smellie (1975) who could find no direct effect of the 
hormone on the isolated enzymes. However, oestrogen may control the 
population of polymerase molecules as in rooster liver, where 
stimulated polymerase II activity is in direct proportion to an 
increase in the number of polymerase molecules per nucleus (Kastern et 
al., 1980).
The increased polymerase II activity accounts for the early oestrogen- 
induced synthesis of nuclear RNAs in immature rats reported by many 
workers (Means & Hamilton, 1966a, b; Hamilton, 1968; DeAngelo & 
Gorski, 1970; Wira & Baulieu, 1971). It also confirms the observation 
that the earliest detectable transcriptional response to oestrogen in 
immature rat uteri is an increase in the synthesis of heterogeneous 
nuclear RNA (hnRNA) seen at 30 minutes after the administration of 
oestradiol-17^ (Know 1er & Smellie, 1971, 1973; Aziz & Knowler, 1978). 
This RNA is identified on the basis of its high molecular weight, base 
composition, polyadenylation, a low degree of méthylation, nuclear 
location and rapid synthesis.and decay. Its synthesis is stimulated 
two-fold, 30 minutes after oestrogen administration and reaches a peak 
ten times control values by 2 hours after injection. Differential 
elution from polyuridylate-sepharose columns using different formamide 
concentrations allows the fractionation of this hnRNA into three 
classes, non-adenylated, oligo-adenylated and polyadenylated. 
Stimulated synthesis of the polyadenylated class accounts for most of 
the early response whilst synthesis of non-adenylated species 
increases dramatically at later times (Aziz & Knowler, 1978). 
Maturation of the hnRNA can be followed kinetically by its appearance 
in extractable hnRNP particles, by detection of mRNA sequences in the 
hnRNA and by entry into the cytoplasm of the newly synthesised mRNA 
(Knowler, 1976; Aziz & Knowler, 1980; Merryweather & Knowler, 1980).
Studies using o<-amanitin, an inhibitor of transcription, show that if 
the early peak of RNA polymerase II activity does not occur the 
subsequent increase in polymerase I activity is abolished (Raynaud- 
J a m m e t  et al., 1972; Borthwick & Smellie, 1975). Inhibitor 
administered after the 30 minute peak in polymerase II activity is 
ineffective in preventing the increased polymerase I activity. Exactly
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the same results are obtained if cycloheximide, a protein synthesis 
inhibitor, is used in place of cx-amanitin. This work shows that new 
ribosome synthesis cannot occur without the prior synthesis of some 
proteins coded for by the hnRNA transcribed as early as 30 minutes 
after stimulation by oestrogen (Baulieu et al., 1972; Baulieu, 1975; 
Knowler et al., 1975). Protein synthesis inhibitors have also been 
shown to block the glucocorticoid-stimulated synthesis of ribosomal 
RNA (Yu & Feigelson, 1973; Feigelson & Kurtz, 1978) and the induction 
of specific messenger RNAs by oestrogen and glucocorticoid (McKnight, 
1978; Chen & Feigelson, 1979). This may mean that early protein 
synthesis is a prerequisite for the continuation of all steroid- 
induced responses. The hormone-receptor complexes may primarily 
interact with genes specifying intermediary regulatory proteins, and 
it may be these that mediate the steroid-induced response.
This scheme may also apply to the early and late transcriptional 
responses in Drosophila. The early chromosome puffs induced by 
ecdysone are independent of protein synthesis, whereas the puffs which 
appear after 5 hours of hormone treatment can be blocked by various 
inhibitors of protein synthesis (Ashburner, 1974). This has led to the 
suggestion that ecdysone-receptor complex regulates the appearance of 
the early puffs, and that a protein product of these then regulates 
the induction of the late puffs (Ashburner & Richards, 1976). The 
possible nature of intermediary regulatory proteins is discussed later 
in this section.
In the hypertrophic responses of the uterus, the most important 
requirement will be the huge increase in protein synthetic activity. 
Incorporation of radiolabelled precursors reveals that messenger RNA, 
derived from the hnRNA synthesised at 30 minutes after oestrogen
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stimulation, accumulates in the cytoplasm and brings about an 
increased aggregation of pre-existing ribosomes into polysomes 
(Merryweather & Knowler, 1980). This is detectable between 30 minutes 
and 1 hour after oestradiol administration and is maximal after 2 to 4 
hours (Teng & Hamilton, 1967; Merryweather & Knowler, 1977). The 
aggregation precedes the oestrogen-induced increase in rRNA synthesis, 
which is detectable at 1  hour and peaks 1 0  to 1 2  times control values, 
2 to 4 hours after oestrogen administration (Knowler & Smellie, 1971). 
There is also some early stimulation by oestrogen of the maturation of 
28S and IBS ribosomal RNA from their precursor molecules, which may 
involve the increased efficiency of the base méthylation or cleavage 
(Knecht & Luck, 1977).
The accumulation of this new rRNA into ribosomes does not occur until 
1 2  hours after hormone injection, when the incorporation of newly 
synthesised ribosomal proteins is also maximal. The synthesis of 
ribosomal proteins is not stimulated until 8  to 1 2  hours after 
treatment with oestradiol, at the same time as the stimulation of 
total uterine protein synthesis. Thus pools of newly synthesised rRNA 
must accumulate in the cells over 2  to 1 2  hours following hormone 
treatment. The peak of new ribosome synthesis at 12 hours is followed 
by the stimulation of total protein synthesis, marked by a second peak 
of incorporation of newly synthesised mRNA into polyribosomes 
(Merryweather & Knowler, 1980).
Support for the precursor-product relationship of the early stimulated 
hnRNA and the cytoplasmic mRNA sequences present after 4 hours of 
oestradiol stimulation comes from hybridisation studies (Aziz & 
Knowler, 1980). The bacterial enzyme reverse transcriptase is used to 
make copies of polysomal polyadenylated messenger RNA which is
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labelled using radioactive ribonucleotides. There is some 
complementarity between polyadenylated hnRNA from rat uterus after 
both 30 minutes and 2 hours of oestrogen treatment, and the abundant 
sequences of complementary DNA (cDNA) transcribed from polyadenylated 
mRNA from 4 hour treated uteri. These abundant cDNA sequences are more 
common in the hnRNA from rats receiving 2 hours of oestrogen 
treatment, than 30 minutes of oestrogen treatment.
Analysis by homologous hybridisation of cDNA to its template mRNA has 
been used to compare the complexity and diversity of polysomal 
poly (A)- containing mRNA sequences in rat uteri in differing hormonal 
states. This method generates an estimate of 36,000 different 
sequences expressed in the adult uterus at pro-oestrus as against
8,000 in the immature rat uterus responding to 4 hours of oestrogen 
treatment. The results suggest that at the earlier stage in oestrogen- 
induced differentiation, there is a greater percentage of highly 
abundant RNA species than is found in the mature animal. The mRNA 
population in the adult is also shown to have a greater base sequence 
complexity in each abundance class than the 4 hour stimulated animal 
(Aziz et al., 1979a).
cDNA-mRNA hybridisation may give underestimates of the number of 
unique sequences, therefore the sequence complexities have been 
recalculated by a second method. Saturation hybridisation of total 
tritiated unique DNA by excess mercurated poly (A)-containing mRNA 
yields hybrids which can be isolated using their affinity for thiol- 
sepharose columns. This method may give over-estimates due to the 
presence of introns in gene sequences, or the estimates may reflect 
differences in mRNA size distribution since rare mRNA sequences may be 
longer than abundant species. The relative merits of the two methods
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remain disputed. The second method gives estimates of 53,000 different 
mRNA sequences in the adult uterus and 12,000 in the 4 hour treated 
animal. As in many other published analyses the method gives higher 
values than cDNA-mRNA hybridisation but it confirms the four-fold 
difference in sequence number between the adult and immature rats. The 
figures for the adult uterus are very high, and may reflect the large 
number of different cell types in the uterus.
cDNA-mRNA hybridisation can be used to analyse changes in mRNA 
complexity by examining the degree to which a cDNA copy of one 
population will hybridise to a different mRNA population (heterologous 
hybridisation). In this way, Aziz et al. (1979b) showed that mRNA from 
untreated immature rat uterus was only able to hybridise with 1 1 % of 
the cDNA prepared from the mRNA of 4 hour treated rat uteri. The 
uterine mRNA of 2 hour treated rats could hybridise to 56% of the same 
4 hour cDNA, though at a much slower rate than in the homologous, 
hybridisation. The slower rate of hybridisation showed that sequences 
common to both populations were less abundant in the 2 hour 
preparation while the incomplete hybridisation showed that some 
sequences, present 4 hours after oestrogen administration, were not 
present at earlier times in the response. These latter sequences, 
particularly those appearing in the uterine population between 3 and 4 
hours after oestradiol administration, may well be important in the 
control of rRNA synthesis which is stimulated at this time. They were 
further investigated and quantified using fractionated cDNA,
4 hour cDNA was fractionated into samples enriched in abundant and 
rare sequences respectively. Abundant sequences were prepared by large 
batch hybridisation of 4 hour cDNA to an excess of its template, to a
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low r^t value, Hydroxylapatite column chromatography was used to 
isolate the double stranded hybrids containing the abundant cDNA 
sequences, followed by recovery of the cDNA strand by alkaline 
hydrolysis. Rare sequences were prepared by extending the 
hybridisation to a high r^t value and separating the single strands 
enriched in rare sequences.
Heterologous hybridisation showed considerable homology between 
abundant fractions of cDNA from 4 hour treated rats and total 
polyadenylated mRNA from 2 hour treated rats. The rarest sequences 
were also very similar in the 2 hour and 4 hour populations but a 
contaminant of intermediate abundance in the 4 hour cDNA preparation 
appeared to have no complementary component in the 2 hour mRNA. 
Attempts to isolate this intermediate abundant cDNA by traditional 
fractionation procedures failed but the sequences of interest were 
isolated and analysed as follows. cDNA to 4 hour m î ^  was hybridised 
to high r^t values against mRNA from 2 hour stimulated uteri. The cDNA 
not forming hybrids under these conditions was isolated using 
hydroxylapatite chromatography. Hybridisation of this fraction to its 
own template, namely mRNA from 4 hour stimulated uteri, showed that 
the sample was considerably enriched in sequences of intermediate 
abundance. The number found was 150, which agreed exactly with the 
total number of sequences of intermediate abundance in 4 hour 
polyadenylated mRNA. This means that all of these sequences are 
produced between 2 and 4 hours after oestrogen stimulation. In 
contrast, of the 9 abundant and 7,800 rare sequences present in 4 hour 
mRNA, only 1 or 2, and 2,500 respectively are not present by 2 hours 
after oestrogen administration . Thus the uterus differs from other 
systems such as chick oviduct and rat prostate, where the most 
profound steroid-dependent changes observed have been in the most
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abundant messenger sequences (Hynes et al., 1977; Parker & Mainwaring, 
1977; Parker & Scrace, 1978). The only report of a similar system 
indicates that the major effect of castration on the protein 
population of rat seminal vesicle is a large decrease in the 
moderately abundant messengers (Higgins et al., 1979). This may 
reflect the function of the proteins coded for by these sequences; the 
overall growth process of the uterus may necessitate moderate 
quantities of proteins coded for by messengers in the intermediate 
abundance class. Ribosomal proteins may fall into this category as it 
is between 2 and 4 hours after oestradiol-17^ administration to 
immature rats that their synthesis begins to increase (Merryweather & 
Know 1er, 1980).
Other proteins possibly encoded in this class of mRNA are specific 
non-histone chromatin proteins. It is possible, for example, that 
stimulation of rPNA synthesis depends on specific newly synthesised 
proteins associating with the ribosomal DNA. Such a repetitive part of 
the genome may require proteins in quantities necessitating fairly 
abundant mPNAs to code for them. This role for non-histones as 
intermediary regulatory proteins in steroid hormone action has been 
suggested frequently (O'Malley et al., 1977; Schrader & O'Malley, 
1978; Lesser & Elliot, 1981) and several authors have reported the 
early appearance of oestrogen-stimulated acidic proteins in the 
nuclear fraction of rat uterus, although none of these has been 
assigned a definite function (Barker, 1971; King et al., 1974; Cohen & 
Hamilton, 1975a,b),
A third group of proteins which might be coded for by the intermediate 
abundant mRNA, are hnRNP and mRNP particle proteins. The mRNAs appear 
in the polysomes at a time when uterine hnRNA synthesis is 10 times
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control values (Aziz & Knowler, 1978) and can be extracted in hnRNP 
particles (Knowler, 1976). The requirement for the proteins associated 
with these particles may necessitate fairly abundant messengers. The 
proteins may participate in processing and post-transcriptional 
modifications of hnRNA and mRNA. They may control the excision of 
intervening sequences and splicing of the coding regions of the 
message, and chemical modifications such as capping and 
polyadenylation (Reviewed by Knowler & Wilks, 1980). Other functions 
must include those concerned with transport of hnRNA sequences from 
the nucleus and there is evidence of functional masking and the 
preservation of mRNA sequences in the cytoplasm. A specific example is 
the translational repression of globin mRNA in free cytoplasmic 
ribonucleoprotein complexes (Civelli et al., 1980).
Other possible candidates for the early induced proteins are receptor 
protein, which is replenished during the oestrogenic response (Mester 
and Baulieu, 1975; Clark et al., 1978a), the type II nuclear receptors 
such as the Y protein in chick oviduct (Smith & Taylor, 1981), and 
possibly structural or secreted proteins. Oestrogen has been shown to 
induce secretion of several proteins in cell cultures of breast cancer 
cells (Westley & Rochefort, 1979, 1980a,b). However, the time between 
induction, synthesis and secretion is not clear since cultures were 
exposed to hormone for 2  days.
Much interest has accrued over the years to an oestrogen-induced 
protein known as IP, which is detectable after 40 minutes of oestrogen 
treatment in immature rat uterus (Notides & Gorski, 1966). It also 
occurs in brain (Walker et al., 1979) where it is constitutively 
synthesised. However, the protein was recently identified as an 
isoenzyme of creatine kinase and it is interesting primarily as a
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rapidly responding and early marker of oestrogen action in rat uterus 
which is not involved in gene action (Reiss & Kaye, 1981). It is 
probably needed to process the excess'of creatine phosphate resulting 
from the early increased uptake and metabolism of glucose, induced by 
oestrogen (Smith & Gorski, 1968). This would ensure a plentiful supply 
of energy for the processes of cell growth and division,
1.6 Differential responses of uterine cell types to oestrogens.
It was demonstrated in early studies that oestradiol is not evenly 
concentrated by the different cell types in the uterus. The location 
of tritiated oestradiol was monitored using autoradiography of tissue 
sections freeze-dried after oestrogen treatment, and this showed that 
8 6 % of the hormone became localised in the epithelial tissue of 
immature rat uteri (Stumpf, 1968b). In more recent studies, McCormack 
St Glasser (1980) fractionated cell types from immature rat uteri and 
measured the amounts and concentration of oestrogen receptor present 
in each cell type. Epithelial and stromal cells from untreated animals 
contain higher concentrations of nuclear oestrogen receptor than 
myom é t r i a l  cells and epithelial cells contain the highest 
concentration of cytoplasmic receptor. Although myométrial cells have 
the lowest concentrations they contain 84-89% of the total uterine 
oestrogen receptors, by virtue of the preponderance of myometrium in 
whole uterus. Epithelium and stroma account for 5% and 10% of 
receptors respectively. Following oestrogen treatment cytoplasmic 
receptors increase in all cell types. The distribution of receptor in 
untreated whole uterus is found to be in the ratio 90% cytoplasmic to 
1 0 % nuclear, in agreement with the existing literature, but all the 
isolated cell types exhibit exactly the opposite partitioning, of 1 0 % 
cytoplasmic to 90% nuclear receptor in untreated tissue, and no 
experimental procedure could be found to account for this unusual
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distribution. This may mean that care should be exercised in 
interpreting responses to steroids of cell culture systems, 
particularly cancer derived cultures such as the human MCF-7 cells 
which show a similar receptor distribution (Lippman et al., 1977; Zava 
& McGuire, 1977; Edwards et al., 1980).
Work on the immature mouse uterus shows a biphasic translocation of 
oestrogen receptors from cytoplasm to nucleus. Following injection of 
tritiated oestradiol, a major peak of nuclear radioactivity occurs at 
1  hour, followed by a rapid decline to control levels by 4 to 5 hours, 
A second increase in nuclear radioactivity occurs at 7 to 8  hours 
after the injection, and reaches about 2 0 % of the maximum level in the 
initial increase (Korach & Ford, 1978; Korach, 1979). Further, 
autoradiographic studies of labelled steroid uptake have shown that 
the initial sequestration of steroid is in the nuclei of stroma and 
glandular epithelial cells. The luminal epithelial cells do not show 
appreciable nuclear accumulation of label until 7 to 8  hours after 
hormone injection (Korach & Lamb, 1981). This may indicate the 
requirement of an additional stimulus from stromal tissue to luminal 
epithelium, such as a factor influencing steroid uptake.
This biphasic uptake is not seen in the rat but there are other 
differential responses in the cells. McCormack & Glasser (1980) report 
a stimulated increase in the incorporation of tritiated cytidine into 
RNA of epithelial cells 2 hours after oestrogen administration. This 
increased nucleotide incorporation is restricted to the epithelium and 
does not occur in either stromal or myométrial cells This effect 
agrees with the early increase of precursor incorporation into total 
uterine BNA seen by Knowler & Smellie (1971), Subsequently, oestrogen 
stimulates the incorporation of ^^C-lysine into acidic nuclear
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proteins, four to six-fold, 4 hours after injection, and incorporation 
declines rapidly thereafter. This occurs only in the epithelia of 
ovariectomised mouse uteri and and stroma does not respond unless 
pretreated with progesterone (Smith et al., 1970; Martin et al., 1976; 
Pollard & Martin, 1977).
One further observation from the autoradiographic analysis of tissue 
sections is that hypertrophy occurs in the stroma and myometrium, 
while hyperplasia occurs in the luminal epithelium of oestrogen- 
treated mouse uteri (Martin et al., 1973). Thus our current knowledge 
of the differential responses of uterine cell types to oestrogen 
treatment is somewhat sketchy, and further investigations may help to 
explain some of the ambiguous results obtained from studies of whole 
uterus.
1.7 The aim of the project.
This project is to investigate the nature of the proteins synthesised 
early in response to oestrogen stimulation of immature rat uterus. 
From the work in this laboratory on sequences found in the mRNA 
populations during the first 4 hours of the response, it seems likely 
that oestrogen induces a small number of relatively abundant proteins 
which are produced between 2 and 4 hours after stimulation. These are 
vital to the mobilisation of the protein synthetic machinery of the 
cell for continuation of the response. In an attempt to detect these 
proteins, the techniques of in vitro translation have been developed, 
together with analysis of the products by two dimensional gel 
electrophoresis.
MATERIALS AND METHODS
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2^ MATERIALS AND METHODS
MATERIALS
2.1 Suppliers
Unless otherwise specified, all chemicals used were, as far as 
possible, AnalaR grade supplied by B.D.H, Chemicals Ltd, Where 
chemicals and equipment were obtained from other sources, this is 
indicated in the text and a list of the names and addresses of the 
suppliers is given below.
B.D.H. Chemicals Ltd., Poole, Dorset, U.K.
Beckman Spinco Ltd., Palo Alto, California, U.S.A.
Bio-Rad Laboratories Ltd., Watford, Herts., U.K.
Corning Glass Works, New York, U.S.A.
Eastman-Kodak Co., Rochester, New York, U.S.A.
Eppendorf GerStebau, Hamburg, W, Germany 
Evans Medical Ltd., Speke, Liverpool, U.K.
Fisons Scientific Apparatus Ltd., Loughborough, Leics., U.K.
*Gurr, Hopkin & Williams Ltd., Chadwell Heath, Essex, U.K.
*Gurr, Searle Ltd., High Wycombe, Bucks., U.K.
Jencons Ltd., Hemel Hempstead, Herts., U.K.
Koch-Light Laboratories Ltd., Colnbrook, Bucks., U.K.
Labsure Animal Foods, Christor Hill Group Ltd., Poole, Dorset, U.K. 
L.K.B. Instruments Ltd., South Croydon, Surrey, U.K.
Pharmacia Fine Chemicals AB, Uppsala, Sweden 
Radiochemical Centre, Amersham, Bucks., U.K.
Rohm & Haas (U.K.) Ltd., Croydon, Surrey, U.K.
Schleicher & Schüll, Dassel, W. Germany.
Sigma (London) Chemical Co. Ltd., Kingston-upon-Thames, Surrey, U.K.
*Gurr, Hopkin & Williams, and Sear le companies are now subsidiaries of 
B.D.H. Chemicals Ltd.
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2.2 Experimental animals
Female, albino rats, derived from the Wistar strain, were bred in the 
departmental animal house. All animals used were 18 to 21 day-old 
weanlings weighing 30-40g. At all times prior to death the rats had 
free access to pelleted feed (CRM diet, Labsure Animal Foods) and 
water.
Oestradiol-17^ (1,3,5, (1*0)-estratriene-3,l|3-diol) (Sigma) was stored 
at -20°C as a stock solution of 20mg/ml in absolute ethanol. 
Immediately before use, a solution of lOjug/ml oestradiol-17^ in 0,5% 
(v/v)' ethanol, 0.15M NaCl, was made as described by Roberts & Szego 
(1947), and hormone was injected intraperitoneally as a single dose of 
l^g hormone in 0.1ml carrier per rat. Control animals received carrier 
only.
2.3 Glassware
Glass homogenisers with motor driven Teflon pestles were purchased 
from Jencons Ltd. and Corex glass centrifuge tubes were obtained from 
Corning Glassworks. All other glassware was obtained from laboratory 
stocks. Pipettes, glass centrifuge tubes, test tubes, flasks and other 
glass items were sterilised at 160^C for at least 4 hours before use. 
Plastic items such as tips for automatic pipettes, millipore filter 
assemblies and capped 1.5ml reaction tubes (Eppendorf), and most 
solutions were autoclaved.
Cellulose nitrate tubes for ultracentrifugation were obtained from 
Beckman Spinco Ltd. and were ethanol washed and rinsed in sterile 
distilled water before use.
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2.4 Radiochemicals and Liquid Scintillation Counting
All radioactive isotopes were purchased from the Radiochemical Centre, 
Amersham. AnalaR grade toluene and PRO (2,5 diphenyloxazole) were 
obtained from Koch-Light Laboratories Ltd,
Preparation of samples is described in the appropriate sections on 
experimental procedures. All samples were counted in lOmls 0.5% PPO in 
toluene, in disposable plastic vials in a Beckman LS8100 scintillation 
counter.
EXPERIMENTAL METHODS
2.5 Preparation of samples
2.5.1 The preparation of radioactively labelled proteins in whole 
uteri.
Animals were killed by cervical dislocation and their uteri removed. 
Each organ was dissected free of adipose tissue, slit longitudinally 
and collected in 5mls Eagles medium at 37^C. During dissection 95% 
0 2 /5 % CO2  was continuously bubbled through this medium. When all uteri 
had been collected, groups of 6 were blotted to remove excess medium 
and transferred to a 5ml conical flask containing 1ml Eagles medium 
with one thousandth the usual concentration of amino acids, and either 
20pCi L-[U-^^C] amino acid mixture (57mCi/mAtom carbon), or 40pCi L- 
[^^S]-methionine (800-1450 Ci/m.mol). Flasks were sealed and incubated 
at 37^C in a gently shaking water bath for 3 hours. The atmosphere in 
the flasks was flushed with 95% 0 2 /5 % CO2  every 10 minutes.
Incubated uteri were washed 3 times with ice-cold 0.9% saline, blotted 
to remove excess moisture and used immediately to prepare total
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protein or cytoplasmic and nuclear fractions.
For total protein samples, groups of 6 labelled uteri were homogenised 
in 2mls Buffer A (O.OIM Tris/HCl pH 7.4, O.OIM NaCl, 0.0015M MgCl 2 . 
Tris (2-amino-2-hydroxymethyl-propane-l,3-diol), was supplied as 
Trizma base by Sigma). This and subsequent steps were conducted at 
0-4^C. Insoluble debris was removed by centrifugation at 10,000g for 5 
minutes in a Sorvall SS34 fixed-angle rotor and the resulting 
supernate was precipitated with 9 volumes acetone containing O.lM HCl 
at -20°C overnight. The precipitate was pelleted by centrifugation, 
washed with acetone, dried in a stream of nitrogen and dissolved in 
lysis buffer for specific activity determination and two-dimensional 
gel electrophoresis.
Uterine nuclear and cytoplasmic fractions were prepared using the 
method of Knowler (1976). After the labelling incubation, groups of 6  
uteri were homogenised in 2mls of Buffer A, containing 1% w/v Triton 
X-100 (Rohm & Haas), using an Ultra-Turrax homogeniser run at 60V for 
20 seconds. The homogenisation and all subsequent steps were carried 
out at 0-4°C. The homogenate was filtered through two thicknesses of 
muslin and the homogeniser and muslin washed with a further 2 mls of 
Buffer A, Crude nuclei were collected by sedimentation at 300g for 5 
minutes in a Sorvall HB4 rotor (1200 rpm). The supernatant was 
precipitated with 9 volumes of acetone, O.lM HCl, at -20*^C overnight. 
Nuclei were resuspended in 2mls of Buffer A, which was then made 0.25M 
with respect to sucrose by addition of an equal volume of 0.5M sucrose 
in Buffer A, This was underlaid with 2mls of 0.32M sucrose in Buffer 
A. Clean nuclei were collected by centrifugation at 800g (2000 rpm) in 
a Sorvall HB4 rotor for 5 minutes and samples were checked for purity 
using phase contrast microscopy. The pellets were resuspended in 1ml
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of Buffer A and precipitated as above with acidified acetone. 
Cytoplasmic and nuclear precipitates were pelleted by centrifugation, 
washed with acetone and dried in a stream of nitrogen. Both samples 
were dissolved in lysis buffer for specific activity determination and 
two-dimensional gel electrophoresis.
2.5.2 Determination of radioactivity in protein samples.
Duplicate 5jul samples were each added to 0.5mls of an aqueous solution 
of 200gg/ml bovine serum albumin. 0.5mls 20% w/v trichloroacetic acid 
was added and the precipitation allowed to proceed for 2 0  minutes at 
room temperature. Precipitates were collected onto 2.5cm Whatman glass 
fibre filters (Fisons), rinsed with 2x5mls 5% w/v trichloroacetic 
acid, dried and counted.
2.5.3 Protein assay.
Protein was determined by the method of Bramhall et al (1969). This 
method is best for samples containing not more than SOjug of protein. 
Its advantage lies in the lack of interference by substances such as 
mercaptoethanol and ampholines, both of which occur in lysis buffer, 
which is used to load samples for the first dimension gels in the 
O'Farrell two-dimensional gel system (see section 2.6.2). Duplicate 
aliquots of 5jul were spotted onto 2.5 cm Whatman No. 1 filter discs 
and dried. These were then put into cold 7.5% w/v trichloroacetic acid 
to fix, and this was then heated to 80*^0 and maintained at this 
temperature for 30 minutes. The discs were then drained and washed 
twice in 7.5% trichloroacetic acid. The protein on the discs was 
stained in a solution of lOmg/ml Xylene Brilliant Cyanin G (Gurr; 
Searle) in 7% v/v acetic acid at 50°C for 15 minutes. Excess dye was 
removed by washing with several changes of hot (50°C) 7% v/v acetic 
acid until the background was almost white. The filters were drained
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and dried. 5mls of destaining fluid (6 6 ml methanol, 34mls water, 1ml 
0 .8 8 % ammonia) was added to each filter disc in a test tube and 
whirlimixed to release the dye. The absorbance of the solution was 
measured at 610nm, in a Gilford 240 spectrophotometer.
2.5.4 Fractionation of uterine cell types.
This followed the method of McCormack and Glasser (1980) who used it 
to study the differential response of individual cell types from 
immature rats (see 1.6). They showed that the cells separated by this 
method were viable in culture and retained their physiological 
integrity. The procedure is an adaptation of an earlier one used to 
separate embryonic epithelial cells by digestion of their basement 
membranes.
All enzyme solutions were made up in Dulbecco's phosphate buffered 
saline, pi 7.2, lacking calcium and magnesium (Grand Island Biological 
Co., GIBCO) and sterilised by filtration through Solectron 
nitrocellulose filters, pore size 0.45 micron (Schleicher & Schüll) 
which had been autoclaved. Pancreatin (GIBCO) was supplied as a crude 
lyophilised extract of pig's pancreas, and solutions required several 
filtrations before the final sterilisation. 1.25g pancreatin was added 
to 50mls phosphate buffered saline and stirred on ice for twenty 
minutes. The resulting extract was passed twice through double 
thicknesses of muslin. Aliquots of the solution were passed through 
Solectron GF92 glass fibre filters, pore size 50 micron (Schleicher & 
Schüll) in a Buchner funnel. The filtrate was then passed twice 
through Solectron nitrocellulose filters (pore size 0,45 micron). 
Trypsin (Sigma, type III) was added to 0.5%, and the solution 
refiltered through Solectron filters, sterilised and stored in 6 ml 
aliquots at -20°C. Trypsin (0.05%)-EBTA (ethylene diamine tetra-acetic 
acid, 0.02%) was frozen in 5ml aliquots, and deoxyribonuclease I
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{CNAase, Sigma) at 400 units/ml and collagenase (Type I, Sigma) at 200 
units/ml were stored in 1ml amounts, all at -20°C.
Foetal calf, serum (GIBCO) was heat inactivated by incubating at 56°C 
for 30 minutes with frequent mixing. After the incubation it was 
cooled to 0°C and 0.25 volumes of dextran-coated charcoal (0.15% Nor it 
A activated charcoal (Sigma), 0.0015% Dextran T-70 (Pharmacia Fine 
Chemicals), 0.25M sucrose, 1.5mM EDTA, lOmM Hepes (N-2-hydroxy- 
ethylpiperazine-N’-2-ethanesulphonic acid, Hopkin & Williams), pH 7.4) 
was added. The mixture was stood on ice for 15 minutes, vortexing 
every 3 minutes. Charcoal was removed by centrifugation at 2,500 rpm 
at 4°C for 5 minutes in a Sorvall HB4 rotor. The stripped serum was 
aliquoted and stored at -20*^C.
Groups of 24 uteri were dissected, trimmed and kept on ice in 
phosphate buffered saline. When the dissection was completed, the 
horns of each uterus were separated at the vagina, slit 
longitudinally, blotted and placed in a vial of ice-cold 
trypsin/pancreatin solution. Vials were held at 0-4°C for one hour, 
and then placed at room temperature for a further hour. Each vial was 
then vortexed for 1 0  seconds and the supernate containing epithelial 
cells aspirated into a clean tube. The tissue was washed with 2 x 
4.5mls phosphate buffered saline and the washes added to the tube 
containing the epithelial cells. 0 . 1  volumes of heat inactivated, 
charcoal stripped, foetal calf serum was added to the cells and they 
were held on ice whilst preparing the stromal and myométrial cells.
Uteri lacking epithelial cells were resuspended in a mixture of 2.5mls 
trypsin-EDTA (0.05%, 0.02%), O.Smls DNAase I (200 units) and 6 , 6 mm 
glass beads were added to the vial. The tissue was incubated at 37°C
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in a shaking water bath for 30 minutes, and the vial was vortexed for 
5 seconds at 15 minutes and 30 minutes after the start of the 
incubation. The turbid supernate containing stromal cells was 
aspirated into a clean tube and the tissue washed with 2 x 5mls of 
phosphate buffered saline. The washes and 0.1 volumes of foetal calf 
serum were added to the cells and they were kept on ice whilst 
preparing myométrial cells.
The uterine tissue and glass beads were resuspended in a mixture of 
2.5mls trypsin/EDTA (0.05%, 0.02%), 0.5mls DNAase I (200 units) and 
1ml collagenase (200 units). This mixture was incubated at 37°C, with 
shaking, for 1 hour and was vortexed for 5 seconds at 30 minutes and 
1 hour after the start of the incubation. The turbid supernate was 
recovered from the mixture by filtering through muslin and the residue 
was washed with 5mls of phosphate buffered saline. The myométrial 
cells were collected in a tube containing 0 . 1  volumes of foetal calf 
serum.
Cell suspensions were cleaned up by filtration over glass bead 
columns. Three 10ml disposable syringes were filled to the 5ml mark 
with 6 m m  glass beads. The cell suspensions were mixed by inversion, 
and poured over the columns. The suspensions were collected in 
centrifuge tubes. Each column was washed with a further 5mls of 
phosphate buffered saline. Cells were pelleted by centrifugation at 
500rpm for 10 minutes at 4°C in a Beckman TJ- 6  bench-top centrifuge. 
The supernate was aspirated off and discarded. Each cell pellet was 
resuspended in 5mls of Eagles medium containing 5% foetal calf serum 
and incubated at 37^C under an atmosphere of 95% 0 2 / 5 % CO 2  for 4 
hours,
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2.5.5 Microscopic examination of cell samples.
Cell samples were examined for purity and damage using phase contrast 
microscopy, immediately after separation, and after resting. Samples 
were also examined by transmission electron microscopy which was 
performed by Mr. I Montgomery of the Physiology Department, University 
of Glasgow.
Briefly, samples supplied as sedimented pellets in Eppendorf tubes 
were fixed in glutaraldehyde-osmium tetroxide, embedded in plastic and 
cut sections were supported on grids. These were stained with lead and 
uranium for visualisation in the electron beam.
2.5.6 Labelling of uterine cell-type proteins
Cells 'rested' in Eagles medium for 4 hours were pelleted and 
resuspended in 1ml Eagles medium lacking methionine but containing 
70pCi L-[^^S]-methionine and 5% foetal calf serum. The cells were 
incubated for 90 minutes at 37®C under an atmosphere of 95% O 2 / 5% 
CO 2 . After the incubation the cells were pelleted at 1000 rpm for 5 
minutes in the Beckman TJ - 6  bench-top centrifuge and the medium 
discarded, the pellets were washed twice in 5mls phosphate buffered 
saline and repelleted. Pellets were resuspended in Iml/saline, 
homogenised, and the solution precipitated with 9 volumes of acetone, 
O.lM HCl overnight at -20^C. Precipitates were washed with acetone, 
dried under nitrogen and dissolved in lysis buffer.
2.5.7 Isolation of uterine polyribosomes
Ribosomes were prepared from immature rat uteri by a method based on 
that of Berridge et al. (1976).
Uteri were collected in groups of 6-12 in plastic tubes immersed in a 
solid-C0 2 /methanol bath and were broken into small fragments with a 
footed glass-rod. Whilst still frozen, uteri were transferred to a 
sterile homogeniser and homogenised in 4.5 mis Buffer 1 (0.2M 
Tris/HCl pH 8.5, 0.05M KCl, 0.015M MgCl 2 , containing 5 pg/ml
cycloheximide (Sigma) and 7mM 2-mercaptoethanol (Koch-Light)). The 
homogenisation and all subsequent steps were carried out at 0-4^C 
using sterile glassware and solutions. The homogenate was adjusted to 
2% (w/v) Triton X-100, by addition of 0.5 ml of a 20% (w/v) solution 
and centrifuged at 10,000g (9,000 rpm) in a Sorvall HB4 swing-out 
rotor for 10 minutes. The resulting supernatant was layered over a 1ml 
cushion of Buffer 2 (0.05M Tris/HCl, pH 8,5, 0.05M KCl, 0.015M MgCl 2 , 
containing IM sucrose, 5pg/ml cycloheximide & 7mM 2-mercaptoethanol) 
and centrifuged at 47,000 rpm for 90 minutes at 4®C in a Beckman 
SW50.1 rotor (200,000g). The resulting supernatants were discarded and 
the inside of the centrifuge tubes were wiped with a clean tissue, 
taking care not to disturb the pellets.
Where sucrose density gradients were to be run for polysome profiles, 
a small amount of post mitochondrial supernatant was run in a separate 
tube to give a separate small ribosome pellet.
Large pellets were washed twice with a small amount of sterile 
distilled water, and then resuspended in 50-100pl sterile distilled 
water. The optical density of the preparation was adjusted to between 
0.25-0.5 A 2 5 0  optical density units per microlitre, and aliquoted for 
storage at -70°C.
Small polysome pellets were rinsed twice with a small amount of Buffer 
3 (0.05M Tris/HCl, pH 7.6, 0.25M KCl, 0.005M MgCl 2 containing 5pg/ml
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cycloheximide and 50^ig/ml heparin (supplied as a pyrogen-free sterile 
solution at a concentration of 5000 U/ml by Evans Medical Ltd.)), The 
pellet was then resuspended in 0.4ml of this buffer using a 1ml 
Teflon/glass homogeniser operated by hand, and carefully layered over 
a 5ml, linear, 15-45% (w/v) sucrose gradient made up in Buffer 3. The 
gradient was centrifuged at 50,000 rpm for 40 minutes at 4°C in a 
Beckman SW50.1 rotor (230,000g). The absorbance at 260nm of the 
gradient was measured by upwards displacement with 50% (w/v) sucrose 
through a flow cell attachment for the Gilford 240 spectrophotometer.
2.5.8 The preparation of polyribosomes from fractionated uterine cell 
types.
The methods of cell fractionation (2.5.4) and polyribosome preparation 
(2.5.7) were combined in this procedure, but were adapted to include 
further precautions against ribosome degradation. In addition to 
ribonuclease inhibitors, protease inhibitors were used to minimise any 
damage caused by the enzymes in the cell fractionation process being 
carried over into the homogenisation step.
In a pilot experiment 44 rats were given 12 hours of oestrogen 
treatment, and their uteri were processed in 2 groups. The epithelial 
cells were pooled and used to prepare polyribosomes. Stromal and 
myométrial cell types were not isolated. Polyribosomes were prepared 
from all three cell types in the subsequent experiment. 132 rats were 
injected with oestradiol-17^ 4 hours before death. The uteri were 
dissected and the horns slit longitudinally under as near sterile 
conditions as possible. The uteri were divided into five groups for 
the cell fractionation which was performed as described in section 
2.5.4.
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As each cell type was isolated, the cells were pooled in a sterile 
tube stood in ice. All subsequent steps were conducted atO-4°C. The 
cells were pelleted by gentle centrifugation. The pellet was 
resuspended and washed in 5mls of sterile Dulbecco's phpphate buffered 
saline, containing ImM benzamidine hydrochloride (Sigma), 5mg/ml 
soybean trypsin inhibitor (Sigma) & ImM PMSF (phenylmethyl sulphonyl 
fluoride (Sigma)). The cells were repelleted and immediately used to 
prepare polyribosomes. After the washing step, cells were resuspended 
in 4.5mls of polyribosome Buffer 1 (see section 2.5,7) containing ImM 
benzamidine hydrochloride, Img/ml soybean trypsin inhibitor and ImM 
PMSF. Triton X-100 was added to a concentration of 2% (w/v) to aid 
cell disruption. The homogenisation and all subsequent steps were 
performed as described in section 2.5.7.
2.5.9 Cell free translation assays.
Rabbit reticulocyte lysate which had been treated with micrococcal 
nuclease to destroy endogenous messenger PNA was purchased from the 
Radiochemical Centre, Amersham. The lysate is sold supplemented with 
all the ingredients necessary to ensure ideal translation conditions 
with high incorporation of labelled amino-acids into protein, and low 
background blanks. Commercial lysates are prepared by a modification 
of the method described by Pelham & Jackson (1976).
The lysate was aliquoted and stored under liquid nitrogen. Just prior 
to use it was thawed and an assay mix of 80% lysate and 2 0 % L-[^^S]- 
methionine (by volume) was made, such that the concentration of label 
was IpCi/pl. Assays were mixed on ice in sterile 1.5ml capped plastic 
tubes (Eppendorf). Each tube contained lOpl of assay mix and 1 jul of 
distilled water (blank) or ljul of a polysome preparation under test. 
The incubation was started by transferring the tubes to a water bath
at 30^C. The assays were incubated for 90 minutes after which they 
were rapidly cooled to 0°C.
Incorporation into protein was assayed as trichloroacetic acid 
precipitable counts, measured as follows, ljul of the translation assay 
was diluted with 9^1 of distilled water and mixed. Duplicate 5pl 
aliquots were spotted onto 2.5cm Whatman 3MM filter discs (Fisons) and 
dried. The discs were then placed in ice cold 10% (w/v) 
trichloroacetic acid (TCA) for 10 minutes to precipitate the protein, 
boiled in 10% (w/v) TCA containing 10 mM L-methionine (Sigma) for 15 
minutes and washed twice in cold 5% (w/v) TCA. Discs were rinsed in 
ethanol, dried and counted in lOmls 0.5% w/v PPO in toluene. The 
remainder of the assays were stored at -70°C until analysis of the 
translation products by two-dimensional gel electrophoresis.
2.5.10 Preparation of protein samples for cofractionation with 
labelled uterine proteins on two-dimensional gels.
a) Rabbit skeletal muscle actin
Rabbit muscle acetone powder was a gift from Dr. J. Dow of this 
department, 2.5 grammes of the powder was added to 50ml of sterile 
distilled water and stirred on ice for 30 minutes. The mixture was 
vacuum filtered through Whatman No.l paper and the residue was 
reextracted by stirring with a further 25mls of sterile distilled 
water, on ice. The extracts were combined and spun at 34,000 rpm in a 
Beckman Ti50 rotor at 4°C for 60 minutes. The supernatant was retained 
and stored at -20*^ 0. Samples were lyophilised, weighed and dissolved 
in lysis buffer at a concentration of 2mg/ml. Aliquots containing 20pg 
were loaded onto first dimension (isoelectric focussing) gels, either 
alone, or mixed with radioactive uterine proteins.
b) Rat leg muscle actin.
A lyophilised pure sample of rat leg muscle actin was a gift from Dr, 
J. Elce of the Department of Biochemistry, Queen's University, 
Kingston, Canada. This had been extracted from acetone powders in a 
similar way to that described for rabbit actin, but had been purified 
by polymerisation and depolymerisation. (Spudich & Watt, 1971; Elce et 
al., 1981). The actin sample was dissolved and used as described for 
rabbit actin, above.
c) Induced protein (IP, creatine kinase).
This was a gift from Dr. A. Kaye of the Weizmann Institute of Science, 
Rehovot, Israel, and was supplied as a lyophilised sample. Full 
details of the isolation and purification have been described by Reiss 
and Kaye (1981), Briefly, cytosol fractions were prepared from 
homogenates of rat brain. Proteins precipitated at 40-65% ammonium 
sulghate were collected and subjected to DEAE-cellulose chromatography 
firstly using step gradient elution and secondly using linear salt 
gradient elution. The creatine kinase was finally purified by 
chromatography on a Reactive Blue 2-Agarose column, IP was dissolved 
in lysis buffer at a concentration of Img/ml and aliquots containing 
lOjug were loaded onto first dimensional gels, either alone or mixed 
with labelled uterine samples. The solution was stored at -20°C.
d) Uterine chromatin proteins.
Uterine nuclei from 24 rats were prepared as described in section 
2.5.1. The nuclear pellet was resuspended in 50 volumes of 0.08M NaCl, 
0.02M EDTA pH 6.3, in a Teflon/glass homogeniser. The pestle was 
pulled hard on the upward stroke, to create a vacuum to break the 
nuclei. The solution was centrifuged for 5 minutes at 12,000 rpm in a 
Sorvall HB4 rotor (23,500g). The suspensions and homogenisation were
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repeated twice, examining a sample under the microscope after each 
spin, for breakage of nuclei. The NaCl/ECTA extractions remove large 
amounts of RNA and protein that are not firmly bound to the chromatin. 
The pellet was re suspended in 50 volumes of 0.35M NaCl and centrifuged 
as before. This helps to remove contaminating ribosomal RNA and acidic 
proteins of the nucleoplasm and cytoplasm. The chromatin was dissolved 
in 50 volumes of 2mM Tris/HCl pH 7.5, O.lM EDTA, and stirred on ice 
for 30 minutes. This solution was centrifuged for 10 minutes at 12,000 
rpm. The pellet was drained well, and dissolved in lysis buffer. The 
concentration of the solution was determined and it was stored at 
-20®C until use. Where non-histone proteins were to be prepared, the 
pellet from the Tris-EDTA extraction was resuspended in 10 volumes of 
cold 0.4N sulphuric acid and stirred for 15 minutes at 4°C. The 
solution was centrifuged at 5,000 rpm (HB4 rotor) for 10 minutes at 
4°C, resuspended in 0.4N sulphuric acid and recentrifuged. The pellet 
was drained well and resuspended in a large volume of O.lM Tris/HCl, 
pH 7.5, 2mM MgCl 2 , 2mM CaCl 2  (TMC). The dehistonised chromatin was 
repelleted (5000 rpm) and resuspended in TMC buffer. The pH of this 
solution was checked and if it was below 7.0 the wash was repeated. 
The washed pellet was then resuspended in 250pl TMC buffer containing 
25jug DNAase I (Sigma) and incubated in a 30°C waterbath for 30 
minutes. The solution was then mixed with an equal volume of lysis 
buffer, a protein determination was carried out and the solution 
stored at -20°C until required.
e) Rat liver hnRNP particle proteins.
Livers of adult male rats, weighing 200-250g were homogenised in 9 
volumes of 2.3M sucrose, lOmM MgCl 2 . Aliquots of 30ml were layered 
over 7ml cushions of 2.3M sucrose containing lOmM MgCl2  and the nuclei 
were pelleted by centrifugation for 1  hour at 40,000g (15,000rpm) in a
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Beckman SW27 rotor at 4°C. HnRNP particles were extracted from the 
purified nuclei by the method of Samarina et al. (1968). Briefly, the 
nuclei were subjected to extraction in a pH 7.0 buffer at O^C after 
which they were repelleted and the extract discarded. The nuclei were 
then extracted 3 times in a pH 8.0 buffer, on ice, and the pooled 
extracts were fractionated on a linear 15-30% (w/v) sucrose density 
gradient. The gradients were scanned at 260nm by pumping through a 
flow cell attachment to a Gilford 240 spectrophotometer. The 305 hnRNP 
monomer peak was collected and precipitated in 2.5 volumes of absolute 
ethanol at -20°C in the presence of 0.15M salt. Precipitates were 
'pelleted by centrifugation, dried in a stream of nitrogen, dissolved 
in lysis buffer and aliquots removed for analysis of protein. 
Solutions were then adjusted to 5mg protein/ml and stored at -20°C. 
Aliquots containing 100-150pg protein alone, or mixed with labelled 
uterine proteins, were fractionated on two-dimensional gels,
f) Ribosomal proteins.
Samples of ribosomal subunit proteins prepared from rat ascites tumour 
cells were a gift from Mr. M. McGarvey of this department. In outline, 
ribosomal preparations were dissociated into subunits in a Tris/HCl 
buffer containing mercaptoethanol and puromycin, and the 40S and 60S 
fractions separated on 15-30% (w/v) linear sucrose density gradients. 
Subunit fractions were dialysed to remove sucrose and precipitated 
with ethanol at -20^C. Subunits were pelleted and resuspended for 
protein extraction. Ribosomal RNA was removed by precipitation with 
acetic acid and the precipitate was reextracted. Ribosomal protein 
extracts were pooled and dialysed against IN acetic acid, lyophilised 
and dissolved in sample buffer at a concentration of Img/ml, for two- 
dimensional gel electrophoresis (section 2.6.5).
2.6 Two-dimensional gel electrophoresis of samples.
2.6.1 The O'Farrell gel system.
The gel system of O'Farrell (1975) is a two-dimensional polyacrylamide 
gel separation devised for the high resolution of proteins from 
complex biological sources. Proteins are separated according to 
isoelectric point, by isoelectric focussing in the first dimension, 
and according to molecular weight by sodium dodecyl sulphate (SDS) 
electrophoresis in the second dimension. Since these two parameters 
are unrelated, it is possible to achieve an almost uniform 
distribution of protein spots across a two-dimensional gel. The 
technique can resolve over 1 0 0 0  different components in a highly 
reproducible manner and therefore is very suitable for use in 
comparing the total protein populations of the immature rat uterus in 
different hormonal states.
2.6.2 First dimension isoelectric focussing gels.
A stock solution of 30% acrylamide (28.38% acrylamide, 1.62% 
bis-acrylamide (N,N'-methylene bis-acrylamide)) was prepared and 
stored at 4°C in the dark. Both constituents were supplied by B.D.H., 
specially purified for electrophoresis. A 10% (w/v) stock solution of 
the detergent Nonidet P-40 (NP40) was also made.
For lOmls of gel mixture, 5.5g of Aristar urea (B.D.H.) was weighed 
into a universal bottle and dissolved in 2ml NP40 stock, and 1.97mls 
of distilled water. The mixture was made 4% with respect to 
acrylamide and 2% with respect to ampholines, by addition of 1.33ml of 
acrylamide stock; 0.3ml of pH range 5-7 ampholines and 0.2ml of pH 
range 3.5-10 ampholines (both supplied as a sterile solution of 40% 
(w/v) am#iolines by L.K.B.). After thorough mixing and degassing under 
vacuum, polymerisation was initiated by addition of lOpl of a freshly
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made 10% (w/v) solution of ammonium persulphate, and Ipl TEMED 
(N,N,N',N'“tetramethylethylenediamine, Koch-Light). The mixture was 
immediately poured into glass tubes 14cm long, with an internal 
diameter of 3mm. 0.8-1.0 ml was used per tube giving a gel 10cm long. 
Each tube was sealed at the base using the rubber caps from Portex 
sterile surgical canulae (Fisons). The canulae were used with a 1ml 
tuberculin syringe to deliver the gel solution into the base of the 
gel tubes without trapping air bubbles. Each gel was overlaid with 
distilled water and left to polymerise for 2 hours. The rubber seals 
were then removed and the water overlay replaced with 2 0 pl of lysis 
buffer (9.0M Aristar urea, 2% w/v ampholines, (comprised of 1.2% pH 
range 5-7 ampholines, 0.8% pH range 3.5-10 ampholines), 5% (v/v) 2- 
mercaptoethanol) which was stored as frozen aliquots. The gels were 
then pre-electrophoresed for 30 minutes at 250V and 30 minutes at 
400V, to remove any isocyanate ions which could cause protein 
carbamylation and thus artifacts in the separation. The cathode 
reservoir (upper) contained 0.02M NaOH and the anode reservoir (lower) 
contained O.OIM H^PO^. After the prerun, the NaOH and lysis buffer 
were removed from the surface of the gels and samples loaded using an 
automatic pipette. Wherever possible, samples did not exceed 50pl or 
150pg of proteins as either excess volume or excess protein may cause 
loss of resolution.
The samples were carefully overlaid with 20pl of lysis buffer and the 
tubes filled with 0.02M NaOH. A blank gel overlaid with lysis buffer 
only, was run at the same time as the samples, and was used to 
determine the pH gradient across the gels after isoelectric focussing. 
The gels were run overnight at 400V for a minimum of 5,000 volt hours, 
and a maximum of 10,000 volt hours. After the run, gels were extruded 
using a syringe attached via a short piece of tubing, and were frozen
pH.
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pH grad ien t  of an i s o e le c t r i c  focusing gel
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immediately in SDS sample buffer (10% w/v glycerol (B.D.H.), 5% v/v 
2-mercaptoethanol, 2.3% w/v SDS, 0.01% w/v Bromophenol blue (.Gurr, 
Searle). Blank gels were extruded, frozen in dry ice and sliced into 
1mm sections using a Mickle gel slicer. Groups of three slices were 
placed into small tubes, each containing O.Smls freshly degassed O.OIM 
KCl, and left to stand for 10 minutes. The pH of each fraction was 
measured using a combination electrode. A typical pH gradient is shown 
in Fig. (i) opposite.
2.6.3 First dimension non-equilibrated pH gradient electrophoresis. 
Although basic ampholytes extending to pH 11 are commercially 
available, the basic end of ampholine generated pH gradients is not 
■generally stable over long periods of electrophoresis. For this reason 
O'Farrell et al. (1977) devised the technique of non-equilibrated pH 
gradient gel electrophoresis, or NEpHGE, to separate mixtures of 
proteins containing basic components. The first dimension separation 
uses the same basic recipe as for the isoelectric focussing gel, but 
the ampholines used are pH range 3.5-10 (L.K.B.) only.
For 10 mis of gel mixture the following recipe was used: 5.5g Aristar 
urea (B.D.H.), 2ml, 10% w/v NP40 stock solution, 1.33mls 28.38% w/v 
acrylamide, 1.62% w/v N,N'-methylene bis-acrylamide stock, and O.Smls 
pH range 3.5-10 ampholines. The solution was degassed and polymerised 
as described in section 2.6.2. Samples were prepared and loaded as for 
isoelectric focussing but gels were not pre-electrophoresed. After 
overlaying samples with 2 0 ^ 1  of lysis buffer the tubes were filled 
with O.OIM H 3 PO4 , The upper reservoir was filled with O.OIM H^PO^ and 
the lower reservoir with 0.02M MaOH. The gels were then run at 500V 
for 4 hours (a total of 2000 volt hours). This ensured that even the 
most basic proteins entered the gel but did not reach their
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isoelectric points. For many proteins their isoelectric points would 
not lie within the gel if electrophoresis were continued to 
equilibrium. This method of separation was used to examine 
heterogeneous nuclear ribonucleoprotein (hnENP) particle proteins for 
which it was adap^rted by Wilks & Know 1er (1980).
2.6.4 Second dimension sodium dodecyl sulphate, polyacrylamide gels. 
The discontinuous polyacrylamide gel system used in the second 
dimension was basically that of Laemmli (1970). The recipes given 
below are those of LeStourgeon & Beyer (1977). Stock solutions of 
acrylamide (30% w/v acrylamide, 0.8% w/v N , N ’-methylene bis- 
acrylamide) and resolving gel buffer (Tris base (Sigma) 180g/l, SDS, 
4g/l, HCl to pH 8 .8 ) were stored at 4°C in the dark. The running 
buffer (Tris base 3g/l, glycine 14.4g/l., SDS lg/1) was made up as a 
lOx concentrate and stored at room temperature.
10% polyacrylamide gels containing 0.1% SDS were made as follows. For 
each gel to be poured, 13mls distilled water, lOmls resolving gel 
buffer and 16,7mls acrylamide stock were mixed in a conical flask and 
degassed under vacuum. For each gel, 150pl of a freshly prepared 10% 
w/v ammonium persulphate solution and lOpl TEMED (Koch-Light) were 
added, mixed and the gels poured immediately. For 8,75% gels 18mls 
distilled water, lOmls resolving gel buffer and 11.7 mis acrylamide 
stock were mixed for each gel.
The gel formers consisted of 2 glass plates 6 mm thick and 18x21 cm. 
One of these had a notch 2.5cm deep and 15cm wide in the short edge. 
The plates were separated by two 0.8cm wide, 1.5mm thick perspex 
strips placed at the sides, and by 2 mm silicon tubing along the side 
and bottom edges. The plates were clipped together with bulldog clips.
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with the notched edge uppermost. The gel solution was poured to within 
0 .5 cm of the notch, overlaid with isobutanol, and left to polymerise 
for 1-2 hours. Before use the silicon tubing was removed and the 
isobutanol washed from the upper surface of the gel, which was then 
rinsed with running buffer.
First dimension gels were thawed and laid along the upper surface of 
the SDS gel ensuring contact along its entire length, h small sample 
well was formed at one end of the gel, by pouring molten 1 % w/v 
agarose around a piece of silicon tube pushed between the glass 
plates, and allowing it to cool for 2-3 minutes. This was used for the 
application of molecular weight standards (Pharmacia, low molecular 
weight range 14,400 - 94,000). Loaded second dimension slab gels were 
run in pairs on a double apparatus. The gel plates were clipped to the 
upper reservoir of the apparatus, which had notches at each side, 
corresponding to those in the gel plates. The lower reservoir was a 
trough surrounding the bases of both gels. Wherever possible first 
dimension gels which had been run together were applied to second 
dimension gels poured from the same batch of solution and were run in 
pairs. Up to 6  slab gels could be run at one time. Gels were run at 
35mA per gel until the dye front reached the base of the gel. For a 
15xl5cm, 1.5mm thick slab, this was usually between 3 and 4 hours. At 
the end of the run gels were placed in 0.25% w/v Coomassie Blue R250 
(Gurr, Hopkin & Williams), 50% v/v methanol, 10% v/v acetic acid and 
left overnight to stain. Gels were destained in several changes of 50% 
v/v methanol, 1 0 % v/v acetic acid.
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2.6.5 Two-dimensional polyacrylamide gel electrophoresis of ribosomal 
proteins.
In outline, ribosomal proteins extracted from purified ribosomal 
subunits were dissolved in sample buffer (8 M urea, O.OOIM 2- 
mercaptoethanol, O.OIM NaHCOg pH 8.3) at a concentration of Img/ml. 
lOOpg ribosomal protein (in lOOpl) was loaded per gel. Two-dimensional 
polyacrylamide gel electrophoresis of ribosomal proteins was carried 
out by Mr. I.M, Kennedy o f  this department, using the standard 
procedure of Kaltschmidt and Wittman (1970), with modifications 
(Lastick & McConkey, 1976). The apparatus used has been described 
previously (Leader, 1975).
For cofractionation, lOOpl aliquots were mixed with messenger 
dependent lysate translation assays directed by uterine polysomal 
messengers. The translation assay contained approximately 10^ cpm [L- 
-methionine (in trichloroacetic acid-precipitable counts), in a 
maximum of 5 to lOjul. The exact counts and volume depended on the 
source of messenger used in different assays. Samples were layered 
over 5cm x 0.4cm, 4% polyacrylamide disc gels containing 6 M urea at a 
pH of 8.7. Electrophoresis was carried out at 3mA per gel for 3 hours, 
the direction of migration being towards the cathode. The tank buffer 
used was a Tris-borate buffer with a pH of 8.0. Pairs of first 
dimension gels were removed from their tubes and laid on top of a 7cm 
X 7cm X 0.4cm, 15% polyacrylamide gel containing 6 M urea at a pH of
4.5. The first dimension gels were annealed into place with 1% w/v 
agarose. Electrophoresis was then carried out at 10mA per gel for 16 
hours, with migration again being towards the cathode. The tank buffer 
used for the second dimension was a glycine-acetate buffer at a pH of
4.05. After the run, gels were stained for 3 hr at 37*^C in 0.1% (w/v) 
Coomassie Brilliant Blue R250 (Gurr,Hopkin & Williams Ltd.) in
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methanol:acetic acid:water (5:1:5) and destained at 37^C in 7.5% (v/v) 
acetic acid.
2.6.6 Fluorography.
Fluorography was routinely used because it improves the efficiency of 
detection of beta-emitting isotopes such as and by at least 
tenfold. Gels were prepared according to the method of Bonner & Laskey 
(1974), with modifications. Gels were washed in tap water to remove 
excess destaining solution and soaked in three successive 250ml 
dimethylsulphoxide (DMSO, Koch-Light) washes for 30 minutes each. The 
gels were then immersed in 4 volumes of 22.2% w/v 2,5-diphenyloxazole 
(PPO) in DMSO, and were shaken gently for 2 hours. All stages 
involving DMSO were conducted in an airtight box. Following their 
impregnation with PPO, gels were left under running tap water for 1 
hour to precipitate the PPO into the gel matrix. The gels were dried 
onto Whatman 3MM paper under vacuum, at 80°C for about one hour on a 
Bio-Rad gel drier. Dried gels were exposed to RP X-Omat X-ray film 
(Eastman-Kodak) pressed between 2 glass plates at -70°C for 4 to 6  
weeks.
RESULTS
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11. RESULTS
3.1 The detection of labelled uterine proteins from immature rats.
This project utilised the technique of labelling proteins of the 
immature rat uterus in vitro, with various high specific activity 
radioactive isotopes, after which they were subjected to two- 
dimensional gel electrophoresis. The proteins were visualised by 
fluorography of the dried second dimension sodium dodecyl sulphate 
(SDS)-polyacrylamide gels.
A number of approaches were used in the attempt to detect differences 
between the protein population of the unstimulated rat uterus and that 
seen in the early stages of oestrogen stimulation. Firstly, whole 
uteri were labelled hi vitro with a high specific activity mixture of 
l^c-labelled amino acids. Both total protein, and subcellular 
fractions were prepared and examined using the techniques described in 
the Methods section. Subsequently these techniques were extended to 
the study of the protein population present in three different uterine 
cell types:- epithelium, stroma and myometrium. In a third approach 
uterine proteins were labelled by the cell-free translation, hi vitro, 
of uterine polysomal messenger RNA, derived from both whole uteri and 
from isolated cell types. Finally, a number of known proteins were 
cofractionated with labelled uterine preparations on two-dimensional 
gels, to try to identify some of the components in the spectrum of 
uterine proteins.
3.2 The investigation of proteins synthesised in vitro in whole uteri. 
The specific activities of total uterine protein samples varied from 
1000 to 2000 cpm/pg protein. Fig, 1 shows gels of ^^C-labelled 
proteins from unstimulated animals, separated by isoelectric
Figure I
Electrophoresis of L-[U-^^C]-labelled uterine proteins on two- 
dimensional polyacrylamide gels
The uteri from 6  immature rats were incubated in 1ml of Eagles medium 
containing one-thousandth the usual concentration of amino acids, and 
20 yUCi of a high specific activity L-[U-^^C]-labelled amino acid mix, 
as described in the Methods section (2.5.1). A total protein sample 
was prepared and the specific activity determined. The proteins were 
subjected to two-dimensional gel electrophoresis by the method of 
O’Farrell (1975), which uses isoelectric focussing in the first 
dimension. The sample was loaded at the basic end of the gel and run 
at 400V for 6000-8000 volt-hours. The second dimension was an 8.75% 
polyacrylamide slab gel containing 0.4% SDS. The gel was stained in 
0.25% (w/v) Coomassie Brilliant Blue R250 in 50% methanol, 10% acetic 
acid, and destained in the solvent mix. The wet gel was photographed, 
prepared for fluorography according to the method of Bonner and Laskey 
(1974) and exposed to X-ray film for 12 days. The gel was loaded with 
250pg protein from L - l a b e l l e d  uteri, containing 10^ cpm. The 
direction of the first dimension was from right (basic) to left 
(acidic), and the slab gel was run from top to bottom.
a) Coomassie Brilliant Blue staining pattern
b) Fluorogram
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focussing in the first d i m ension and SDS-polyacrylamide gel 
electrophoresis in the second dimension. Fig. la shows the Coomassie 
Blue staining pattern achieved, and Fig. lb the fluorograph of the 
same gel. This gel was overloaded {250pg protein, 2x10^ cpm) to show 
the staining pattern. The major protein species lie in the acidic part 
of the gel and form a complex, distinct pattern. Many minor components 
are present, and these are difficult to compare between gels due to 
their faintness, even after long exposures. O’Farrell (1975) suggests 
a maximum loading of lOOpg protein per gel, to avoid artifacts in the 
separation. He indicates that the main problem is in the change of 
major spot shape and the displacement of minor spots as larger 
neighbours increase in size. However in a complex mixture of proteins, 
only a small number of species are present as major components, and 
gels can be severely overloaded with respect to these with only a 
small decrease in overall resolution of the majority of species. The 
arrowed area of Fig. 1 illustrates the distortion of a labelled 
component by a major stainable spot. This particular distortion occurs 
on all gels of total and cytoplasmic protein.
O'Farrell further suggests that for true comparison, the same loading 
of protein must be used on each gel. This is not always possible using 
the uterine samples, due to variation in the specific activities 
between different preparations. Most gels were run with a loading of 
1 0 ^ cpm , but the possible effects of variation in protein loading on 
the results obtained must be borne in mind in all subsequent gel 
analyses.
Although many of the stained proteins in Fig. la also appear as 
labelled species in Fig. lb there are many more spots visualised by 
fluorography and the pattern is very complex. To try to simplify this
bü
picture and allow easier detection of hormone-induced changes, the 
labelled uterus was fractionated into cytoplasmic and nuclear 
preparations before analysis on gels. Such fractionations had the 
added advantage that oestrogen-induced changes might be identified 
with specific cell compartments.
Specific activities for cytoplasmic protein samples varied from 500 to 
2,500 cpm/pg protein, and for nuclear samples from 600 to 2800 cpm/jug 
protein. The degree of labelling varied with hormone treatment, and 
preparations from control animals generally had lower specific 
activities. Nuclear samples always had higher specific activities than 
their corresponding cytoplasmic fractions.
Fig. 2 shows the spot patterns of ^^C-labelled cytoplasmic uterine 
proteins. The fluorograms shown are typical of the protein populations 
found in immature rats responding to 0, 2 and 4 hours of oestrogen 
stimulation. The overall resemblance of these fluorograms to each 
other and to the spot pattern in Fig. 1 is obvious. However, once the 
general pattern is recognised, it is possible to detect some 
differences between the preparations from control and hormone-treated 
animals. Spots arrowed and numbered 1 to 6 appear after hormone 
treatment or increase in response to it. Spots 7 and 8  appear between 
2 and 4 hours of treatment and the spots marked 9 progressively 
decrease and are absent from the population after 4 hours of oestrogen 
treatment. However, these differences are not consistent for every 
set of gels. For example, the three spots marked 1 are absent from the 
control gel of Fig. 2a, but some or all of them regularly appear on 
other control gels (e.g. Fig. 3a, following page 69). The two spots 
marked 3 are a similar case. These increase in intensity after the 
longer hormone treatment and cannot be seen in the control sample 
(Fig. 2a), only the reference spot 'A' being present.
Figure 2.
Electrophoresis of L- -labelled uterine cytoplasmic proteins
from rats responding to short periods of oestrogen stimulation.
Groups of six immature female rats received Ipg oestradiol-17^ in 
saline by intraperitoneal injection, 2 or 4 hours before death. 
Control animals received saline only, 4 hours before death. Uteri were 
labelled as described in the legend to Figure 1. After incubation, the 
uteri were homogenised and nuclei were isolated using the method of 
Know 1er (1976). Protein samples were prepared from the post-nuclear 
supernatant and the nuclear pellet, as described in the Methods 
section (2.5.1). The samples were subjected to two-dimensional gel 
electrophoresis as described in the legend to Figure 1. Gels were 
fluorographed and films were exposed for 12 days. The fluorograms 
shown are as follows:-
a) Control uterine cytoplasmic protein. The first dimension gel was 
loaded with 130jug protein containing 10^ cpm.
b) Uterine cytoplasmic proteins from rats receiving Ipg 17^-
oestradiol 2 hours before death. Loading: 40pg, 10^ cpm.
c) Uterine cytoplasmic proteins from rats receiving Ijag 17^-
oestradiol 4 hours before death. Loading: 95pg, 10^ cpm.
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However, it is exceedingly difficult to locate these two spots on any 
other gel, for example the 12 hour sample in Fig. 3. Furthermore, they 
may even be present in the control sample in Fig. 1 just below and to 
the left of the arrowed distortion. The two spots marked 6  correspond 
to the expected position of IP. These are exclusively cytoplasmic, as 
is IP (See Fig. 5, following page 70) but occur in some control gels 
(Fig. 3a, following page 69). Spot 7 seems to be a more reliable 
difference. It appears between 2 and 4 hours after oestrogen and 
cannot be seen on any control gel. It is also absent from the 12 hour 
sample and would therefore be a good candidate as a key intermediary 
protein. However, further experiments have shown that this spot is 
also very difficult to identify consistently.
Other examples of minor differences can be seen but the validity of 
these is even more difficult to assess, because of the variation 
between gels and samples of cytoplasmic protein from uteri receiving 
the same hormone treatment. The basic end of a gel always shows the 
largest variation. This is where the most interference from any 
nucleic acids in a sample may be expected, and where the pH gradient 
is most variable between first dimension gels that have not been run 
together (O'Farrell, 1975).
Fig. 3 shows a direct comparison between samples of the same specific 
activity, from control animals and those receiving oestrogen 
stimulation 12 hours before death. The most obvious result of this 
comparison is the high degree of similarity between the newly made 
proteins in the uterine cytoplasms of control and hormone-stimulated 
animals. No major changes can be identified in the population, and 
many of the recognisable 'constellations' of minor proteins agree 
closely between the two fluorograms. This is surprising in view of the
Figure 3.
Electrophoresis of L - [U-^^C]-labelled uterine cytoplasmic proteins 
from rats responding to 0 _ £  1 ^  hours of oestrogen stimulation.
Groups of 6  immature female rats received either Ipg of oestradiol-17^ 
or saline only, 12 hours before death. Experimental details are the 
same as those for Figure 2. Films were exposed for 11 days and the 
fluorograms are shown. The first dimension gels were each loaded with 
ISQug of proteins containing 1 0 ^ cpm.
a) Control uterine cytoplasmic proteins.
b) Uterine cytoplasmic protein from rats responding to 12 hours of 
oestradiol-17^.
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Figure 4.
The effect of oestradiol-17^ on polysome profiles of immature rat 
uteri.
Immature female rats were given a single injection of I^g oestradiol- 
17pf in saline, at various times before death. Control animals received 
saline only. Polysomes were prepared from the uteri and analysed on 
15-45% (w/v) sucrose density gradients as described in the Methods 
section (2.5.7). The profiles shown are examples of polysomes from 
uteri responding to the following times of oestrogen treatment:
a) 0 hrs, b) 2 hrs, c) 4 hrs, d) 12 hrs.
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difference in protein synthetic activity in vivo, between 0  and 1 2  
hours of oestrogen stimulation. The profiles of sucrose density 
gradient separations of polysomes in various hormonal states can be 
seen in Fig. 4. These show that the majority of ribosomes in the 
untreated immature rat uterus exist as free monosomes or in small 
aggregates of two or three ribosomes. As oestrogen treatment 
progresses the ribosomes are isolated in increasing amounts at the 
heavy end of the gradient as large polysomes. This indicates that the 
unstimulated uterus is a quiescent tissue not very active in protein 
synthesisf whereas after 1 2  hours of oestrogen treatment, the tissue 
has entered the phase of vastly increased protein synthesis 
characteristic of the hypertrophic response. In view of this, and in 
view of the known changes in uterine mENA populations in the oestrogen 
‘treated rat (Aziz et al., 1979b), one might have expected to see 
considerable differences between the control and 1 2  hour protein 
populations shown in Fig. 3.
The comparison of nuclear samples at first seemed more informative. 
The protein populations seen at 0, 4 and 12 hours are shown in Fig. 5. 
The spot patterns share some of the proteins seen in the cytoplasmic 
samples, but there are fewer components resolved. Greater differences 
can be seen between the control and hormone-treated samples on the 
gels shown than for the cytoplasmic samples and these are arrowed in 
yellow. These differences are not reproducible, with the exception 
that the synthesis of the protein arrowed in white always decreases 
after hormone treatment. A recent analysis of mouse uterine proteins 
shows a very similar spot pattern (Korach et al., 1981). The authors 
and a number of workers with other cell systems, have identified a 
protein migrating in the same position, as a subunit of tubulin 
(Schultz et al., 1979; Bravo & Cells, 1980). There is also reason to
Figure 5.
Electrophoresis of L- [U-^^C] -labelled uterine nuclear proteins from 
rats in various hormonal states.
Nuclear protein samples were prepared from labelled uteri by the 
method of Knowler (1976). Details of the labelling in vitro, and
electrophoresis are given in the legend to Figure 1. Fluorograms were
exposed for 11 days in a) and b), and for 21 days in c) and d). The 
rats were treated with oestradiol-17^ for the following times:
a) 0 hrs. Loading: 80pg protein, 10^ cpm.
b) 4 hrs. Loading: lOOpg protein, 10^ cpm.
c) 0 hrs. Loading: 80jug protein, 5x10^ cpm.
d) 12 hrs. Loading: SOjug protein, 5x10^ cpm.
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suppose that the major triple spot below the arrowed spot is actin. 
This is discussed later.
3.3 The investigation of the protein population of isolated cell 
types.
Light microscopy was used to look for damage to cells during the 
fractionation procedure, and samples of each cell type were also 
examined by transmission electron microscopy (TEM). This allowed a 
check on the integrity of cells after preparation, and an assessment 
of the degree of contamination between cell types. These methods were 
used by McCormack & Glasser who developed the fractionation procedure 
(1980), and the micrographs compare well with their published results.
Epithelial cells were isolated as large plaques of cells in which many 
lipid droplets could be seen under both light and transmission 
electron microscopy. They also had many microvilli on their surfaces 
(Fig. 6 a). There were very few cells of any other kind in epithelial 
fractions.
The stromal cells did contain a few small epithelial plaques, but 
these did not exceed 5% of the preparation. The cells appeared rounded 
and had large nuclei, but could not easily be distinguished from 
myométrial cells under the light microscope, TEM revealed separated 
stromal cells to be engaged in the production of collagen fibrils and 
they showed small irregular blebs and protrusions at their surfaces 
(Fig. 6 b). This agreed with the appearance of these cells in the 
scanning electron micrographs published by McCormack & Glasser. TEM 
also showed the presence of intact glandular epithelial structures in 
this fraction (Fig. 6 c).
Figure 6.
Transmission electron microscopy of fractionated uterine cell types.
Uterine cell types were isolated using an enzymatic digestion 
technique developed by McCormack & Glasser (1980). Full experimental 
details are given in the Methods section (2.5.4). Samples were sent 
for electron microscopy immediately after isolation. This analysis was 
performed by Mr. I. Montgomery of the Physiology Department, 
University of Glasgow. The figure shows typical micrographs of the 
cell types isolated from control uteri.
a) Luminal epithelial cells x3,900.
b) Stromal cells x3,900.
c) Glandular epithelial structure in the stromal fraction x2,350.
d) Myométrial cells x7,800.
mv, microvilli; L, lipid droplets ; c, collagen fibrils; 
p, protrusions; gl, glycogen granules; t, membrane thickening; 
sf, stress fibres.
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The myométrial cell fraction contained no epithelial cells, but did 
contain some stromal contamination. This was difficult to assess 
except where stromal cells could be seen in micrographs but appeared 
to be at a low level. The myométrial cells were irregular and often 
elongated with nuclei occupying a much smaller proportion of the cell 
than in the stromal cells. The cells possessed membrane thickenings 
indicative of subsarcolemmal filament attachment areas, and also 
contained glycogen granules and stress fibres (Fig. 6 d).
After isolation, each cell type was labelled vitro with 
methionine and total protein samples were prepared and subjected to 
two-dimensional gel electrophoresis. Specific activities for these 
samples varied from 500 to 800 cpm/jag protein for epithelial and 
stromal cell types but were always below 500 cpm/jug, and were usually 
about 2 0 0  cpm/ug for myométrial cells.
Fig. 7 shows the patterns of radioactive proteins detected in 
epithelial, stromal and myométrial cells from the uteri of control 
animals. The patterns are not as complex as those seen for total or 
cytoplasmic protein samples from whole uteri, and do not at first 
appear very similar. The staining patterns (not shown) showed a few 
faint spots, and one large spot which was identical in position to the 
major component arrowed in Fig. la (following page 6 6 ). This 
polypeptide was not labelled in vitro but is severely overloaded on 
these gels and causes a serious distortion spreading over a larger 
area of the gel than in Figs. 1-3. It completely displaces the more 
basic of the spots which migrate at the same molecular weight position 
and is particularly prominent in the myométrial fraction. This 
distortion is useful as an internal marker for comparing the 
fluorograms of cell-type proteins with those of whole uteri. Although
Figure 7.
Electrophoresis of proteins from L-[^^S]-labelled fractionated cell 
types.
The uteri of 24 immature rats were used to prepare- epithelial, 
stromal and myométrial cell fractions, as described in the Methods 
section (2.5.4). Following isolation, e^ch cell type was rested for 4 
hours at 37^C in an aerated tube containing 5 mis of complete Eagles 
medium. After this incubation each cell type was washed twice in 
phosphate buffered saline, and then incubated in 1ml Eagles medium 
lacking methionine, and containing 5% charcoal-stripped, heat- 
inactivated foetal calf serum, and 70pCi o f .L-[^^S]-methionine. 
Protein samples were prepared from each cell type as described in the 
Methods section. Two-dimensional gel electrophoresis and fluorography 
were performed for each sample as described in the legend to Figure 1, 
except that second dimension slab gels were 10% polyacrylamide. All 
subsequent figures of SDS gels show 10% polyacrylamide slabs. Films 
were exposed for 28 days.
a) Control epithelial cell-type proteins. Loading: 190|ug protein, 
9.6x10^ cpm.
b) Control stromal cell-type proteins. Loading: lOOpg protein, 7x10^ 
cpm.
c) Control myométrial cell-type proteins. Loading: 150pg protein, 
3.6x10^ cpm.
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they have not run so far, the gels in Fig. 7 may be compared most 
easily with those in Fig. 3 (following page 69). The putative actin 
spot, and a distinctive constellation of higher molecular weight 
proteins in the acidic region are arrowed in yellow in Fig. 7a. All of
these are easy to identify in Fig. 3 and in other gels. They can be
seen in gels published by Walker & Kaye (1981). Many other spots are 
less easy to identify particularly without the molecular weight 
markers which were not used on the early gels.
The combination of the three cell-type spot patterns does not add up 
to the total spectrum of uterine proteins seen in the earlier gels. A 
few proteins are exclusive to the epithelial cell types (black 
arrows), but there are no obvious stromal or myométrial markers. The 
spot arrowed in Fig. 7b is discussed in the section on Fig. 8 . Most of
the proteins are common to the three cell types.
Fig, 8  shows the epithelial and stromal cell patterns from uteri 
responding to 4 hours of oestrogen. A satisfactory gel of myométrial 
proteins was never obtained. The greatest difference found, was in 
fact, in the specific activities of the stromal fractions. These were 
consistently stimulated following 4 hours of oestrogen treatment from 
about 500 to 2000 cpm/jug protein. The specific activities of 
epithelium (500 cpm/jug) and myometrium (200 cpm/pg) were unaffected.
There is virtually no change in the proteins labelled in the 
epithelium after 4 hours of oestrogen treatment, except that three of 
the proteins exclusive to the epithelium increase in response to the 
hormone (black arrows, compare Figs. 7a & 8 a). When the stromal 
proteins of untreated (Fig. 7b) and 4 hour oestrogen-treated rat 
uterus (Fig. 8 b) were compared, however, hormone-induced differences
Figure 8 .
Electrophoresis of L-[^^S] -labelled uterine cell-type proteins from 
immature rats responding to 4 hours of oestrogen treatment.
24 immature female rats received lug oestradiol-17(3 4 hours before 
death. All other experimental details are the same as described in the 
legend to Figure 7. Films were exposed for 28 days.
a) 4hr oestrogen-treated epithelial cell proteins. Loading: 200pg 
protein, 1 .2 x 1 0 ^ cpm.
b) 4hr oestrogen-treated stromal cell proteins. Loading: 65jug 
protein, 1.45x10^ cpm.
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were detected. Firstly, as expected from the higher specific activity 
of the protein from oestrogen-treated animals, most proteins were more 
heavily labelled. In addition some new spots were detected after 
hormone treatment and those which proved reproducible are indicated by 
black arrows in Fig. 8 b. Most of these are exclusive to the stroma. 
The labelling of a single stromal polypeptide decreased after hormone 
treatment; this is arrowed in Fig. 7b.
Some further differences were detectable between the two cell types, 
particularly in the labelling of the putative actin spot relative to 
the other components. In epithelium, this is a major triple spot, with 
a smaller streak to the acidic side of the gel. In stroma the spot is 
considerably smaller and may consist of only a single polypeptide. 
Actin is known to occur in multiple forms which have peptide 
differences. Garrels and Gibson (1976) have identified three major 
actins of which two occur in all eukaryotic cells (beta, gamma) and 
the other (alpha) is exclusive to muscle cells. Although there are 
clearly three components to the actin spot in fluorograms of protein 
samples from whole uteri (e.g. Fig. 1, following page 6 6 ), it is 
difficult to resolve the exact number of components in the cell-type 
protein samples. However, there is clearly some difference between the 
epithelial and stromal cell types. Another noticeable difference is in 
the spots in the same positions as those identified as tubulins by 
Korach et al. (1981) (yellow arrows. Fig. 8 b). These are easily 
recognisable in gels of whole uteri and are heavily labelled in 
hormonally treated stromal fractions. In contrast, the epithelium has 
a number of smaller spots which migrate at this position. These are 
probably different forms of the cK and ^  tubulins which are known to 
exhibit microheterogeneities between different tissues, and during 
development, in many species (Raff et al., 1982). It is odd that, in
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these stromal preparations the synthesis of this putative tubulin was 
strongly stimulated (compare Figs. 7b & 8 b), while the investigations 
of isolated nuclei showed what appeared to be the same protein 
synthesised in smaller quantities after hormone treatment (Fig. 5, 
white arrow, following page 70). Korach et al. (1981) have described 
hormone-induced movement of specific proteins into different cell 
compartments and this may explain the anomaly.
The efficient labelling of the separated cell types was only possible 
after they had been allowed to recover from the trauma of isolation, 
by resting in a complete, aerated medium for 4 hours. Thus it is 
possible that the differences between the labelled protein patterns of 
cell types and whole uteri, stemmed from the labelling technique, 
rather than the source of material. To test this possibility, cell 
types were prepared from uteri which had been labelled vitro as in 
the earlier experiments. To avoid any artifacts due to storage, cell 
protein samples were always prepared on the same day as the uteri were 
isolated, immediately following the labelling incubation. The specific 
activities of cell types were higher using this method; about 2500 
cpra/pg for epithelium and stroma, and 1500 cpm/pg for myometrium. Fig. 
9 shows the pattern of ^^S-methionine labelled proteins derived in 
this way from the uteri of immature rats responding to 4 hours of 
oestrogen treatment. The films, although over-exposed, show almost all 
of the components seen in the comparable experiment in which the cells 
were labelled after fractionation (Fig. 8 ). The spot patterns of the 
epithelial and stromal preparations (Figs. 9a & 9b) are very complex, 
but there are still relatively few differences between the two 
fluorograms. However, these preparations are enriched in low molecular 
weight and basic proteins relative to those of Fig. 8 . Most of the 
exclusive and hormone-stimulated stromal proteins seen in Fig. 8 b can
Figure 9.
Electrophoresis of L-[^^S]-labelled uterine cell-type proteins, 
fractionated from pre-labelled uteri.
24 immature female rats received oestradiol-17p , 4 hours before 
death. The uteri were incubated in 1ml Eagles medium lacking 
methionine, but containing 150pCi L- -methionine. The labelling 
incubation and preparation of fractionated cell-type protein samples 
was conducted as described in the Methods section. Fluorograms of the 
two-dimensional separations of the 3 cell types are shown. A 
separation of total, L-[^^S]-labelled uterine proteins is included for 
comparative purposes. This sample was prepared from the uteri of 6  
rats responding to 4 hours of oestrogen-treatment. These were labelled 
in 1ml Eagles medium lacking methionine but containing 50pCi L-[^^S]- 
methionine. Protein samples were prepared as described in the Methods 
section.
a) 4 hour epithelial cell-type proteins. Loading :80/jg protein, 
1.9x10^ cpm.
b) 4 hour stromal cell-type proteins. Loading: 75pg protein, 
2.25x10^ cpm.
c) 4 hour myométrial cell-type proteins. Loading: lOBjug protein, 
1.54x10^ cpm.
d) 4 hour oestrogen treated total uterine proteins. Loading: 12Qug, 
2 x 1 0 ^ cpm.
Films a,b & c were exposed for 40 days and film d for 27 days.
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be picked out in Fig. 9b (black arrows) and some additional 
differences between the epithelium and stroma are also arrowed. The 
differences between the epithelial and stromal 'actin' spots in Figs. 
7 & 8  are not detectable in the samples shown in Fig, 9. The spot 
labelled '4' in Fig. 9a is for reference in discussing Fig. 12, and 
Fig. 9d is a total uterine protein population included for comparative 
purposes.
The myométrial sample (Fig. 9c) shows few spots, and none are 
exclusive to the myométrial fraction. This is in agreement with all 
the gel separations performed with material from this fraction. The 
spots in this prelabelled 4 hour treated myometrium are, however, 
difficult to identify with those of control myometrium labelled after 
separation from whole uteri (Fig, 7c, following page 72). As 
previously described, attempts to label isolated myometrium from 
hormone-treated uteri were unsuccessful and the control preparation of 
Fig. 7c was labelled very inefficiently and therefore may not 
represent proteins made in vivo. The higher specific activity of the 
prelabelled myométrial sample enabled protein overloading to be 
avoided for this gel and the distortion in Fig. 7c was thus abolished. 
The prelabelled sample shows the 'actin' spot to be a major component 
whereas it is very faint in Fig. 7c,
Protein samples from whole uteri (Figs, 1-3 & 5) were labelled with a 
mixture of high specific activity amino acids, whilst the protein 
preparations from isolated cell types shown in Figs, 7-9 were from 
^^S-methionine labelled tissue, or cells. To ensure that any 
differences observed were not due to the use of different radioactive 
precursor, one of the prelabelled cell-type samples was prepared 
again, using amino acid mixture in the labelling incubation. The
/ /
sample prepared was from unstimulated rat uteri and thus could be 
compared with ^^S-labelled control cell samples labelled post­
fractionation (Fig. 7); and with the ^^C-labelled total uterine 
protein population from control rats (Figs. lb & 13d, following pages 
66 & 68).
Fluorograms of the prelabelled cell-type samples are shown in Fig. 
10. This figure shows a much greater difference between one cell type 
and another than was detected after ^^S-methionine labelling. Spots 
exclusive to, or particularly heavily labelled in, each cell type are 
arrowed. Most of these are seen in the epithelial fraction (Fig. 10a) 
but there are four proteins which are very heavily labelled in the 
stroma only (Fig. 10b). The myometrium (Fig. 10c) shows no exclusive 
components. Some of the arrowed proteins in Fig. 10a correspond to 
exclusively epithelial proteins in Fig. 7a. Most of the labelled 
species correspond to stainable proteins (Fig. 11) although not all 
stainable proteins are labelled (see arrows. Fig. 11a).
The 'actin' spot differs between the cell types. The epithelium shows 
only two components whereas there are clearly three components in the 
stroma and myometrium. From Garrels & Gibson's observations (1976) one 
would expect the most acidic spot, alpha actin, to be absent from 
epithelial and probably stromal fractions since they have shown it to 
be exclusive to muscle cells. It is clearly absent from the epithelial 
fraction but is present in the stroma. This is in contrast to Figs. 7 
& 8 which show the stroma to have less ^^S-labelled actin-like 
components than epithelium. As in the other cell protein samples the 
preparations of Fig. 10 are enriched in basic species.
When comparing Figs. 9 & 10, it is seen that most proteins labelled
Figure 10.
Electrophoresis of L - [U-^^C]-labelled uterine cell-type proteins, 
fractionated from pre-labelled uteri.
24 immature rat uteri from control animals were labelled as described 
in the legend to Figure 1. All other experimental details are the same 
as those for Figure 9. Fluorograms of the two-dimensional separations 
of the three cell types are shown. Films were exposed for 30 days.
a) Control epithelial proteins. Loading; 130pg protein, 9.1x10^ cpm.
b) Control stromal proteins. Loading: 200pg protein, 9.9x10^ cpm.
c) Control myométrial proteins. Loading: 130pg protein, 6x10^ cpm.
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Figure 11.
Staining patterns of control cell-type proteins.
These photographs show the Coomassie Brilliant Blue staining patterns 
of the three gels whose fluorograms appear in Figure 10 a-c.
a) Control epithelial proteins. Loading: 130pg protein.
b) Control stromal proteins. Loading: 200pg protein.
c) Control myométrial proteins. Loading: ISOpg protein.
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with ^"^C-amino acids are also labelled with ^^S-methionine. The 
multiple spots in the region of the polypeptides identified by others 
as tubulins, are not seen in the ^^S-labelled samples. This may be 
either a difference in the labelling of the proteins, or an artifact 
due to sample preparation of the ^^C-labelled fractions. This area of 
the gel is also difficult to compare with that in Fig. 7 (following 
page 72), which comprises protein species labelled in isolated cell 
types labelled after fractionation from control uteri. The 
constellation of spots arrowed for reference (black) in Fig. 7a is not 
obvious in Fig. 10a and may either be absent or have been disguised by 
streaking. Most of the major spots, however, are consistently 
reproduced.
The comparison between ^^C-labelled samples from total uterus (Fig. 
3a) and cell types (Fig. 10) shows little similarity. The gel of total 
protein is better resolved and has run further. If the 'actin' spot is 
used as a reference point, some of the other spot groupings can be 
recognised. However, many of the minor components are not present in 
the cell fractions.
3.4 The investigation of uterine proteins synthesised in vitro by 
cell-free translation systems.
3.4.1 The choice of translation system.
The third method of examining any possible changes in the uterine 
protein population in response to oestrogen, was to use cell-free 
protein synthesising systems to label samples.
Initially, several approaches were used. Firstly, uterine polysomal 
messenger RNA was prepared, and polyadenylated messengers were
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purified by oligo-dT cellulose column chromatography. These samples 
were translated in wheat germ extracts prepared by the method of 
Roberts and Paterson (1973), The results from this system were not 
always consistent and the method required that several additions be 
made to the translation cocktail immediately prior to the incubation. 
This, and the fact that wheat germ extracts varied considerably with 
source, as to endogenous ribonuclease activities, probably accounted 
for the unreliable results. A messenger-dependent translation system 
(MDL) was also prepared, from rabbit reticulocyte lysates, according 
to the method of Pelham & Jackson (1976). This proved to give better 
results and was easier to use. Another approach was to use polysomes 
rather than purified mRNA and this was tried in both wheat germ and 
MDL assays. Preparation of polysomes was faster and gave a better 
yield for the number of animals used. The use of polysomes also 
avoided the loss from the sample of any non-polyadenylated messenger 
species being translated vivo at the time of death. Furthermore, it 
has the advantage that nascent polypeptides being translated at the 
time of death potentially from hormone-induced mRNA, are completed and 
made radioactive. The use of polysomes in MDL assays became the system 
of choice.
For a period of 18 months I used MDL prepared by myself and optimised 
for salt concentration, pH, and messenger levels, but this was 
subsequently dropped in favour of a commercially produced lysate, for 
a number of reasons. The preparation of the lysate was laborious and 
involved trauma to the rabbits which sometimes died before their 
treatment was complete. The waste of animals and effort was not 
justified for the small-scale usage of the lysate. In addition the 
results from the home-made lysate were not as good as those produced 
by a commercial lysate because the samples often caused a 'fogging' of
80
the fluorograms which obscured the labelled spot patterns, A number of 
methods were tried to alleviate this, but all failed. The best results 
were obtained when Amer sham ' MDL was used and this was adopted for all 
subsequent experiments.
3.4.2. Cell-free translation directed by total uterine polysomes. 
Incorporation of label into acid-precipitable material varied with the 
preparation of polysomes used, and with the number of hours of 
oestrogen treatment given to the rats vivo. Levels of incorporation 
varied from 2 x background to 15 x background incorporation, but an 
average was 6  x background.
Fig. 12 shows the protein translation products using the uterine 
polysomes from rats in various hormonal states. Fig. 12a shows the 
proteins translated by the polysomes of unstimulated rat uteri. The 
pattern is somewhat different to the proteins visualised by labelling 
the whole organ vitro (for example, see Fig. 9d, following page 75) 
but a number of common, major proteins are seen. The putative actin 
spot is obvious (see Fig. 12a, yellow arrow, 1) as are the spots 
identified as tubulins by Korach (2,3). However, some other protein 
spots do not appear in the patterns of total protein obtained from 
labelling the whole organ (eg. Fig. 9d). An example is the spot 4. 
Since this appears consistently in fluorograms of cell free 
translation products and of heavily loaded gels of isolated cell 
proteins (e.g. Fig. 9a, following page 75) it may represent a 
relatively minor protein with a high rate of turnover, thus it is 
enriched in the sample obtained by cell-free translation.
Translation products of polysomes from uteri responding to 2, 4 and 12 
hours of oestrogen treatment are shown in Fig. 12b,c & d. The most
Figure 12.
Electrophoresis of MDL translation assays directed by total uterine 
polysomes from rats in various hormonal states.
A translation cocktail containing MDL (Amersham) and ImCi/ml L-[^^S]- 
methionine was mixed freshly before each experiment. Polysomes in 
distilled water were added in a volume not exceeding 10-15% of the 
final volume, and an equal volume of distilled water was added to the 
control assay. The incubation was performed in a sealed 1.5ml 
Eppendorf tube for 90 minutes in a gently shaking water bath at 30^C, 
and the assay was stopped by rapid cooling to O^C. Ipl duplicates from 
the lOpl or 25jul incubation mix were assayed for counts incorporated 
into acid precipitable material, as described in the Methods section 
(2.5.9).
For electrophoresis, equal volumes of lysis buffer were added to the 
MDL samples and gels were run in the usual way. 10% SDS slab gels were 
used for all experiments. Fluorography was performed on the slabs and 
films shown were exposed for 42 days. Sample loadings given below have 
been adjusted for control assay incorporation. Fluorograms of MDL 
translation products of polysomes from uteri responding to the 
following periods of oestradiol treatment are shown:
a) 0  hrs, 1.47x10^ cpm,
b) 2 hrs, 2.05x10^ cpm.
c) 4 hrs, 2.5x10^ cpm.
d) 12 hrs, 1.71x10^ cpm.
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striking observation is the exceptionally high degree of 
correspondence between the fluorograms, even in the most minor spots. 
Some of the most marked differences are arrowed in black. Spots which 
are new or strongly stimulated in the 2  hour sample are arrowed in 
Fig. 12b whereas those decreasing after oestrogen treatment are 
arrowed in the control sample (Fig. 12a). These changes are maintained 
in the 4 hour sample (Fig. 12c), except that the two spots of 
molecular weight about 49,000 which have increased at two hours are no 
longer stimulated. These are marked IP on Figs. 12b & 13b and 
correspond to the expected position of the induced protein creatine 
kinase. Some further increases and new spots are arrowed in black. The 
two 'tubulin' spots also decrease in intensity at four hours (yellow 
arrows) which was also observed in the nuclear fractions from whole 
labelled uteri (Fig. 5, following page 70). The labelled translation 
products of 12 hour polysomes (Fig. 12d) show virtually no difference 
to those of the 4 hour pattern. An exception is the tubulin spot 
marked 3 in Fig. 12a which has decreased markedly (see also Fig. 5d). 
The decreases noted between 2 and 4 hours of oestrogen treatment are 
maintained, as are some of the increases,
A large number of comparisons of the cell-free translation products of 
polysomes from rats in various hormonal states have been performed. 
The patterns obtained show a high degree of correspondence of most of 
the spots when examined closely. However, many of the apparent 
hormone-induced differences observed are not conserved between 
different preparations of polysomes. Fig. 13 illustrates this point. 
The figure shows the protein population produced from control (Fig. 
13a) and 2-hour (Fig. 13b) polysome-directed translation. Spots 
decreasing after oestrogen treatment are arrowed in (a) and those 
increasing are arrowed in (b). Only those increases arrowed in yellow
Figure 13.
Comparison of MDL translation products of polysomes from uteri 
responding to short periods of oestrogen treatment with total 
L-[U-^^C]-labelled uterine protein.
Details of experimental procedure are given in the legend to Figure 
12. The L - - l a b e l l e d  total uterine protein sample was prepared 
as described in the legend to Figure 1 and a gel (d) is included for 
comparative purposes. Fluorograms shown are of MDL translation assays, 
directed by polysomes from uteri responding to the following periods 
of oestrogen treatment:
a) 0 hrs, 1.39x10^ cpm.
b) 2  hrs, 1.61x10^ cpm.
c) 4 hrs, 2.3x10^ cpm.
d) Total L-[U-^'^C]-labelled uterine protein from immature rats
responding to 4 hours oestrogen stimulation. Loading: SOjag
protein, 1 0 ^ cpm.
Films a-c were exposed for 36 days; Film d for 27 days.
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correspond to those seen in Fig. 12b. These increases are consistently 
observed.
The 4 hour sample is shown in Fig. 13c. The first dimension gel was 
loaded with 1 0 0 , 0 0 0  cpm more than the control sample, and strictly, 
therefore, cannot be compared to the control or 2  hour samples. 
However, it illustrates the large number of components that can be 
resolved using this method of labelling uterine proteins. The species 
present in this separation may be compared to a typical gel of in 
vitro ^'^C-labelled total uterine protein from 4 hour oestrogen-treated 
rats (Fig. 13d). Although the gel has run further, most of the major 
spots can be identified; the polysome directed translation products 
are enriched in high molecular weight basic proteins and minor 
species. Some major spots are missing however, such as the more basic 
of the two spots of molecular weight 87,000 and the 150,000 molecular 
weight protein. These are arrowed in Fig. 13d. There are also 
differences in the 'actin' spots which appear to have four components 
in Fig. 13c, but only three in Fig. 13d.
3.4.3. Cell-free translation directed by polysomes isolated from 
fractionated cell types.
This was the last method used to detect proteins synthesised early in 
the oestrogenic response of immature rat uterus. The experiment was 
very difficult in that the time required to prepare the isolated cells 
and their polysomes was 4 to 6  hours, which made the mRNA and the 
protein synthesising enzymes very vulnerable to ribonuclease and 
proteolytic digestion. These problems were made even worse by the time 
involved in the excision of the uteri from the large numbers of 
animals used.
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Two experiments of this type were performed and polysomes were 
prepared from the uterine epithelial cells of 1 2  hour oestrogen- 
treated rats and from the epithelial, stromal and myométrial cells of 
4 hour stimulated rats. Although sufficient polysomes were recovered 
for the cell-free translations presented in Figs. 14 & 15, the yields 
were very low and did not justify further experimentation. The 
polysome yields from 132 rats treated with oestradiol for 4 hours 
were: 3.99, 2.73 and 0.39 Optical Density Units (260nm) from the 
epithelial,- stromal and myométrial fractions respectively. Far too 
many rats would have been required for the preparation of polysomes 
from the fractionated cells of unstimulated rats.
The cell-free translation assays incorporated about 5 x background 
counts into trichloroacetic acid-precipitable material using 
epithelial polysomes from 1 2  hour treated uteri, 2  x background for 
epithelial polysomes from 4 hour treated uteri, and 3.5 x background 
for stromal polysomes. Myométrial polysomes only incorporated 1.3 x 
background counts. These activities were considerably less than those 
achieved using polysomes from whole uteri (average 6 x background) but 
gave sufficient counts to attempt two-dimensional gels. Fluorograms of 
these are shown in Figs. 14 & 15. There were insufficient myométrial 
polysomes at too low a concentration to repeat the translation assays 
and the fluorogram was too faint to reproduce. However, the very few 
spots detected, were also present in the epithelial and stromal 
patterns, which are shown in Fig. 14. These epithelial and stromal 
translation products resemble each other closely. Furthermore, all of 
the spots can be identified with total polysome translation products 
from 4 hour stimulated uteri (Fig, 12c, 13c, following pages 80 & 81). 
It must be stressed that these gels, although duplicated, emanate from
Figure 14.
Fluorograms of MDL translation products of polysomes isolated from 
fractionated uterine cell types.
132 rats received Ipg oestradiol-17p 4 hours before death. The uteri 
were fractionated into epithelial, stromal and myométrial cell types, 
each of which was used to prepare polysomes. Full details of these 
techniques are given in the Methods section (2.5.8), MDL translation 
assays were conducted as described in the legend to Figure 12, and the 
samples subjected to two-dimensional gel electrophoresis, and the gels 
to fluorography. Films were exposed for 46 days. Loadings have been 
adjusted for control assay incorporation.
a) Translation products of 4 hr oestrogen-treated epithelial cell 
polysomes. Loading: 1,44x10^ cpm.
b) Translation products of 4 hr oestrogen-treated stromal cell 
polysomes. Loading: 2.4x10^ cpm.
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Figure 15,
Translation products of epithelial cell-type polysomes from uteri 
responding to 1 2  hours oestrogen treatment,
44 immature female rats received Ipg oestradiol-17^ 12 hours before 
death. The uteri were used to prepare epithelial cells and from these 
a polysome fraction was isolated. Translation assays and analysis of 
the products was performed as described in the legend to Figure 12. 
The film was exposed for 30 days. The loading, adjusted for control 
assay incorporation, was 3x10^ cpm.
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single preparations and are therefore only preliminary results.
Fig, 15 illustrates the proteins labelled in cell-free translation 
assays directed by epithelial polysomes isolated from the uteri of 
rats receiving oestrogen 12 hours before death. Again, a large number 
of spots are resolved in a highly reproducible manner. Considerable 
differences can be seen between the translation products of these 1 2  
hour epithelial cell polysomes and those of the 4 hour epithelial 
preparation, but thesedata wefêderived from a single preparation of 
polysomes and, as discussed with respect to Figs, 12 & 13, different 
preparations appear to give slightly different results. All that can 
be said with confidence is that many of the polypeptides detected in 
Figs. 14 & 15 are also seen in Figs. 12 & 13 and in other figures, but 
that the significance of the differences between the different 
preparations remains uncertain.
3.5 Cofractionation of known proteins with labelled uterine samples,
3.5.1 The contribution of the cofractionation technique to the 
identification of uterine proteins.
In order to identify some of the proteins synthesised in the immature 
rat uterus a number of approaches are possible. Firstly it is possible 
to raise antibodies to purified proteins and use them to identify 
proteins labelled vitro in the uterus or in cell-free translation 
assays. Secondly, uteri labelled in vitro could be used to prepare 
. specific proteins and see if oestrogen treatment stimulates isotope 
incorporation into these fractions. Examples of proteins which could 
be used are ribosomal proteins, hnENP proteins, mRNP proteins, and the 
nucleolar proteins. However, a number of technical problems with 
either method have made them difficult or impractical to develop in 
the time available.
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A third approach is to cofractionate isolated proteins with 
radioactive uterine protein samples. Comigration of a protein with 
another of known identity can help to confirm their possible unity, 
and may also be useful as a negative assay, although it is not a 
sufficient test to identify a protein unambiguously. This last method 
was however, the only one feasible in the time available.
3.5.2 Cofractionation of uterine protein samples with actin.
Because the most prominent spot in labelled uterine protein gels ran 
at a position expected for actin on two-dimensional gels, and its 
multiple components resembled published spot shapes of the protein 
(Garrels and Gibson, 1976; Korach et al., 1981) this was the first 
purified protein to be analysed. Actin was obtained from two sources. 
Firstly, it was extracted from a rabbit skeletal muscle acetone powder 
kindly donated by Dr. J. Dow of this Department. Secondly, a sample of 
pure rat leg muscle actin was obtained from Dr. J. Elce of the 
Department of Biochemistry, Queen's University, Kingston, Canada.
Lyophilised actin was dissolved in lysis buffer and a sample was 
subjected to two-dimensional gel electrophoresis. The gel was stained 
and compared with the staining patterns of actin coelectrophoresed 
with labelled uterine samples. Fig. 16a shows the position of a sample 
of rabbit muscle f-actin on the two-dimensional gels used. Fig. 16b 
shows the staining pattern obtained when the rabbit protein was 
cofractionated with ^^C-labelled total uterine protein, and Fig. 16c 
shows the fluorogram of this gel. The centre of the major triple spot 
in the fluorogram is displaced by the unlabelled rabbit muscle actin, 
the position of which is arrowed.
Figure 16.
Cofractionation of rabbit muscle actin with L - -labelled uter ine 
proteins on two dimensional gels.
Actin was extracted from rabbit skeletal muscle acetone powder as 
described in the Methods section (2.5.10,a). This was subjected to 
two-dimensional gel electrophoresis alone, and mixed with total L-[U- 
-labelled uterine protein from 4 hour oestrogen-treated rats. Slab 
gels were stained and photographed. Those with labelled samples were 
then fluorographed. The film was exposed for 20 days,
a) 20jug unlabelled rabbit muscle f-actin, stained with Coomassie 
Brilliant Blue.
b) Coomassie Brilliant Blue staining pattern of 20pg unlabelled f- 
actin coelectrophoresed with L-[U-^'^C]-labelled uterine protein 
from oestrogen-treated rats. The uterine sample contained llOjug 
protein and 1 0 ^ cpm.
c) Fluorogram of b). The arrow marks the position of the stained 
actin spot.
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Figure 17.
Cofractionation of pure rat leg muscle actin with L-[U-^^C]-labelled 
uterine proteins.
A purified sample of rat leg actin was obtained from Dr. J. Elce of 
the Department of Biochemistry, Queen's University, Kingston, Canada. 
Two-dimensional gel electrophoresis was performed with samples of pure 
actin and samples of actin mixed with L-[U-^^C]-labelled total uterine 
protein from rats responding to 4 hours of oestrogen-treatment. Gels 
were stained and photographed and those with labelled samples were 
fluorographed. The film was exposed for 28 days.
a) lOpg pure rat leg actin stained with Coomassie Brilliant Blue.
b) Staining pattern of lOjug pure rat leg actin cofractionated with a 
L-[U-^^C]-labelled uterine protein sample from 4 hr oestrogen 
treated rats. The uterine sample contained lOOpg protein and 10^ 
cpm. The arrow marks the position of actin.
c) Fluorogram of b). The arrow marks the position of actin in b).
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Pure rat leg muscle actin was also cofractionated with ^^C-labelled 
uterine protein. Fig. 17a shows the two-dimensional gel of a sample, 
stained with Coomassie Brilliant Blue. Fig. 17b shows the staining 
pattern when mixed with total ^^C-labelled uterine protein prior to 
electrophoresis, and Fig. 17c shows the fluorogram of this gel. The 
staining pattern and the fluorogram show that this actin sample 
exactly comigrates with the multiple spot in the labelled uterine 
protein population. This would seem to confirm that the major multiple 
spot in all the fluorograms is indeed actin. The displacement of the 
spot by rabbit actin in Fig. 16c could be explained by slight 
differences in the actins of different species, such that the 
migration characteristics were slightly different.
3.5.3 Cofractionation of labelled uterine proteins with IP (creatine 
kinase).
The oestrogen induced protein known as IP, first described by Notides 
& Gorski (1966), has recently been shown to be mainly composed of 
creatine kinase (Reiss & Kaye, 1981). These workers have further shown 
that the enzyme is identical to rat brain creatine kinase which they 
have purified, and the brain enzyme used here was the generous gift of 
Dr. A.M. Kaye of the Weizmann Institute, Rehovot, Israel.
The results obtained with creatine kinase cofractionation were very 
disappointing. A stained two-dimensional gel of lOjug of the protein is 
shown in Fig. 18a. The compact spot was, however, distorted and spread 
into a streaked shape when mixed with uterine samples (Fig. 18b,d, 
yellow arrows) but the position of migration relative to actin agrees 
closely with published patterns (Manak et al., 1980; Walker & Kaye, 
1981). The fluorograms of labelled uterine samples cofractionated with 
IP samples show only very diffuse and slight darkening of the film at
Figure 18.
Cofractionation of purified rat brain IP with labelled uterine 
proteins.
A sample of the oestrogen-induced protein IP was obtained from Dr. A. 
Kaye of the Weizmann Institute, Rehovot, Israel. Aliquots were 
subjected to two-dimensional gel electrophoresis alone, or mixed with 
uterine protein populations labelled in vitro in the whole organ or 
translation assays. Summaries of these techniques are given in the 
legends to Figures 1 & 2. Gels were stained, photographed and 
fluorographed as described in the Methods section (2.6). The films 
were exposed for 37 days.
a) Coomassie Brilliant Blue staining pattern of lOpg IP.
b) Coomassie Brilliant Blue staining pattern of lOpg IP,
coelectrophoresed with L-[U-^^C]-labelled uterine protein from 4 
hr oestrogen-treated rats. The uterine sample contained lOOpg 
protein and 1 0  ^ cpm.
c) Fluorogram of b).
d) Coomassie Brilliant Blue staining pattern of lOpg IP,
coelectrophoresed with L-[^^S]-methionine labelled MDL translation 
products of 4 hr polysomes. 2x10^ cpm (discounting background) 
were loaded,
e) Fluorogram of d).
Arrows mark the position of IP.
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this spot (Fig. 18c,e, see arrows).
It cannot be said with certainty whether any spot in either of the 
labelled samples corresponds to the position of IP. Two proteins which 
may be IP are found in cytoplasmic uterine proteins (Fig. 2, spots 6 , 
following page 6 8 ) and these increase rapidly in response to 
oestrogen. These spots are not seen in nuclear samples which is 
consistent with their possible identity. The same proteins can be seen 
in the fluorograms of translation products of total polysomes. Both 
Figs, 12 & 13 show that the proteins are strongly stimulated early in 
the response; their labelling has greatly increased at 2  hours (see 
IP, Fig. 12a,b; Fig. 13a,b, following pages 80 & 81).
3.5.4 Cofractionation of MDL translation products with non-histone 
chromatin proteins.
Chromatin proteins were isolated from uterine nuclei. Non-histone 
proteins were obtained in small yield from the chromatin pellet, and 
were very difficult to dissolve in sample buffer; but sufficient 
protein was recovered after DNA digestion and histone removal to 
produce the staining pattern shown in Fig. 19b. Total chromatin 
proteins were used for cofractionation, because the yields from the 
preparation were greater, and they were more easily dissolved for 
electrophoresis. Fig. 19d shows the staining pattern of total 
chromatin proteins. There is some streaking due to DNA in the sample, 
and there is a small amount of actin in the sample. This may or may 
not be a contaminant (see discussion), but the major components are 
the acidic chromatin proteins present in Fig. 19b. The staining 
patterns of the MDL cell-free translation system and of chromatin 
cofractionated with MDL are shown in Fig. 19a & c respectively. The 
fluorograms of a & c are shown in e & f. MDL was used in this
Figure 19.
Cofractionation of purified rat uterine chromatin proteins with 
labelled uterine proteins.
Uteri from 24 rats responding to 4 hours of oestrogen-treatment were 
used to prepare uterine nuclei. From these, chromatin pellets were 
prepared using a modification of the method of Spelsberg (2.5.10,d). 
Non-histone proteins were prepared from the chromatin by 
dehistonisation and ENA digestion. MDL translation assays directed by 
uterine polysomes from 4 hour oestrogen-stimulated rats were prepared 
and samples analysed on the two-dimensional gels listed below. Gels 
were stained and photographed and those with labelled samples were 
fluorographed. Films were exposed for 27 days.
Staining patterns:-
a) lOpl MDL translation assay, loading: 2.75x10^ cpm.
b) Non-histone protein sample, loading: 70pg.
c) Chromatin proteins cofractionated with MDL translation assay. lOpl 
of MDL containing 2.75x10^ cpm, and 135pg chromatin protein were 
loaded.
d) Chromatin proteins, loading: 135pg.
Fluorograms:-
e) Fluorogram of a), MDL translation products of 4hr oestrogen 
treated uterine polysomes.
f) Fluorogram of c). MDL translation products of 4hr oestrogen 
treated uterine polysomes cofractionated with chromatin. The 
arrows mark the position of chromatin proteins stained in c) and 
d).
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cofractionation because it was more likely to show minor components 
and could be used in the small volumes required for the first 
dimension gels.
The labelled proteins are the translation products of polysomes 
isolated from uteri responding to 4 hours of oestrogen treatment. The 
pattern in Fig. 19f shows that there are pale distortions in the 
background fogging of the film, which denote the position of some of 
the stained non-histone proteins (arrowed). That there are no labelled 
proteins present in this area of the gel can be seen in the fluorogram 
e. None of the non-histone proteins present in stainable quantities in 
b are labelled in Jji vitro translation assays.
3.5.5 Cofractionation of MDL translation products with hhRNP particle 
proteins.
Since these are basic proteins they cannot be resolved using 
isoelectric focussing in the first dimension, because the equilibrium 
pH gradient is too short at the basic end. However, basic proteins can 
be separated using basic ampholines in the first dimension gel, which 
is not run to equilibrium. This technique is known as N o n ­
equilibrated pH gradient gel electrophoresis or NEpHGE (O'Farrell et 
al., 1977).
hnRNP particles were isolated from rat liver and the staining pattern 
of the proteins is shown in Fig. 20a. This compares favourably with 
published protein profiles of hnBNP particles (Wilks & Knowler, 1980). 
Labelled translation products of 4 hour polysomes, separated by NEpHGE 
in the first dimension are shown in Fig. 20b. The fluorogram pattern 
characteristic of samples separated by isoelectric focussing in the 
first dimension can be recognised but is contracted because the acidic
Figure 20.
Cofractionation of rat liver hnRNP particles with MDL translation 
products using NEpHGE.
Adult male rat livers were used to prepare nuclei by the method of 
Chauveau et al. (1956) and hnPNP particles were extracted from them by 
the method of Samarina et al, (1968). Experimental details are given 
in the Methods section (2.5.10,e). Samples of hnPNP particles and MDL 
translation assays were separated alone, or mixed, on two-dimensional 
gels. Non-equilibrated pH gradient gel electrophoresis (NEpHGE) 
(O'Farrell et al. 1977) was used in the first dimension (section 
2.6.3) and 10% SDS polyacrylamide slabs in the second dimension. Gels 
were stained and photographed, and those with labelled samples were 
fluorographed. Films were exposed for 28 days.
a) Coomassie Brilliant Blue staining pattern of 150jug rat liver hnPNP 
particle proteins, showing nomenclature of Wilks and Knowler 
(1981).
b) Fluorogram of MDL translation products of uterine polysomes from 
rats responding to 4hrs of oestrogen treatment (10^ cpm.)
c) Coomassie Brilliant Blue staining pattern of 150pg rat liver hnBNP 
particle proteins, cofractionated with MDL translation products of 
uterine polysomes from 4hr oestrogen-treated rats (10^ cpm.).
d) Fluorogram of c). The arrows show the positions of labelled 
species comigrating with hnBNP particle proteins.
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end of the pH gradient is much shorter in these gels.
The stained gel of the cofractionated samples. Fig. 20c, shows a 
heavily staining, low molecular weight spot beneath the hnRNP 
proteins, which does not enter the first dimension when isoelectric 
focussing is used. This is a component of the MDL system.
The fluorogram. Fig. 20d, shows a few very faint spots which comigrate 
with hnRNP proteins. Using the nomenclature of Wilks & Knowler (1981) 
these are B2, B3, B4, A4 & two of the C-group proteins. Also, the spot 
A1 displaces a labelled protein, and the unnamed spot below Al also 
comigrates with a labelled species,
3.5.6 Cofractionation of MDL translation products with ribosomal 
subunit proteins.
Ribosomal proteins cannot be satisfactorily separated in two- 
dimensions by either of the gel systems used. In order to determine 
whether ribosomal proteins were being synthesised in my in vitro 
systems, the established two-dimensional gel system of Kaltschmidt & 
Wittmann (1970) modified by Lastick & McConkey (1976) was employed.
Rat ascites tumour ribosomal subunit proteins were donated by Mr. M. 
McGarvey of this Department. They were coelectrophoresed with small 
samples of MDL translation products from uterine polysomes by Mr. I. 
Kennedy, also of this Department. The staining patterns and 
diagrammatic representations of the 40S ribosomal subunit proteins 
showing the accepted mammalian ribosome nomenclature (McConkey et al.,
1979) are shown in Fig. 21a-d. MDL translation assay proteins do not 
contribute to the staining pattern because far too little assay sample 
was used. As can be seen from the fluorograms (Fig. 21e & f), many of
Figure 21.
Cofractionation of small ribosomal subunit proteins with MDL 
translation products of uterine polysomes.
40S ribosomal subunit protein samples were prepared from rat ascites 
tumour cells by Mr. M. McGarvey. Samples were mixed with small volumes 
of MDL translation assays and subjected to two-dimensional gel 
electrophoresis by the method of Kaltschmidt and Wittmann (1970) with 
modifications (Lastick & McConkey 1976). The electrophoresis was 
carried out by Mr. I. Kennedy as described in the Methods section 
(2.5.10/f). The direction of migration was from left to right in the 
first dimension and from top to bottom in the second dimension. Gels 
were stained, photographed and fluorographed in the same way as for 
O'Farrell gels and films were exposed for 51 days.
Coomassie Brilliant Blue staining patterns:
a) lOOpg 40S ribosomal subunit proteins cofractionated with MDL 
translation products of control uterine polysomes (1.5x10^ cpm.).
b) lOOpg 40S ribosomal subunit proteins cofractionated with MDL 
translation products of 4hr oestrogen-treated uterine polysomes 
(2.5x10^ cpm.).
c) Schematic representation of a).
d) Schematic representation of b).
e) Fluorogram of a) (Control polysome translation products).
f) Fluorogram of b) (4hr polysome translation products).
g) Schematic representation of e).
h) Schematic representation of f).
The schematic representations of the subunit proteins use the 
nomenclature of McConkey et al. (1979).
HI - histone HI, PS6  = phosphorylated S 6 , nr = non-ribosomal
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the proteins translated in vitro from control and 4 hour polysomes, 
comigrate with ribosomal proteins of the 40S subunit. These are shown 
in the diagrammatic representation of the fluorograms (Fig. 21g & h). 
Most prominent are those comigrating with S4, SIO, S14/15 & S19. A 
dark spot lying between S4 and SIC does not coincide with any 
ribosomal protein and is found at a position where the histone HI 
migrates in this gel system. Some low molecular weight protein and 
some material which does not enter the first dimension are also non- 
ribosomal proteins (nr).
Large subunit {60S) proteins cofractionated with MDL assays are shown 
in Fig. 22. This sample shows some contamination by 4OS proteins and 
these are marked in the diagrams of the staining patterns (Fig. 
22c,d). The fluorograms (e,f) show more detail than those in Fig. 2.1 
although the same MDL samples were used. In addition to the labelled 
40S ribosomal proteins in Fig. 21e & f, some large subunit proteins 
can be seen. The most heavily labelled of these are LlO, L13/15, L26 & 
L32/33. The composition of the sample buffer and loading volume for 
these gels was critical and therefore the volume of MDL added to the 
ribosomal sample was kept to a minimum. Because MDL has a very high 
incorporation of counts in small volumes, small variations in the 
actual volume could quite easily account for the variation in the 
actual number of counts loaded and hence the variation between the 
films. The diagrams (g,h) show the spots identified in the 
fluorograms. Although some differences are seen between 0 and 4 hour 
translation products in Fig, 21, these are minimal in Fig. 22 and, due 
to the loading problem, no significance should be attached to them.
Figure 22.
Cofractionation of large ribosomal subunit proteins with MDL 
translation products of uterine polysomes.
60S ribosomal subunit protein samples were prepared from rat ascites 
tumour cells by Mr. M. McGarvey. All other methodological details are 
the same as those given in the legend to Figure 21.
Coomassie Brilliant Blue staining patterns
a) lOOjLig 60S ribosomal subunit proteins mixed with MDL translation 
assays using control uterine polysones {1.5x10^ cpm).
b) lOO^g 60S ribosomal subunit proteins mixed with MDL translation
assays using 4hr oestrogen-treated uterine polysomes {2.5x10^
cpm).
c) Schematic representation of a).
d) Schematic representation of b),
e) Fluorogram of a).
f) Fluorogram of b).
g) Schematic representation of e).
h) Schematic representation of f).
The schematic representations of the subunit proteins use the 
nomenclature of McConkey et al. (1979).
HI = Histone HI, PS6  = phosphorylated S 6 , nr = non-ribosomal.
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4_^  DISCUSSION
The aim of this project was to investigate the nature of any 
oestrogen-induced changes in the protein population of immature rat 
uterus responding to the hormone. In particular, it was hoped to 
detect individual proteins whose synthesis was induced by oestrogen 
very early in the uterotropic response*- Before discussing 'the results 
it is pertinent to assess the experimental approaches used.
It is not possible to label rat uterine protein vivo to a specific 
activity adequate for the analysis of the individual components of the 
population. This is because of the dilution and metabolism of labelled 
precursor before it reaches the organ. Therefore a number of different 
methods were used to investigate the effects of hormone treatment in 
vivo by monitoring the in vitro incorporation of precursor into the 
uterine protein of oestrogen-treated rats.
The success of this approach depended on several factors. Firstly, it 
is necessary that the response initiated jji vivo should be continued 
in vitro without alteration, and without any additional response 
caused by the post mortem manipulation of the tissue. This is 
virtually impossible to establish before the study is conducted, 
particularly since the protein population of the uterus is complex and 
ill-characterised. With a clear-cut response, such as the induction of 
a specific protein detected vitro, it would be possible to confirm 
retrospectively that the response occurs in vivo. This would employ 
specific probes such as antibodies or, in the case of proteins such as 
ovalbumin, and vitellogenin, by cDNA hybridisation to detect the 
messenger RNAs. If the protein is abundant enough, staining of gel 
separations may suffice. In the uterine system, gel staining did not 
reveal any clear cut difference between control and hormone-treated
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animals, so the assay depended on the faithful labelling jji vitro of 
proteins whose synthesis had been induced vivo. This made the 
physiological state of the tissue of prime importance, so that as far 
as possible, labile substances and processes were preserved.
Three methods of labelling proteins vitro were tried. Firstly, the 
whole organ was labelled in a nutritive medium containing a high 
specific activity amino acid mix. Labelled uteri could then be 
fractionated into cell types or subcellular fractions for analysis. 
This method should entail the least trauma to the tissue, with the 
least interruption in the time course of the response.
Secondly uteri were fractionated into epithelial, stromal and 
myométrial cell types before the labelling incubation, which should 
overcome the possibility of over- or under-representing the proteins 
of a particular cell type in the labelled population. This could occur 
if diffusion or uptake of label was unequal in the different cell 
layers of the uterus. The possible disadvantages of the method are the 
greater length of time between death, or the initiation of the 
response, and the time at which the resulting products were labelled. 
This gives rise to the possibility that very early, transient products 
may not be detected, and that the interruption of the response in vivo 
may have altered the chain of events.
Thirdly, polyribosomes were isolated from uteri immediately after 
death. These were added to cell-free translation systems containing 
radioactive amino acids, to label the uterine proteins synthesised in 
vitro. This method had several advantages: the oestrogenic response 
was effectively frozen at the time of death which prevented any 
spurious results due to trauma. The isolation of polyribosomes meant
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that only the products of messengers actually being translated at the 
time of death would be labelled, and, having immediate access to the 
radioactive precursors, these should be labelled more efficiently. The 
use of polysomes to direct the cell-free translation system, rather 
than polyadenylated messenger RNA also avoided the omission of any 
proteins from the analysis that were encoded by nonadenylated 
messengers.
Other factors influencing the success of the experimental approach 
were the methods of separating and detecting the labelled products. 
Two-dimensional gel electrophoresis was used because of the large 
number of components it is capable of resolving. A sample of labelled 
uterine protein shows up to 1 0  times more components when separated on 
two-dimensional rather than one-dimensional polyacrylamide gels. The 
reproducibility of shape and juxtaposition of individual spots are 
also of use in comparing separations. Indeed, some workers are 
currently trying to identify and catalogue protein populations by 
defining their positions on two-dimensional gels run under controlled, 
standardised conditions (Bravo & Celis, 1980; Cells & Bravo, 1981; 
Clark, 1981). The use of labelling increases the detection of uterine 
proteins many-fold as can be seen by comparing Figs. la and lb 
(following page 6 6 ). Labelling depends on the turnover rate of the 
proteins and hence it is also a method for screening out components 
which are abundant in the tissue, but are not turning over, for 
example the protein arrowed in Fig, la. As described in the Methods 
section, the use of fluorography increases the efficiency of detection 
ten-fold over that achieved by autoradiography for carbon- and 
sulphur-labelled compounds.
The three labelling methods yielded different results. The labelling 
of the whole organ vitro revealed a very complex population of 
proteins in the uteri of both control and oestrogen-treated rats 
(Fig,2, following page 6 8 ). This was not expected because the immature 
rat uterus is a quiescent tissue before hormone stimulation, having 
its ribosomes largely in the form of monosomes, and making very much 
less RNA and protein than in stimulated animals (Merryweather & 
Knowler, 1980). The lack of difference between the two samples was 
also apparent when a double label technique was employed (Choo et al., 
1980). In this system, control uteri were labelled with amino 
acids and protein samples mixed with ^H-labelled samples from hormone 
treated uteri. Two-dimensional gel separations of this mixture were 
subjected to fluorography which detects both isotopes, and then 
exposed autoradiographically through carbon paper. This detects only 
the low energy beta-particles of tritium having too short a path 
length to reach the film and PPO fluorescence being blocked by the 
carbon paper. This technique failed to show any hormonal effects on 
the protein population that were not detectable using separate gels.
There is some precedent for believing that the incorporation of 
precursors in incubations vitro may distort results. Knowler (1976) 
demonstrated that oestrogen-stimulated hnPNA synthesis can be observed 
by this method, although stimulated rRNA synthesis is apparently 
abolished. Nevertheless, stimulated synthesis of ribosomal proteins 
(Merryweather & Knowler, 1980) as well as IP (Notides & Gorski, 1966) 
can be detected by this method. It may be that oestrogen-stimulated 
protein synthesis is obscured because the incubation conditions also 
induce protein synthesis. The other possible explanation is that the 
gel system is detecting only abundant proteins. If protein abundance 
mirrors messenger abundance, this would agree with the results of Aziz
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et al. (1979b) that there are few changes in the abundant class of 
messenger RNA in the first 4 hours of the oestrogenic response.
The patterns of uterine protein separations described in this thesis 
are representative of similar fractionations by others. Thus, Korach 
et al. (1981) have fractionated the proteins of mature mouse uteri and 
have published polyacrylamide separations which are very similar to 
those shown in Figs. 1 & 2 (following pages 6 6  & 6 8 ). In their study, 
the uteri of mice treated in vivo with oestrogen were labelled in 
vitro with radioactive methionine. In order to test their hypothesis 
that oestrogen caused movement of proteins between intracellular 
compartments, they also added the hormone to the Jji vitro incubation. 
They then went on to prepare and fractionate the 30% ammonium sulphate 
precipitable cytoplasmic proteins, the supernatant proteins from this 
fraction and salt extractable nuclear proteins. Their results, which 
revealed only very minor oestrogen-induced differences in the 
cytoplasmic fractions, hardly substantiate their claim that some 
proteins move from the cytoplasm to the nucleus. Nevertheless, the 
hypothesis that oestrogen causes movement of proteins between cellular 
compartments is interesting, and could explain the apparent loss of 
some of my proteins after hormone treatment. Indeed, LeStourgeon et 
al. (1974) propose a flux of contractile proteins in and out of the 
nucleus during changes of chromatin structure.
The differences between my own cytoplasmic fractions are rather more 
clearcut than in the mouse study, but their lack of reproducibility 
argues that the system is responding in a more random manner than the 
hormone should dictate.
This problem may also apply to the studies on fractionated cells, but 
these experiments did help to answer some of the questions concerning 
the differential responses of the cell types. Firstly, the specific 
activities of samples from cells isolated after the labelling of whole 
uteri show that all cell types are represented in the labelled protein 
population, although the myometrium contributes least. Secondly, the 
labelling of uteri jn vitro does not favour the epithelium because the 
serosal surface has more immediate access to the labelled precursors 
in the medium. Qualitatively, there is great similarity in the protein 
patterns of the epithelium and stroma but the two cell types are 
strikingly different in their responses to the hormone. The synthesis 
of many of the stromal proteins is consistently stimulated, although 
this is less detectable in prelabelled samples. It is difficult to 
determine whether some of the stimulated proteins are completely 
absent in control samples as the gels are faint, but many stromal 
species did appear to be present only after hormone stimulation and to 
be exclusive to that cell type (Fig. 8 , following page 73). This could 
not be predicted from the available evidence that we have on the 
response of individual cell types in the rat (see 1 .6 ), although in 
the mouse, hypertrophy is a property of the stroma and myometrium, 
whilst hyperplasia occurs in the luminal epithelium. Hypertrophy is 
known to be the earlier event and it may be the manifestation of the 
synthesis of proteins vital to the epithelial response, as suggested 
by Korach & Lamb (1981).
The results obtained with prelabelled cell proteins are slightly 
different to those obtained with cells labelled after fractionation. 
The spot patterns achieved using the former correlate closely with the 
gels of whole uteri but are slightly more complex than those of cell 
types labelled after fractionation (compare Figs. 8  & 9, following
pages 73 & 75). This may be due to a greater loading on the gels seen 
in Fig, 9, but it may also reflect the different method of labelling. 
Indeed, if there is stimulation of the whole organ by incubation in 
vitro, this would show in Pig. 9, whereas cells labelled in isolated 
fractions may not respond in the same way. For example, an isolated 
cell type cannot be influenced by another to react to the incubation 
conditions. Alternatively, the cells may be disturbed by the trauma of 
isolation and may not be responding fully to the stimulation by 
oestrogen iii vivo. This is possible because the cells will not 
incorporate label into proteins immediately after isolation, but 
require the four hour rest described in the Methods section. This 
suggests that there could be some perturbation to normal protein 
synthesis. Cells are capable of quite marked responses to trauma. An 
example is the shutdown of current protein synthesis and rapid 
induction of the ’heat-shock' proteins in HeLa and Drosophila after 
short periods of temperature shock. A more likely explanation is that 
the cell membrane and transport systems require some reorganisation 
after the enzymic damage during isolation. The appearance of the cells 
under the electron microscope, and the fact that they exhibit the same 
stimulated RNA synthesis as the whole organ (McCormack & Classer, 
1980), argue against the cells being damaged by the isolation 
procedure.
There is some precedent for expecting a difference in the response of 
fractionated cells to that of the whole tissue. Higgins et al. (1981) 
showed that castration markedly decreases the incorporation of 
labelled methionine into proteins by seminal vesicle tissue, but not 
by isolated cells. Higgins also discounts the possibility of cell 
damage, and finds that isolated cells are more active in protein 
synthesis than tissue pieces. He noted that the activities of the
98
cells are modified by epithelial-stromal interactions in the tissue, 
and that epithelial cells are subject to vectorial constraints, which 
are removed when they are isolated. It is not entirely clear how these 
factors could account for my results. If isolation released the cells 
from some vivo operative repression of protein synthesis then all 
the cell types should have exhibited a similar derepression. In the 
seminal vesicle study described above, the tissue was not fractionated 
into cell types.
Perhaps the technique of choice for a study of this sort is the 
translation of uterine messengers by cell-free systems. With this 
method, one can be sure that there is no change in the actively 
translating polysome population present at death, before the proteins 
being translated are labelled. It is also possible to check the 
integrity of the polysomes immediately prior to the translation assay 
(see Fig. 4, following page 69). The system yields samples of high 
specific activity which enable the ideal loadings to be used on 
isoelectric focussing gels, thus reducing the problems of streaking 
and spot displacement which can result from overloading. It also means 
that the likelihood of detecting minor species is increased.
The system has a high translational efficiency ranging from five to 
fifty rounds of chain reinitiation during the assay (Pelham and 
Jackson, 1976). Reinitiation can be demonstrated indirectly by 
incubating the assay with sparsomycin, which increases the average 
size of polysomes seen on subsequent sucrose density centrifugation. 
This also demonstrates the virtual absence of ribonuclease activity. 
In these respects the messenger-dependent reticulocyte lysate system 
(MDL) is far preferable to the wheat germ system which has much lower 
levels of reinitiation and has variable and often high ribonuclease
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activities (Doel & Carey, 1976; Pelham and Jackson, 1976). Both 
systems do have some aminopeptidase activity which may account for the 
background fogging on films, but this is 1-3000 times lower in rabbit 
reticulocyte lysates than wheat germ extracts, which also have a 
trypsin-like activity (Mumford et al., 1981). For ovalbumin, it has 
been demonstrated that reticulocyte lysate acetylates the protein 
during its synthesis in vitro. Although it is not glycosylated, the 
product is indistinguishable from the naturally secreted ovalbumin if 
this is synthesised in the presence of the glycosylation inhibitor 
tunicamycin (Palmiter et al., 1978). Thus the protease activity may 
not be a problem and apart from large modifications such as 
glycosylation the lysate produces an identical product to the tissue 
in vivo.
If protease action is minimal then the differences between the 
products of cell-free translation and the labelling of the whole organ 
in vitro must have some other basis. One possible explanation is that 
the tissue is derepressed by removal from the animal and that the 
normally quiescent, inactive uterus of the immature animal is 
stimulated by incubation vitro.
Another suggestion is that, because the bulk of tissue in immature 
uteri is myometrium, purified total polysome samples consist 
predominantly of myométrial ribosomes and messengers, Ihree lines of 
evidence refute this. Firstly, the specific activities of myométrial 
samples prepared from labelled uteri are lower than those of 
epithelium and stroma, suggesting this cell type to be less active in 
protein synthesis. Secondly the isolated myométrial cells also give 
samples of lower specific activity. The lower levels of incorporation 
and the consistently small number of proteins visualised in the
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myométrial samples probably indicates that the myometrium is comprised 
of relatively few types of proteins which are mainly structural and 
have low rates of turnover in the cell. Lastly, the isolation of 
polysomes from fractionated cell types yields ten times more polysomes 
from epithelium and seven times more polysomes from stroma than from 
the myometrium of the same group of oestrogen-stimulated uteri. At all 
times it was difficult to obtain satisfactory gels of myométrial 
samples, thus it is extremely unlikely that the translation products 
of total uterine polysomes are significantly enriched in myométrial 
proteins.
The differences obtained between the translation products of 
oestrogen-stimulated and control polysomes labelled in MDL are fairly 
slight. Although several species decrease or increase with oestrogen, 
only five protein spots are consistently stimulated in the first two 
hours of the hormone stimulation {Fig. 13b, following page 81). Of 
these, two correspond to the expected position of the induced protein, 
IP. This also appears as two spots on the two-dimensional patterns 
published by Manak et al. (1980) and has been shown to contain a major 
component, creatine kinase, and a minor component, enolase, of very 
similar molecular weight (Reiss & Kaye, 1981). Skipper et al. (1980) 
report that it has a third minor component, but this has not been 
identified. Of the other three proteins, the one just below actin 
(molecular weight 42,000) an exclusively nuclear component as can 
be seen by comparing Figs 2 & 5 (following pages 6 8  & 70). In nuclei 
isolated from labelled whole uteri, the synthesis of this protein is 
not seen to be stimulated until 1 2  hours after hormone administration. 
This may be because it is at too low a level to be significant in such 
a complex protein mixture, or because its increase is masked by the 
derepression in vitro of other species. Its translation by polysomes
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is greatly stimulated between 0 and 2 hours as seen in Figs. 12 & 13 
(following pages 80 & 81). It cannot be identified in any of the 
protein groups studied by cofractionation, but it may correspond to a 
non-histone protein described by King et al. (1974). This can be 
induced by administration of oestrogen to uteri vitro for one hour. 
The fourth protein, of molecular weight 39,000 is stimulated by 
oestrogen in preparations from whole labelled uteri. This small 
stimulation occurs in both nuclear and cytoplasmic compartments and is 
therefore not likely to be a component specifically regulating gene 
expression. The last protein, of molecular weight 20,000 could be the 
20,700 molecular weight oestrogen-induced non-histone protein 
described by Cohen & Hamilton (1975b), but it is not readily 
identified on gels of uterine nuclear proteins. It may be the smallest 
of the hormone-enhanced stromal proteins seen in Fig. 8 (following 
page 73). These results are internally consistent and corroborate the 
earlier work by other authors. However, the study has not revealed as 
much information as could have been expected. Neither has it been 
possible to unequivocally identify any of the induced proteins with 
the key intermediary proteins considered likely to be involved in 
oestrogen-induced uterine growth.
Estimates of the maximum theoretical resolving power of the O'Farrell 
gel system range from 2,500 to 5,000 different components (O'Farrell, 
1975; Chrambach, 1980). The total sequence complexity of the polysomal 
mPNA in immature rat uterus shows that there are 8 to 12,000 distinct 
sequences (Aziz et al., 1979a). Even if only 50% of the protein types 
do not enter the isoelectric focussing gel, this heterogeneity is 
sufficient to overwhelm the theoretical resolving power of the system. 
In animal cells, relatively few specific proteins (50-60) may comprise 
greater than 50% of the total cellular protein mass (Peterson &
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McConkey, 1976). These two factors taken together with the limitations 
of total protein load, restrict the absolute amounts of minor 
constituents in the sample applied to the gel to low levels. Thus it 
is more than possible that the gel system is only detecting the 
abundant protein species of the uterus. This explanation would account 
for the results, although it is likely that there is an additional 
incubation effect on whole uteri.
A recent study by Higgins and Fuller (1981) has also used two- 
dimensional gel electrophoresis to detect differences in rat seminal 
vesicle proteins before and after castration. This is the only other 
system where hybridisation studies show that the major effect of a 
steroid hormone is on mRNA sequences of moderate abundance (Higgins et 
al., 1979). The 100-200 intermediate abundant mRNA species decrease 
ten-fold after castration, but of the 2 0  or so protein species which 
are depleted, about half seem to be secretory products, previously 
shown to be encoded by highly abundant messengers. Examination of the 
fluorograms of these authors reveals that many of the depleted 
proteins are very minor components of the total population. These 
results support the idea that changes in moderately abundant proteins 
may not be detectable using two-dimensional gels. However, Higgins et 
al. (1981) propose that the action of testosterone in this system is 
the stabilisation of the messengers or proteins, rather than the 
control of transcription, so that one cannot draw too close a parallel 
between the uterine and seminal vesicle systems.
There is further support for our explanation, in that the proteins we 
expected to identify by cofractionation, namely, hnRNP particle 
proteins, non-histone chromatin proteins, and to a lesser extent 
ribosomal proteins, were very difficult to detect in labelled uterine
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samples. If these proteins are representative of moderately abundant 
proteins then our inability to detect them supports the contention 
that we were only detecting abundant uterine species efficiently. Thus 
it is clear that efficient analysis of oestrogen-induced changes in 
the synthesis of uterine proteins must depend on a more sensitive 
assay. This could employ more efficient fractionation, further 
subfractionation of proteins of higher specific activity, or cell-free 
translation by fractionated cell-type polysomes. Preliminary results 
using the latter approach did reveal a more marked difference between 
4 hour- and 12 hour-stimulated epithelia (Figs. 14 & 15, following 
page 83).
A method which has been used to increase the detection of minor 
components (particularly IP) is three-dimensional gel electrophoresis 
(Skipper et al., 1980), This incorporates non-denaturing gels as the 
first separation and the stacking of several corresponding gel 
segments onto a single isoelectric focussing gel, followed by the 
final SDS slab gel. This is a time-consuming procedure and does not 
simultaneously analyse all the components in a single protein map. The 
non-denaturing gel also allows protein-protein interactions which may 
cause the distribution of a single component between several segments 
of the gel. This could confuse the final analysis especially if minor 
components participate in such interactions.
The cofractionation studies reported in the results section were only 
partially successful. Whilst confirming the migration positions of 
proteins thought to be actin and IP, the labelled species comigrating 
with IP and hnRNP particle proteins were so faint in samples from 
hormone-treated animals that comparison with control samples would not 
have been convincing.
1U4
Ribosomal proteins were shown to be synthesised in cell-free 
translation assays using messengers from both control and 4 hour 
hormone treated rats. The small differences between these two samples 
and the faintness of the spots after long exposure times, supports the 
observation that ribosomal protein synthesis is not stimulated until 8  
to 12 hours after treatment with oestradiol (Merryweather & Know 1er, 
1980) .
No labelled proteins could be seen comigrating with non-histone 
proteins. A possible exception is actin which was present on the gel 
of chromatin proteins and is a major uterine species. There is 
controversy as to whether actin is, or is not, a nuclear protein 
species (Comings & Harris, 1976), but it has been reported to be a 
constituent of non-histone chromosomal proteins in a wide variety of 
organisms. These include the myxomycètes Physarum & Dictyostelium, 
HeLa cells and rat liver (Douvas et al., 1975; Peterson & McConkey, 
1976; Fukui & Katsumaru, 1980). It has been suggested that actin and 
other contractile proteins found in the nucleus may function in the 
condensation of chromatin and chromosomes (LeStourgeon et al., 1974, 
1975). Fukui & Katsumaru (1980) demonstrated that DMSO induced the 
formation of huge bundles of actin filaments from the nuclear matrix 
in Dictyostelium nuclei and suggested their involvement in changes of 
nuclear shape and possibly of chromatin structure. It has also been 
suggested that microfilaments as well as microtubules are involved in 
chromosome movement during mitosis (reviewed, Fukui & Katsumaru,
1980).
Actin shows no increase in response to oestrogen in the uterus, but 
this does not preclude its involvement in early nuclear events
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initiated by the hormone. The nuclear matrix is a residual structural 
element, remaining after nuclease digestion, salt extraction and 
detergent treatment of nuclei. Actin is most probably a constituent of 
this, which suggests a number of ways in which it might be involved in 
the oestrogenic response. Firstly it may participate in specifying the 
salt-resistant oestrogen binding sites, reported by Barrack's group to 
reside in the nuclear matrix (Barrack et al., 1977; Barrack & Coffey,
1980). Secondly there is growing evidence that the nuclear matrix 
plays an important role in transcription and replication. DNA is 
arranged in the cell nucleus in supercoiled loops which are attached 
by their ends to this matrix (Cook & Brazell, 1976).
A number of actively transcribing gene sequences and virtually all of 
the rapidly labelled RNA have been isolated in association with this 
skeleton and a similarly isolated structure known as the nuclear cage 
(Herman et al., 1978; Miller et al., 1978; Jackson et al., 1981). 
Ultra-violet light-induced crosslinking studies in HeLa cells have 
shown that hnRNA sequences are specifically associated to the matrix 
via two of the particle proteins. These proteins are those tightly 
associated to the FNA in hnRNP particles (van Eekelen & van Venrooij,
1981). The genes for ribosomal RNA in rat liver, SV40 in transformed 
mouse cells, beta-globin in duck erythrocytes and Alu family sequences 
in human tissue culture cells have all been isolated in association 
with the nuclear matrix (Pardoll & Vogelstein, 1980; Nelkin et al., 
1980; Maundrell et al., 1981; Small et al., 1982).
The best evidence, however, for the specific requirement for matrix 
attachment during transcription, comes from a recent study on the 
ovalbumin gene (Robinson et al., 1982). Ovalbumin gene sequences are 
preferentially associated to the nuclear skeleton in the target
-LUO
tissue; chick oviduct, but are not, in a non-target tissue; liver. A 
control probe complementary to beta-globin gene sequences shows that 
non-transcribed sequences are not associated to the matrix in oviduct 
nuclei.
Thus all of the proteins which are candidates as key intermediary 
proteins; non-histone chromosomal and matrix proteins, hnRNP particle 
proteins, contractile proteins, and also the different types of 
receptor, may all interact in the process of gene transcription.
Actin and the other contractile proteins are also found in large 
amounts in the cytoplasm, in a variety of skeletal filaments and 
matrices. These extend throughout the cell and have many functions 
including maintenance of structure and shape, cell mobility and 
surface attachment. If actin does interact with oestrogen or its 
receptors, this could help to explain the existence of type II 
cytoplasmic binding sites, and the numerous reports of oestrogen- 
specific sites in the membranes and cytoskeletons of various cells 
(Pietras & Szego, 1979; Puca et al., 1981; Puca & Sica, 1981). There 
is some variation in the forms of actin found in the different cell 
types which may result from these forms having different functions or 
locations in the different cells.
Although it turns over rapidly in the uterus, actin is not however, 
one of the small number of uterine proteins specifically induced 
between 2 and 4 hours of oestrogen stimulation. The attempts in this 
study to identify these have succeeded only in showing that two 
proteins of MW about 40,000 and 20,000 are consistently induced early 
after oestrogen administration. There is no evidence that these are 
the key intermediary proteins we set out to investigate. The latter
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may be at too low a level to detect by the methods used.
It seems likely that many of the problems of the control of gene 
expression in hormone-responsive tissues can only be resolved using 
the elegant and sensitive tools of recombinant DNA technology. Cloned 
cDNAs and genomic sequences have so far been used to show that 
increased levels of mRNA mirror increases in the cellular content of 
many hormone-induced proteins (PaImiter, 1973; Parker & Scrace, 1978). 
They have been used to show that the protein induction can result from 
increased transcription of the specific genes (Palmiter, 1973; Ryffel 
et al., 1977; Swaneck et al., 1979a), and other studies have indicated 
that hormones can influence the stability and turnover of specific 
mRNA species (Guyette et al., 1979). More recently, cloned genes have 
been used to show that hormones produce their effects by interacting 
with the DNA close to the activated genes. Two systems have been 
particularly informative in this respect. Both these systems involve 
glucocorticoid-inducible genes - rat liver o^ p-globulin and the mouse 
mammary tumour virus (MMTV) ENA, Genomic DNA coding for o^ ju-globulin 
and cDNA to MMTV RNA were each cloned by different research groups 
into vector plasmids carrying marker enzyme genes, and were used to 
transfect host cells lacking these enzymes. Selection of transformed 
cells led to the isolation of clones carrying the ju-globulin gene 
and MMTV cDNA (Kurtz, 1981; Hynes et al., 1981; Buetti & Diggelman,
1981). The host cells used in both these sytems contained 
glucocorticoid receptors and these hormones were shown to induce the 
expression of the cloned DNAs. This showed that the DNA specifying 
their response was included in the cloned sequences.
The MMTV study has progressed further using chimaeric plasmids 
constructed from the terminal repeat sequences of the MMTV gene and a
lUb
cloned marker gene specifying dihydrofolate reductase which is not 
normally under glucocorticoid control. Cells transformed with such a 
plasmid acquire dexamethasone-inducible expression of dihydrofolate 
reductase (Lee et al., 1981), thus showing that in this system, 
hormonal responsiveness is associated with the long terminal repeat of 
the viral DNA.
The system of the oestrogen-inducible uterine proteins is more complex 
since there are no known products. This makes the cloning of 
individual DNAs c o m p l e m e n t a r y  to single specific messengers 
impossible, and the making of specific probes difficult. Some recent 
progress has been made in this laboratory in cloning some of the DNA 
complementary to the polyadenylated messengers appearing in the 
polysome population between 2 and 4 hours of oestrogen administration. 
The isolation of these was described at the end of section 1.5.3, and 
these should include the sequences coding for at least some key 
intermediary proteins. With such cloned sequences, it should be 
possible to quantify and study oestrogen-induced transcription and to 
trace more precisely the kinetics of their appearance and processing 
in the nuclear and cytoplasmic ENA populations.
Notwithstanding the contribution of genetic manipulation to the study 
of hormone action, it cannot at the moment answer all problems. Thus 
although one might identify, through cloned sequences, many species of 
uterine mENA induced by oestrogen it is technically very difficult to 
use an mRNA or a cloned derivative of it to identify a protein. It is 
the proteins however, on which the hormonal response of a cell 
depends, and it is clearly important to identify them. Also, it is 
unlikely that all the responses of a cell to a steroid hormone will be 
at a transcriptional level and it would be of tremendous advantage in
luy
studying the effects of oestrogen on possible post-transcriptional and 
translational control of gene expression in the uterus, if induced 
proteins and antibodies to them were available as probes. For these 
reasons it is unfortunate that the work described in this thesis has 
not provided a more usable indicator of oestrogen-induced growth.
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